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Abstract

The biophysical mechanisms governing receptor diffusion and force generation
during efferocytosis are poorly understood. The diffusion of CD93, a putative efferocytic
receptor, was studied in the membrane of human monocytes and Chinese Hamster Ovary
cells using single particle tracking. We found that 70% of CD93 molecules were confined
in compartments (mean confinement radius of 242 ± 7 nm) consistent with actin corrals,
while 26% moved freely (mean diffusion coefficient of 0.07 ± 0.01 µm2/s). Cage effect
analysis showed short-lived caging of free CD93 and longer-lasting caging of confined
CD93, with smaller corrals resulting in stronger caging. The motion of both free and
confined CD93 was found to be consistent with a subdiffusive continuous time random
walk, suggesting that CD93 diffusion is affected by several processes on a range of length
and time scales. We also sought to develop a total internal reflection fluorescence
compatible traction force microscopy substrate intended for use in force characterization
in frustrated efferocytosis. TIRF-compatible silicone substrates of a uniform thickness
were manufactured successfully, but were found to be unsuitable for reliable force
measurements due to their susceptibility to the non-specific adsorption of quantum dots.

Keywords: efferocytosis, CD93, single particle tracking (SPT), anomalous diffusion, cage
effect analysis, continuous time random walk (CTRW), traction force microscopy (TFM),
total internal reflection fluorescence microscopy (TIRF), substrates.
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Chapter 1
Introduction and Literature Review
1.1 Introduction of Concepts and Overview of Chapter
The plasma membrane of a living cell consists of a protein-rich phospholipid
bilayer that separates the inner contents of a cell from the extracellular matrix 1–3. Protein
molecules embedded in the membrane, as well as its phospholipid constituents, play an
integral role in mediating the cell’s interactions with its environment. Membrane-based
processes, such as the initiation of intracellular signaling cascades in response to an
external stimulus, the transport of material across the bilayer through protein channels, the
migration of a cell along a surface, and the engulfment of extracellular matter, are all
influenced by the mobility of the participating proteins and lipids4. The diffusion of many
membrane molecules, however, remains uncharacterized, despite its crucial role in
regulating the aforementioned interactions5. The forces exerted by a cell on its environment
in many of these processes are likewise poorly understood6. The overall goal of our
research was to characterize the diffusion of CD93, a specialized transmembrane protein
involved in efferocytosis, while simultaneously developing a novel method for the
characterization of the forces involved in this process7,8.
Efferocytosis is the removal of dying cells within the body by other cells capable
of binding to, engulfing and processing such apoptotic cell remnants9,10. It differs from but
shares many biophysical characteristics with phagocytosis, a more general process
characterized by the recognition, internalization and destruction of large particles more
than 0.5 μm in size11. Whereas phagocytosis is only performed by specific cells, including
macrophages, dendritic cells and neutrophils – the so-called “professional phagocytes”,
efferocytosis is carried out by numerous cell types11,12. The primary role of efferocytosis is
to maintain homeostasis within the body13,14. The failure of efferocytosis to prevent the
release of the contents of dead cells into the extracellular matrix can lead to inflammation15.
Tissue inflammation, which normally results from an infection, exposure to toxins, or
physical stress, is characterized by swelling, redness, pain and fever. Defects in
efferocytosis also contribute to the development of autoimmune disease, wherein the body

2

attacks its own cells and tissues16. The primary role of phagocytosis, conversely, is to
defend the body against foreign infectious agents11. In older literature, however,
efferocytosis has simply been referred to as the phagocytosis of apoptotic cells.
In both processes, the forces exerted by the cell on the particle during its
internalization have been suggested to push the plasma membrane protrusions around the
particle and then to pull the enveloped particle into the cell6. The cellular mechanisms
responsible for the generation of such forces are largely unknown. The transduction of
forces to the engulfed target is thought to involve receptor proteins, responsible for
anchoring the target to the cell during internalization and inducing downstream signaling
pathways17,18. How freely-diffusing receptors could transduce such forces instead of being
displaced themselves is, however, unclear. The diffusion of membrane molecules,
including phagocytic receptors, has previously been shown to be regulated by the actin
cytoskeleton, a protein-based cortical mesh that lines the inner surface of the cell
membrane and helps the cell to maintain its shape3,17,18. Furthermore, particle engulfment
is thought to depend on successful cytoskeletal remodeling17,18 Understanding the
relationship between receptor diffusion, the cytoskeleton and the mechanisms of force
generation in the context of efferocytosis forms the long-term aim of our research.
In Section 1.2, we introduce the methods previously employed to characterize
membrane receptor diffusion and to study the forces involved in the engulfment of
particles. The specific objectives of this thesis are then presented. The rest of this chapter
is comprised of a literature review, providing detailed motivation for the objectives of this
study. Section 1.3 presents an overview of efferocytosis, and is followed by a discussion
of the putative mechanisms of force-generation in phagocytosis in Section 1.4. A general
introduction to receptor diffusion in the context of the picket fence membrane model is
given in Section 1.5. A summary of previously conducted research on CD93, the putative
efferocytic receptor studied in this work, is left for Section 1.6.

1.2 Forces and Diffusion in Efferocytosis: Methods of Study and Project Objectives
The relationship between receptor diffusion and the mechanisms of force
generation in efferocytosis remains poorly

understood.

Techniques

traditionally

employed to study the forces involved in phagocytosis include optical tweezers, atomic
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force microscopy (AFM) and micropipette aspiration19–22. These methods are, however,
unable to provide a real-time evolving map of the differential forces exerted by the cell on
the captured target. Traction force microscopy (TFM) is a technique that has been used to
characterize the forces exerted by the cell on its environment in the context of cell adhesion
and cell migration23–25. TFM may prove to be a useful tool for investigating the forces
involved in phagocytosis and efferocytosis, as it is capable of producing a map of the
associated cellular tractions. Furthermore, total internal reflection fluorescence (TIRF)compatible TFM substrates may enable us to probe the mechanisms responsible for force
generation with photoactivatable fusion proteins26,27. Receptor mobility, conversely, is best
assessed using single particle tracking (SPT) methods. In this project, SPT is first employed
to characterize the diffusion of unengaged CD93 molecules with epifluorescence
microscopy7. The development of TIRF-compatible TFM substrates is then pursued, with
the long-term goal of simultaneously characterizing forces and receptor diffusion in a
model of frustrated efferocytosis.
Forces in Particle Engulfment: Classical Methods of Study
To date, common methods for the study of forces involved in the engulfment of
particles include optical tweezers, atomic force microscopy and micropipette
aspiration19,20,28. In micropipette aspiration, a small glass pipette with a known suction
pressure is used to take up a cell21. By tracking the leading edge of the cellular surface
during this process, one can extract information about the cell’s mechanical properties. In
the context of phagocytosis, Herant at el. have used micropipettes to measure the changes
in cortical tension of neutrophils during particle engulfment19,20. This technique, however,
is not suitable for all cell types29. It is best applied to larger and more deformable cells, as
changes in curvature can damage the cell membrane. It is also difficult to account for
friction between the cell and the micropipette wall29. These disadvantages and the limited
information that micropipettes provide make them minimally useful for studying the forces
involved in particle internalization.
Optical tweezers are a minimally-invasive, contact-free force spectroscopy
technique30. Optical tweezers use a highly-focused laser to generate a strong electric field
gradient in the region around the narrowest point of the beam31. Dielectric particles, which
get directed to the center of the beam along this gradient, are said to be optically trapped.
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For small particle displacements, the optical trap behaves like a Hookean spring31. Optical
tweezers have been used to bring targets in contact with the phagocytic cell, to characterize
the retentive forces of target-bound filopodia, to investigate membrane tension and to probe
intracellular morphology30,32–39. Tam et al. and Neto et al. have utilized optical tweezers to
manipulate the position of living fungal pathogens and parasites32,34. Dual optical traps
have been applied to study the engulfment of ligand-coated beads by suspended
neutrophils37. Kress et al. and Flannagan et al. used traps to measure the retraction forces
of actin-driven protrusions following particle capture35,36. Wei et al. used optical tweezers
to calculate the forces mediating the binding of LPS to macrophage cell surface receptors39.
Despite the versatility of optical traps, this technique has a number of distinct
problems28. First, optical tweezers lack specificity, since they will trap any dielectric
impurities found within the range of the trap. Second, the forces generated by optical traps
are on the order of 0.1 − 100 pN, which are less than the forces involved in the engulfment
process. Finally, use of the tweezers may result in local heating and photo-damage. The
limited specificity and trap strength of optical tweezers can be overcome with magnetic
tweezers, which only act on magnetic particles and can exert forces on the order of 1 nN28.
Magnetic tweezers are, however, more difficult to implement than optical tweezers28.
Neither of these techniques is capable of yielding a detailed description of the forces in
play during engulfment.
AFM provides an alternative means of performing force spectroscopy. In AFM, a
piezoelectric scanner is used to control the position of a cantilever with a sharp tip, which
scans the investigated surface28. During the scan, interactions between the tip and the
surface cause the cantilever to be deflected in a manner that reflects the force of these
interactions. In the imaging mode, information obtained by tracing the cell contours allows
one to visualize the plasma membrane microstructure. Accordingly, AFM has been used
to visualize distinct features of the plasma membrane during the internalization of cancer
cells and fungal pathogens40,41. AFM scans of living cells are dominated by the
cytoskeleton underlying the soft and deformable membrane, while gently-fixed cells
exhibit more distinct membrane features41.
Performing force spectroscopy with AFM typically requires tip functionalization
with a specific ligand42. The interaction force can then be measured as a function of
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distance, by first bringing the tip into close contact with the sample and then gradually
retracting it. Unfortunately, studies applying AFM to characterize the forces of target
internalization are few in number. Li et al. have used AFM with an antibody-functionalized
tip to characterize the affinity of ligand binding for Fcγ receptors on macrophage cells 43.
The Young’s modulus of macrophages was also determined by the same group, using
similar methods40. The chief drawbacks of AFM spectroscopy are its limited range of
forces and limited applicability to living cells42. AFM measurements of live cells can easily
disrupt their membrane structure and have been reported to cause the cells to detach or
move41,42. The low temporal resolution of conventional AFM systems, on the order of
seconds, is insufficient for capturing the nuances of the process of particle engulfment.
Forces in Particle Engulfment: Traction Force Microscopy
Traction force microscopy (TFM) is a technique for measuring the forces exerted
by a cell on the environment underneath, originally developed to study the forces involved
in cell migration23–25. The cell is placed on a functionalized, elastic substrate that contains
embedded fluorescent particles, as illustrated in Fig. 1.1. As the cell engages the substrate
surface, the forces exerted on the substrate by the cell result in local deformations of the
matrix and cause the embedded particles to shift. The particle displacements, measured by
tracking the beads, are then used to numerically calculate a map of the associated traction
forces. The analysis is quite complex and a number of computational methods exist for the
solution of this ill-posed, inverse problem44–46. TFM has been used extensively to
characterize the forces and force-generating mechanisms in the migration and adhesion of
various cell lines, including fibroblasts, keratinocytes and neutrophils24,25,47–50. It has been
applied to study the effects of shear stress on cell migration, to investigate the tugging
forces in cell-to-cell adherens junctions, and to assess the effects of substrate rigidity on
cell migration, growth and apoptosis51–54. To our knowledge, TFM has not been used to
look at force generation in phagocytosis, efferocytosis or related internalization
mechanisms such as endocytosis and macropinocytosis.
In studies of frustrated phagocytosis, receptors on the surface of the cell are
engaged by a ligand-functionalized glass surface55–57. The cell is then imaged while it
attempts to engulf an essentially infinite target, and the entire area of contact becomes a
phagocytic cup. It is therefore logical to suppose that frustrated engulfment may similarly
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Figure 1.1. The principles of Traction Force Microscopy (TFM). A cell
migrating on a functionalized, elastic substrate exerts traction forces on the substrate
to propel itself forward. In response, changes in the positions of fluorescent beads
embedded in the substrate reflect the resulting local substrate deformations. The
particle displacements can then be used to determine the underlying forces of cell
migration or other processes.

7

be achieved using functionalized TFM substrates. This would allow for the real-time
tracking of the associated traction forces and the study of the responsible cellular
mechanisms. Traditionally, they have been probed with chemicals that disrupt actin and
myosin dynamics, such as cytochalasin D and blebbistatin36,58. Unfortunately, the
wide-spread, non-specific effects of such agents on the cell leave a more targeted method
to be desired59. A novel photo-dimerization system, used in conjunction with TIRF
microscopy, may allow for the selective recruitment of biological regulators of cytoskeletal
remodeling to the site of phagocytosis26.
The photodimerization system, described by Kennedy et al. and presented in Fig.
1.2, consists of two proteins, CIBN and Cry2PHR, that undergo reversible dimerization
upon light exposure26. According to Kennedy et al., cytosolic Cry2PHR can be reversibly
recruited to membrane-anchored CIBN when excited by a 488 nm light pulse. Total
internal reflection fluorescence microscopy, described in detail in Chapter 4, allows for the
selective excitation of molecules in a thin region of the cell adjacent to the plasma
membrane, where the cell contacts the coverslip60–62. Idevall-Hagren et al. have shown that
TIRF-excited cytosolic Cry2PHR can be selectively recruited to a specific, TIRFilluminated membrane region at the bottom of the cell27. They were able to use this
photodimerization system to target Cry2PHR-fused 5’-phosphatase molecules to this
membrane area alone, dephosphorylating the lipids therein. A similar approach can be
utilized to locally disrupt the mechanisms of force-generation by recruitable regulators of
cytoskeletal remodeling, such as cofilin, while the cell is engaged by the substrate. Such a
set-up, however, necessitates the development of TIRF-compatible TFM substrates.
A good TFM substrate must meet a number of requirements. For the extracted
forces to be accurate, the Young’s modulus, Poisson ratio and stress-strain behavior of the
matrix must be known23. The substrate must be soft enough for the forces to result in
significant deformations and stiff enough for the strains to fall within the linear response
regime. It must also be amenable to experiment-specific functionalization for covalent
attachment of the phagocytic/efferocytic ligands, have a uniform thickness, and be
sufficiently transparent for fluorescent microscopy measurements of the positions of
embedded particles and fluorescently-tagged effectors in the cells. Substrates meeting
these criteria, most commonly used for TFM, include polyacrylamide (PAA) and
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Figure 1.2. Photodimerization recruitment system. The photodimerization
system consists of two proteins, Cry2PHR and CIBN. Upon exposure to 488 nm
light, Cry2PHR changes its conformation, allowing it to reversible dimerize with
CIBN. In this schematic, CIBN is membrane-bound, while Cry2PHR is found in the
cytosol. A protein of interest is fused to Cry2PHR. When a portion of the cell is
illuminated using TIRF microscopy, Cry2PHR molecules in that region are
activated and selectively recruited to the illuminated portion of the cell membrane.
The protein of choice, fused to Cry2PHR, is thus recruited to the membrane.
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polydimethylsiloxane (PDMS) gels23. Their properties are reasonably well-known and they
can be used for measuring forces over a range of magnitudes due to their tunable stiffness.
Their Young’s moduli depend on the amount of added cross-linker and the curing
temperature. Patterned TFM substrates, made using micro-printing techniques, are an
active area of development63.
In addition to the above requirements, TIRF-compatible TFM substrates must meet
one additional criterion - an index of refraction greater than that of the cells and sufficiently
close to that of glass (approximately 1.5), in order to ensure that total internal reflection
occurs at the substrate-cell boundary, rather than at the glass-substrate boundary. Neither
PAA nor PDMS substrates meet this requirement. In TIRF microscopy, a beam of light
travelling through a glass coverslip of a high refractive index undergoes total internal
reflection when reaching the low-refractive index region of the cells60,61. The generated
evanescent wave then excites the fluorophores in a thin, 50-250 nm region of the cell
adjacent to the coverslip. For TIRF-compatible TFM, the substrate must be placed between
the coverslip and the cells. Total internal reflection must then occur between the cell and
substrate layers. The refractive indices of PAA and PDMS gels are, however, too low, and
would result in total internal reflection between the substrate and the coverslip. The
successful use of high refractive index, optical-grade silicone substrates for simultaneous
TFM and TIRF has been reported by two lab groups64–66.
Receptor Diffusion: Single Particle Tracking Methods
Receptor diffusion during efferocytosis can be characterized using single particle
tracking (SPT) methods67. The receptor of interest is first labelled with a fluorescent protein
or quantum dot at a density high enough to yield sufficient data and low enough to avoid
overloading the chosen particle tracking algorithm. The location of each molecule in each
image is then determined. When the light emitted by an ideal, infinitely-small point source
passes through the microscope objective, it yields a corresponding diffraction pattern in the
image plane, owing to the limited focusing capacity of the lens68. This pattern can be
described by a point spread function (PSF), with a central Gaussian intensity profile. By
fitting a Gaussian kernel to the point spread function of each fluorophore, their positions
can be estimated with sub-pixel accuracy68,69. Once the receptor locations in each frame
are known, the real challenge of SPT lies in determining the track of each molecule from
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frame to frame while accounting for the merging, splitting and disappearance of particles.
An algorithm developed by Jaqaman et al. in 2008 has been reported to perform this task
in an efficient, globally-optimized manner67.
Single particle tracking has been employed to study membrane receptor diffusion
with epifluorescence and TIRF microscopy alike55,58,70–73. Epifluorescence microscopy
images include the fluorophore signals from an entire cell. TIRF microscopy has the
advantage of eliminating background fluorescence, focusing on a thin region near the
membrane. While TIRF microscopy therefore results in more efficient particle tracking due
to a relative absence of background fluorescence, it is limited to imaging the basal surface
of the cell. Epifluorescence microscopy, conversely, allows for the particle tracking of
molecules in any cell portion. Several receptors with a role in particle engulfment have
been studied using SPT. Andrews et al. and Spedier et al. have used TIRF microscopy to
analyze the diffusion of Fcε molecules58,74. Jaqaman et al. and Jaumouille et al. have
studied the mobility of CD36 and FcγRIIA receptors respectively, utilizing SPT in
conjunction with epifluorescence microscopy55,70. Notably, Jaumouille et al. have used
SPT techniques to track the diffusion of free FcγRIIA receptors while the cells were
engaged in frustrated phagocytosis on ligand-coated glass coverslips55. It is thus reasonable
to suggest that SPT techniques could also be employed to study receptor mobility in cells
engaged by ligand-functionalized TFM substrates.
Project Objectives and Summary of Work
The relationship between receptor diffusion, the cytoskeleton and the mechanisms
of force generation in the context of efferocytosis is poorly understood. The overall goal
of this thesis was to characterize the diffusion of CD93, a potential efferocytic receptor,
while simultaneously developing a novel method for the characterization of forces involved
in efferocytosis8. As discussed in Section 1.6, CD93 was chosen as the target molecule of
study based on its putative roles in efferocytosis and its physiological relevance8. The two
objectives of this work were as follows:
1) To characterize CD93 mobility in resting monocyte cells, comparing the modes of
its diffusion before and after the cells are treated with a CD93 shedding-inducing
agent.
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2) To develop a total internal reflection fluorescence (TIRF)-compatible traction force
microscopy (TFM) substrate with the long-term goal of simultaneously studying
forces, force-generating mechanisms and the diffusion of CD93 and other
efferocytic receptors in a model of frustrated efferocytosis.
The first of these objectives is addressed in Chapters 2-4. The second objective is discussed
in Chapter 5.

1.3 Overview of Efferocytosis
Efferocytosis is the process of apoptotic cell clearance in which cells undergoing
programmed cell death are removed from the tissue without triggering an inflammatory
response9. A term coined by Henson et al. in 2001, efferocytosis comes from the Latin
word “effero” or “to carry to the grave” and describes the recognition, engulfment and
internal processing of apoptotic cells and cell remnants by the efferocytic cell types that
they recruit9,10. The functions of efferocytosis are manifold, ranging from ongoing
maintenance of homeostasis and the prevention of undue inflammation to the remodeling
of embryonic tissues and clearance of intracellular infections13,14,75. The failure of
efferocytosis to efficiently clear away apoptotic targets is associated with the development
of immune system-mediated diseases, such as atherosclerosis and systemic lupus
erythematosus76–79. The study of the biophysical mechanisms underlying efferocytosis may
therefore not only illuminate our understanding of this process, but also identify potential
therapeutic targets for the treatments of associated pathologies.
Billions of cells undergo apoptosis daily as part of the normal cell turnover within
the body10,16. In general, cells become apoptotic in response to both intrinsic and extrinsic
death signals15. Intrinsic cues include DNA damage, hypoxia, the absence of growthassociated signals, or an infection. The extrinsic pathway is induced by specific receptors
and cytokines (growth factors), as well as by effector molecules secreted from some
immune cells80–82. Although the extrinsic pathway is triggered by extracellular stimuli,
while the intrinsic pathway is induced by intracellular stress, both pathways converge on a
shared signaling cascade that induced the death of the cell.
Once apoptosis is initiated, it proceeds in a highly organized manner. The cellular
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metabolism shuts down, the cell shrinks, its DNA is fragmented and its contents are
systematically disassembled15. Throughout this process, the cell membrane remains intact,
but the cell fragments into smaller apoptotic bodies, which bud off the membrane in an
actin-myosin contraction-assisted process known as “blebbing”83. In contrast, in
unregulated cell death, termed “necrosis”, the integrity of the cell membrane is
compromised following an infection, exposure to toxins, or mechanical stress. In such
cases, the cellular contents are released into the extracellular environment through holes in
the cell membrane, resulting in a damaging immune response15. In absence of efficient
clearance, apoptotic cells and bodies likewise spill their pro-inflammatory contents in a
process known as “secondary necrosis”84. Under normal conditions, however, the apoptotic
bodies are quickly removed by neighboring efferocytic cells in an immunologically silent
manner.
Cells with efferocytic capacity include immune cells such as macrophages,
monocytes and dendritic cells, as well as non-immune cell types such as fibroblasts and
epithelial cells12. In general, efferocytosis may be thought of as a specialized form of
phagocytosis, a process characterized by the receptor-mediated recognition, engulfment
and destruction of large particles more than 0.5 μm in size by professional phagocytes11.
Regardless of cell type, efferocytosis proceeds through four generalized stages:
recruitment, recognition, engulfment and post-processing. In the first stage, the apoptotic
cells release soluble “find-me” signals to recruit the efferocytes to the site of apoptosis in
a timely fashion82. Such recruitment ensures that the apoptotic cells are cleared away prior
to becoming necrotic. This step is especially critical when dealing with a large number of
apoptotic cells, as may occur at sites of tissue injury. The find-me signals themselves are
chemoattractant molecules, capable of initiating the directional migration of chemotaxiscompetent cell types up their concentration gradient. As such, factors influencing the
effectiveness of a particular molecule as a find-me signal include its solubility, initial
concentration and half-life.
The most-well researched find-me signal is a soluble sphingolipid, sphingosine-1phosphate (S1P), made from a related membrane lipid, sphingomyelin, by virtually all
apoptotic cells85. S1P is capable of recruiting far-away efferocytes due to its long half-life
and has been established to induce migration at physiologically-relevant concentrations85.
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Fractalkine, a membrane-bound protein involved in mediating cell adhesion, has also been
suggested to be a find-me signal in its cleaved (soluble) form86. Other potential signals
include adenosine triphosphate (ATP) and uridine triphosphate (UTP), nucleotides that are
released in limited quantities from apoptotic cells87. The short extracellular half-lives of
ATP and UTP, however, likely restrict their roles as find-me signals to nearby efferocytic
cells88. Lysophosphatidylcholine, a phospholipid present at a low concentration in the cell
membrane, has also been proposed to act as a find-me signal when released from the
mebrane89. Whether the investigated find-me signals act independently of each other, or in
a synergistic fashion, is yet to be determined.
In the second stage of efferocytosis, distinct markers present on the surface of
apoptotic cells are recognized by specialized receptors on the recruited efferocytes82. These
apoptotic cell markers, known as “eat-me” signals, are absent from normal, viable cells
and appear on apoptotic cell plasma membrane as a consequence of the apoptosis process.
The apoptotic cell membrane differs from that of a normal cell in phospholipid
composition, levels of lipid and protein glycosylation and oxidation, extent of lipid
composition asymmetry between the inner and outer leaflets, and surface charge13. These
differences form the basis of most of the eat-me signals. The most well-studied eat-me
signal is the phospholipid phosphatidylserine (PS), which is normally found only on the
inner leaflet of the plasma membrane, but is flipped to the outer leaflet in response to early
apoptosis-associated signaling90. Other eat-me signals include protein and glycan groups
normally restricted to the intracellular membranes of the Golgi and the endoplasmic
reticulum (ER)10,91. As these intracellular membranes are delivered to the cell membrane
to replenish the membrane lost during apoptotic blebbing, eat-me signals such as
calreticulin, an ER chaperone protein, and N-acetylglucosamine, a Golgi-restricted
monosaccharide derivative of glucose, are exposed on the outer cell surface92,93.
The formation of the “engulfment synapse” between the eat-me signal and the
efferocytic receptor may be formed by direct interactions of efferocyte receptors with eatme signals, or may require opsonins, bridging molecules found in the extracellular space
that serve to link the eat-me signals to their cognate receptor on the efferocyte13. Several
receptors on the surface of efferocytes are known to recognize their eat-me signals directly.
CD91 is a receptor that binds to calreticulin on the surface of dying cells92. Stabilin-2, BAI1
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and TIM4 bind directly to PS, though TIM4 may require the β1 integrin as a co-receptor to
initiate internalization94–97. The scavenger receptor CD36 can recognize and bind to
modified lipids, such as oxidation-derived derivatives of PS and phosphatidylcholine98.
Efferocytic receptors of the TAM family, which includes Tyro-3, Axl and MerTK, require
specific opsonins, such as protein S and Gas6, which link the receptors to PS on the
apoptotic cell surface99. Similarly, αvβ5 and αvβ3 integrins bind to PS through milk fat
globule epidermal growth factor (EGF) factor 8 (MFG-E8)100. Potential binding partners
of other efferocytic receptors, such as CD93, are currently under investigation101,102. The
significant number of efferocytic receptors discovered up to date suggests that their
function may be redundant or synergistic in nature.
Once the apoptotic cell is recognized by the efferocyte, engulfment begins. The
signaling responsible for initiating internalization is receptor-specific and, for most
efferocytic receptors, is yet to be determined. The underlying biophysical mechanisms of
engulfment, however, are likely to be receptor-independent. A detailed discussion of the
physical nature of these mechanisms in relation to the more general process of phagocytosis
is presented in Section 1.4. The universality of these mechanisms, however, is supported
by the observation that a number of proposed receptor signaling pathways all converge on
the Rho-family GTPases Rac1, Cdc42 and RhoA, which are small guanine nucleotidebinding proteins responsible for cytoskeletal remodeling103.
The signaling pathways of several efferocytic receptors have been shown to involve
direct or integrin-mediated activation of Rac1 and Cdc4294,96,97,104,105. Both Rac1 and
Cdc42 can activate the Arp2/3 protein complex, which then induces actin polymerization
and the formation of branched actin networks106. Since much of the actin cytoskeleton is a
cortical mesh that lines the inside of the cell directly beneath the cell membrane, this
dynamic cytoskeletal re-arrangement exerts a local outwards force on the membrane,
resulting in the formation of membrane protrusions that extend around and eventually
engulf the apoptotic cell13. The third Rho-family GTPase, RhoA, drives the contraction of
actin, mediated by the phosphorylation of the myosin light chain107. Since it promotes cell
contraction, RhoA activation has been shown to prevent membrane protrusions from
forming, while the loss of RhoA activity has been associated with enhanced
engulfment108,109. Nonetheless, it can be suggested that RhoA-mediated contraction may
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be important for pulling the membrane-enveloped apoptotic body into the cell.
In the terminal stage of efferocytosis, the engulfed apoptotic cells are then digested
into their building blocks inside membrane-bound intracellular structures termed
efferosomes13. The mechanisms responsible for their processing are thought to include a
gradual acidification of the efferosome, the action of specific pH-dependent enzymes and,
ultimately, fusion with the lysosome organelle, which contains yet more hydrolytic
enzymes11,13. The engulfment and digestion of apoptotic cells results in an antiinflammatory profile for the efferocytic cell82. The secretion of anti-inflammatory
cytokines, i.e., the negative regulators of immune system function such as interleukin(IL)10 and transforming growth factor 𝛽 (TGF-𝛽), increases, while the production of proinflammatory, immune system-activating compounds, such as IL-12, IL-1𝛽 and tumour
necrosis factor 𝛼 (TNF-𝛼), is down-regulated82,110–113. Such a molecular profile then
promotes further efferocytosis and discourages tissue inflammation.
By clearing away the naturally-dying cells and preventing inflammation,
efferocytosis allows for the ongoing maintenance of homeostasis. The clearance of
apoptotic germ cells, for example, is critical for proper spermatogenesis and maintained
fertility114. In the eye, retinal pigment epithelium cells engulf the continually shed outer
segments of photoreceptor cells in a TAM-family-dependent manner, maintaining
photoreceptor renewal78,115. The lack of outer segment clearance in MerTK-deficient mice
and rats is associated with inherited retinal dystrophy116,117. Efferocytosis has also been
implicated in assisting with the clearance of infection, though some pathogens have coopted this process to promote survival75. Pathogens eliminated by efficient efferocytosis of
the infected, dying cells have been reported to include Mycobacterium tuberculosis,
Mycobacterium marinum and the influenza A virus118–121. Other pathogens, such as
Leishmania major, are suggested to use a “Trojan Horse” model of infection. In this model,
dying infected cells are engulfed by efferocytes, which then becomes the predominantly
infected cell type122–124.
From a clinical standpoint, defects in efferocytosis have been linked to the
development of inflammatory and autoimmune disease. In absence of clearance, apoptotic
cells undergo secondary necrosis and release their contents into the extracellular space84.
These contents include danger signals that promote a pro-inflammatory phenotype in
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neighboring cells, as well as enzymes and reactive oxygen species, which damage the
tissue. Their intracellular components are normally isolated from cells of the immune
system. The release of these molecules into the extracellular matrix, along with the
associated danger signals, cause them to be perceived as foreign to the body, activating the
adaptive immune response. Their combined effects thus lead to the production of selfreactive antibodies, which target the organism’s own tissues. The end result is the
development of a pathology similar to that of systemic lupus erythematosus (SLE), a bodywide autoimmune disorder that affects approximately 5 million people today79,125. Indeed,
it has been shown that individuals with SLE have a decreased number of macrophages in
their lymph nodes in vivo and that their macrophages have a decreased efferocytic ability
in vitro79,126–128. An SLE-associated phenotype was furthermore observed in mice deficient
in CD93, an efferocytic receptor of interest to our lab group (see Section 1.6)129.
Chronic inflammatory diseases associated with a failed efferocytic clearance within
specific tissues include atherosclerosis, inflammatory lung diseases and Type II diabetes84.
In early stages of atherosclerosis, macrophages in the blood vessel walls take up cholesterol
and oxidized lipids, routinely becoming apoptotic, and are efferocytosed by other nearby
macrophages. In the latter stages, however, these apoptotic “foam cells”, so called due to
their high fat content, are not cleared away, instead becoming a source of inflammatory
cell debris and the foundation of atherosclerotic plaque76,77,130,131. Increased numbers of
apoptotic cells in the lung tissue have been linked to chronic conditions such as cystic
fibrosis, asthma, and chronic obstructive pulmonary disease132. A failed efferocytic
clearance of apoptotic 𝛽-cells, responsible for producing insulin in the pancreas, has been
associated with increased obesity and Type II diabetes84,133. New insights into the
mechanisms underlying efferocytosis may therefore not only expand our fundamental
knowledge of this process, but could also lead to the development of better treatments and
management strategies for a number of associated inflammatory and autoimmune
disorders.

1.4 Mechanisms of Force-Generation in Phagocytosis
The biophysical mechanisms underlying apoptotic cell engulfment are yet to be
explored. The specific mechanisms governing efferocytosis, however, can be understood
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by studying the process of force-generation and particle internalization in the broader
context of phagocytosis11. Experimental observations of particle uptake by phagocytes
point to a possible role for several biophysical parameters, including particle size, shape,
orientation and rigidity, as well as membrane tension and availability in governing this
process134. Theoretical considerations of the general means by which actin polymerization
may drive the motion of the plasma membrane suggest two types of mechanistic models
for the “pushing mechanism” discussed in this section: Brownian Ratchet (BR) models and
Clamped Filament Elongation (CFE) models6. Several recent studies seek to provide a
mechanism by which membrane tension, bond density and other biophysical parameters
could mediate phagocytic engulfment, and attempt to account for the role of the actin
cytoskeleton in this process134. The relationship between actin-driven force generation and
receptor diffusion, however, remains poorly understood.
The lack of available literature necessitates a comparison with phagocytosis to
provide guidance on the possible biophysical mechanisms of efferocytosis. Unlike
efferocytosis, phagocytosis is a pro-inflammatory process and is crucial for the removal of
pathogens and the presentation of “antigens”, their so-called related foreign molecules, to
cells of the adaptive immune system11. It is a process usually carried out only by
professional phagocyte cells, including macrophages, dendritic cells and neutrophils, and
employs distinct signaling cascades to initiate internalization. Nonetheless, as a highly
conserved process, phagocytosis likewise relies on proteins that regulate actin
polymerization and myosin-motor activity to mediate engulfment11,135. Furthermore,
“efferocytosis” is a fairly-recently coined term; this process has previously been treated
simply as the phagocytosis of apoptotic cells. Apoptotic cell internalization and the
engulfment of large particles are therefore very likely to proceed in a mechanisticallysimilar manner and to be governed by the same biophysical parameters.
Biophysical Parameters of Phagocytosis
Factors influencing successful particle uptake have been reported to include particle
size, geometry, rigidity and orientation relative to the cell membrane of the phagocyte. In
2006, Champion and Mitragotri examined the role of target geometry in phagocytosis by
studying the engulfment of polystyrene particles of varying shapes by alveolar macrophage
cells136. They found particle shape and its orientation relative to the cell to be critical
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determinants of whether engulfment would take place. Elliptical disks, for example, were
internalized more efficiently when contacting the cell tip-first along their major axis.
“Worm-like” particles with a high aspect ratio were found to exhibit negligible uptake
when compared to spherical particles of equivalent volume137. Elongated nanoparticles and
polystyrene ellipsoids were shown to have enhanced attachment and reduced
internalization relative to spheres138,139.

Various studies have likewise reported a

dependence of engulfment efficiency on particle size, wherein smaller particles are
phagocytosed more efficiently136,140,141 Target rigidity also appears to play a role, with a
preferred engulfment of more rigid particles than softer targets142. A well-developed model
of engulfment should therefore ideally take these differences into account.
Membrane tension and availability are two other biophysical parameters central to
particle internalization. The cell membrane is not very elastic, yet neutrophil cells are
capable of engulfing particles with a 5 μm radius, requiring more membrane than can be
provided by stretching20,143. The increase in membrane surface area associated with
phagocytosis is generally attributed to one of two sources: the smoothing-out of membrane
wrinkles and the delivery of internal membrane to the surface by focal exocytosis144,145.
According to Herant et al., the unfolding of wrinkles in neutrophils requires a force to
release the membrane held in “Velcro-like” bonds, which become less “sticky” during
phagocytosis19. Internal sources of membrane have been reported to include early and
recycling endosomes, lysosomes, and specialized secretory vesicles in some cell types,
whereas the endoplasmic reticulum and the Golgi have been excluded as major contributors
of the phagocytic membrane145,146. The role of membrane tension in phagocytosis is
controversial. Herant et al. report that phagocytosis does not result in a significant increase
in tension prior to sealing the phagocytic cup, while Masters et al. suggest that increased
membrane tension acts a mechanical signal to initiate cytoskeletal reorganization19,38. The
limited availability of membrane and its delivery rate, however, represent two potential
constraints that should be taken into account in a model of particle engulfment.
Models of Actin-Polymerization-Dependent Force-Generation
Before the biophysical principles specific to phagocytosis can be discussed, the
more fundamental question of how actin polymerization results in membrane motion must
first be addressed6. Processes such as cell migration, dynamic probing of the extracellular
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environment, and receptor-mediated particle engulfment all rely on the formation of actindriven membrane protrusions6,36,134. In the 1980s, Hill and Kirschner suggested that actin
polymerization alone, in absence of ATP-driven motor proteins, could generate enough
free energy to result in membrane deformation147–149. This role for actin polymerization in
driving the formation of membrane protrusions of living cells is now widely accepted6.
Filamentous(F)-actin polymerization proceeds predominantly through the addition
of G-actin monomers to the “barbed” end of the actin filament, which is located closer to
the membrane150. Such preferential polymerization causes the actin filaments to grow
unidirectionally, enabling them to push on the membrane, which acts a barrier on which
the filaments do mechanical work. Depolymerization occurs predominantly on the other,
“pointed” end of the microfilament. As such, while new actin subunits are added to the
barbed end of the filament, older subunits can simultaneously be removed from the pointed
end, resulting in a process known as treadmilling. Specific actin-nucleating proteins
frequently assist polymerization151. The formation and growth of linear filaments is driven
by a family of formins, while branched networks result from the action of the Apr2/3
complex, which initiates the nucleation of new “daughter” filaments from the “mother”
filaments at a 70° angle.
The cortical cytoskeleton of a resting cell consists mostly of crisscrossing
unbranched filaments, running parallel to the inner membrane leaflet. The F-actin
organization in the pushing network responsible for various dynamic membrane structures
is believed to be structure-specific. Thin membrane projections known as filopodia are
driven predominantly by bundles of unbranched actin filaments, guided by formins. The
formation of Fcγ receptor-mediated phagocytic cups relies primarily on Arp2/3-driven,
branched F-actin to push the membrane, while other forms of engulfment rely
predominantly on linear filaments.
Existent structural models attempt to delineate the organization of the active actin
network, while mechanistic models address the exact means by which the actinpolymerization-generated forces are applied to the membrane152–156. From a
thermodynamic standpoint, the energy available for a single microfilament to exert a force
on the membrane has two potential sources – monomer binding and ATP hydrolysis6. The
free energy of binding released when a G-actin monomer binds to the microfilament can
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alone account for a force on the order of 1 pN. All actin polymerization requires ATP
hydrolysis to proceed. Whether the change in the filament structure in response to ATP
hydrolysis directly contributes to the production of a force is, however, yet to be
determined. Monomer binding and ATP hydrolysis are together hypothesized to yield a
force on the order of 10 pN6.
Mechanistic models of the pushing mechanism may be broken down into two major
subtypes: Brownian Ratchet (BR) models and Clamped Filament Elongation (CFE)
models154–156. In 1993, Peskin et al. proposed the classic BR mechanism of force
transduction154. In this model, thermal fluctuations of the membrane are the primary source
of its motion. Such fluctuations create a gap between the membrane and the barbed end of
the actin filament, providing an opportunity for a new, randomly-diffusing actin subunit to
be added the barbed end. If a new subunit is added, its addition prevents the membrane
from deforming back from its new, extended position. In this regards, more long-term
membrane deformation is therefore actin-driven. In its mathematical framework, the BR
model predicts a convex relationship between load force and filament velocity, wherein the
velocity of the polymerization ratchet decreases sharply with increasing force for small
loads and more gradually for larger ones. Similar force-velocity curves have been measured
experimentally for actin-propulsion-driven polystyrene beads and for the actin-driven
motion of the intracellular pathogen Listeria monocytogenes157,158.
Other BR models include the Elastic BR (EBR) model and the Tethered Ratchet
(TR) model155,159. Within the classic BR model, actin filaments are described as stiff rods
placed perpendicularly to the fluctuating membrane surface155. The EBR model refines this
mechanism by instead treating the actin filaments like elastic springs that are anchored to
a rigid actin network and approach the membrane at some acute angle. These elastic actin
rods are assumed to bend as a result of thermal energy and this bending generates the gap
where new subunits are attached. The longer rod then exerts a greater force on the
membrane. The TR model offers further improvements by distinguishing force-generating
“working filaments” and membrane-tethered “attached filaments”159. When new actin
subunits are added to the working filaments in accordance with the EBR mechanism, they
push the membrane forward, resulting in increased tension in the anchored filaments that
stabilizes the movement of the load. Some of the attached filaments dissociate from the
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membrane to become working filaments in response to increased tension, while new
attached filaments arise as a result of nucleation. Working filaments are simultaneously
eliminated by capping. Overall, the TR model offers a more physiologically-relevant
description of membrane motion than the classic or elastic BR models159.
The Clamped Filament Elongation (CFE) model of actin-derived forces assumes
that all the relevant actin filaments are tethered to the membrane by means of a clamp156.
In 2002, Dickinson and Purich were motivated by evidence of stepwise motion of bacteria
strongly anchored to actin filaments to formulate this alternative model. Their proposed
“Lock, Load and Fire” mechanism consists of three steps. In the first step, the clamp
connecting the membrane to the filament is locked onto the terminal actin subunit. The
structure of this clamp is such that it allows for a new actin subunit to be attached to the
proximal filament end. While a new actin monomer is “loaded”, the hydrolysis of ATP on
the prior terminal subunit provides the energy to change its conformation. In response, the
clamp loses its affinity for this subunit and translocates to the new ATP-bound terminal
monomer, where it once again locks in place. This model predicts a load-independent
velocity for small, opposing forces and a concave force-velocity curve for larger loads.
Measurements of the force-velocity relationship in the leading edge of migrating keratocyte
cells, extracted using atomic force microscopy, were in close agreement with the
predictions of the CFE model160. Several proteins, such as the members of the ENA/VASP
family, meet the biophysical requirements of the clamp machinery in this model, though
its exact identity has not yet been established.
Mechanisms of Phagocytic Engulfment
The classic “zipper mechanism” is one of the first phagocytosis-specific models of
particle engulfment to be described161,162. In the 1970s, a series of experiments performed
by Griffin et al. led them to propose that, following initial receptor-ligand based attachment
of the phagocyte to the particle, the formation of further receptor-ligand bonds in a zipperlike manner is required to facilitate internalization161,162. A schematic of the zipper
mechanism illustrating this principle is presented in Fig. 1.3(a), which shows new bonds
being made as the actin-driven membrane protrusions surround the engaged particle. In the
original studies, the sequential formation of such bonds was found to be required for the
engulfment of ligand-coated sheep erythrocytes and mouse lymphocytes by macrophage
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a)

b)

Figure 1.3. Mechanisms of Phagocytic Engulfment.
a) A schematic of the zipper mechanism, proposed by Griffin et al. in the 1970s.
Receptor-ligand bonds are formed in a sequential manner, following the initial
recognition of target. Filamentous(F)-actin-driven membrane protrusions facilitate
the formation of new bonds, resulting in a ‘zippering’ of membrane around the target
for its engulfment. b) A model of internalization proposed by Herant et al., 2006, in
which passive, zipper-like engulfment is assisted by two active mechanisms. Actin
polymerization pushes the membrane forward to surround the target, due to a
repulsion-mediated force between the cytoskeleton and the cell membrane.
Simultaneously, a contractile myosin-generated force pulls the membrane close to
the cytoskeleton below the center of the phagocytic cup.
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cells161,162. Receptor-ligand bonds were further shown to be important when half-coated
particles, with a ligand-free hemisphere, could not be ingested following attachment. These
findings challenged the “all-or-none” perception of phagocytosis, wherein the cell’s
commitment to complete engulfment was made as soon as the particle was engaged,
initiating a “trigger mechanism” that would then ensure internalization134.
Various studies have since demonstrated that phagocytosis requires close receptorligand mediated contact between the phagocyte and the particle11. The all-or-none
mechanism has instead been found to better describe processes such as macropinocytosis,
in which the cell uses large membrane ruffles to take “gulps” of the surrounding
extracellular fluid17,163. Phagocytosis is now believed to be a largely unidirectional process,
resulting in either complete particle engulfment or the formation of stalled phagocytic
cups11. The zipper mechanism is still frequently cited as the underlying mechanism
mediating engulfment. The basic zipper model, however, fails to account for the effects of
particle- and cell- based biophysical parameters on the internalization process and does not
address the role of actin polymerization directly. Furthermore, it fails to provide a desired
mathematical framework for this process. A number of recent studies have addressed these
shortcomings by suggesting alternative mechanisms of engulfment19,20,164–167.
In 2006, Herant et al. used a finite element model to study the engulfment of ligandcoated beads of varying size by neutrophil cells20. After testing a series of mechanical
models, Herant and his colleagues developed an improved version of the zipper mechanism
that best matched their experimental observations of the evolution of cell shape, phagocytic
cup morphology, and cortical tension during internalization. In their model, once a cell
engages a particle, receptor-ligand interactions proceed in a passive, zipper-like fashion,
while two active mechanisms come into play. Actin polymerization drives membrane
protrusions forward around the particle, by means of a repulsion-mediated force between
the cytoskeleton and the cell membrane at the edges of the cup. Concurrently, a flattening
contractile force, which could be attributed to unconventional myosins, pulls the membrane
closer to the cytoskeleton below the center of the cup. As presented in Fig. 1.3(b), the
simultaneous application of these two forces allows the cell to envelop the particle while
pulling it inwards. Notably, Herant et al. showed that including the contractile force in their
simulations yielded a much closer morphological match to the observed cups. Furthermore,
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while their model may be most applicable to neutrophils, it has the advantage of
incorporating biophysical parameters such as cytoplasmic viscosity, cytoskeletal density
and cortical tension.
An alternative biophysical description of engulfment was provided by van Zon et
al. in 2009164. They used confocal microscopy to track the internalization of 3 μm diameter
and 6 μm diameter ligand-coated particles by cells rendered phagocytic through an induced
expression of a relevant receptor. They observed great variability in the morphology of the
phagocytic cups and internalization speed. Even identical particles, bound to the same cell,
were nonetheless ingested in some cases, yet not in others. Monitoring the size of the
phagocytic cups over time yielded a distribution that eventually became bimodal, with
particles that were either completely ingested or stalled in a less than half-enveloped state.
In order to explain these observations, van Zon et al. developed a deterministic model of a
“mechanical bottleneck”.
In this model, membrane deformations were assumed to depend on the
concentration of freely-diffusing receptors, stationary ligand-bound receptors and cortical
actin, connected by a series of reaction-diffusion partial equations. The binding of a
receptor to a ligand was assumed to initiate actin polymerization. The extent of actin
polymerization was accordingly proportional to the bound receptor density. The cell
membrane and cortex were together modelled as an elastic surface capable of storing
energy, with a local bending modulus and a local surface tension determined by the actin
filament concentration. The deformation of the cell cortex in response to the pushing force
exerted by actin polymerization resulted in a restoring force at the rim of the phagocytic
cup. The authors calculated this restoring force and found it to increase at the half-cup stage
and then to remain constant. When the actin-driven deforming force was greater than the
maximum restoring force of approximately 1500 pN, the particles were ingested. They
were otherwise stalled in an equilibrated, less than half-enveloped state. In testing their
model, van Zon et al. experimentally confirmed that reduced actin polymerization would
not result in failed phagocytosis, since the cortical stiffness was likewise dependent on
actin. Their model also agreed with the observed effects of particle shape on internalization
reported by Champion and Mitragotri136. The shortcomings of their study, however,
include the use of the COS-7 cell line, which is non-phagocytic, and the failure to account
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for endo-membrane delivery and to explicitly incorporate a myosin-driven contractile
force.
A more recent study by Tollis et al. addressed the role of actin-driven force
generation in the engulfment of particles of variable size and shape through a series of
three-dimensional, stochastic simulations166. Their model of the zipper mechanism of
internalization as an actin-driven Brownian ratchet is the first of its kind. In this model,
thermal fluctuations of the membrane result in the formation of reversible ligand-receptor
bonds between the particle and the phagocyte. An active zipper then stabilizes these bonds
by actin polymerization, which secures the membrane protrusions in place, in line with the
BR model of actin-driven force generation154. To describe the energy stored in the cell
membrane and cortex, the authors factored in the cost of stretching or bending the
membrane, the cost for increasing cellular volume and the binding energy released from
the formation of receptor-ligand bonds. The morphology of the phagocytic cup was
accordingly dependent on surface tension and the cell-volume constraint, with thinner cups
resulting from a more stringent volume constraint and relatively low membrane tension.
Small variations in the tension parameter resulted in a bimodal distribution of phagocytic
cup sizes with fully and half-engulfed particles, providing an alternative explanation for
the observations of Van Zon et al.164 The predictions of the model regarding the uptake of
spiral and ellipsoid shapes agreed with the observations of Champion and Mitragotri136.
To investigate the role of actin polymerization in their model more directly, Tollis
et al. distinguished between active and passive zippers166. For the active zipper, actin
polymerization rendered the ligand-receptor bonds irreversible, resulting in a steady
progression of the membrane around the particle. For the passive zipper, particular bonds
were kept only when their binding energy was greater than the energy cost of the associated
membrane deformations. Their simulations showed that smaller, 3 μm particles, but not
the larger, 6 μm particles, could be successfully engulfed by the passive zipper. Passivezipper-mediated internalization was found to be slower, to exhibit a more variable cup
morphology and to be more reliant on membrane ruffles. These results were experimentally
confirmed using fibroblast cells, transfected such that they would have either an active or
a passive zipper. At the terminal stage of engulfment, however, there was no close
agreement between the simulations and the observed cells. In the simulations, cup closure
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proceeded in a slower, more disorganized manner, likely owing to the absence of myosinbased contractile forces in this model. The model of Tollis et al. nonetheless remains the
first three-dimensional, stochastic model of phagocytosis and connects engulfment to a
more general mechanism of actin-driven force generation.
A new biophysical study, co-authored by Richards and Endres in 2014, contrasts
with all others by proposing a two-stage model of engulfment governed by receptor
diffusion167. In this work, Richards and Endres first looked at the engulfment of polystyrene
beads by neutrophil cells by monitoring the engulfed arc length of the beads as a function
of time. Two distinct stages were observed. In the first stage, lasting until the bead was
approximately half-engulfed, the rate of internalization was slow and further decreased
with time. In the second stage, the engulfment rate increased dramatically, leading to a
quickly completed internalization of the particle. The model developed to explain these
observations was as follows. The authors first supposed that the energy required to deform
the membrane came from the formation of ligand-receptor bonds, which were in turn
dependent on the local receptor density in the engulfed membrane region. They then
assumed that free receptors farther from the contact region entered the contact region either
by Brownian diffusion or active transport.
A solution to the “free diffusion” model was found to accurately describe the first
engulfment stage. The second stage was better explained by the “active transport” model,
in which receptors were transported to the edge of the phagocytic cup. Combining these
two models resulted in a two-stage mechanism that accurately predicted the whole process,
with a receptor-density-dominated flow in the first stage and a drift-dominated flow in the
second stage. Richards and Endres then incorporated a signaling molecule to control the
receptor drift velocity. This prototypical signaling molecule was assumed to be produced
in the cup membrane in response to ligand-receptor interactions and assigned its own
diffusion constant, as well as a specific lifetime. Increasing the density of the signaling
molecule in the rim on the cup was then shown to result in enhanced drift velocity and
faster engulfment. The authors suggest that, biologically, insufficient signaling could
therefore lead to the lack of a “trigger” for the second stage, and result in the formation of
stalled cups observed in earlier studies164,167. Like the models of van Zon et al. and Tollis
et al., their model also matched the observed effects of particle shape and orientation on
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the engulfment process.
Despite the existence of several models for the mechanisms of phagocytic
engulfment, numerous questions remain largely unaddressed. A number of myosin motor
proteins, including myosin IC, myosin X and myosin II, have been detected in the
phagocytic cup and myosin-mediated contractions are suggested to be fundamental for
efficient particle internalization and cup closure20,168–171. The exact involvement of specific
motor proteins is, however, yet to be determined. Similarly, the effect of ligand density on
the internalization process remains controversial. The model of Richards and Endres
predicts the existence of some optimal, intermediate ligand density for best engulfment167.
Pacheco and colleagues conversely report the engulfment efficiency of small polystyrene
particles, less than 2 μm in size, to be strongly dependent on their ligand density, with no
such correlation for larger targets141. Flannagan et al. have shown the internalization of
poorly coated particles to be more reliant on the ability of phagocytic cells to actively probe
their surroundings by actin-driven membrane ruffles and filopodia36. Further research is
necessary to elucidate the potentially ligand-specific relationship between ligand density
and efficiency of phagocytosis.
Receptor mobility within the phospholipid bilayer may also affect engulfment.
Higher receptor mobility has been suggested to lead to improved engulfment efficiency in
a number of ways. The binding affinity of some receptors to their ligands is low11. A better
measure of how well such receptors can secure their target is their avidity, or “functional
affinity”, which refers to the combined strength of a number of receptor-ligand interactions
and reflects both receptor density and mobility17. Furthermore, receptor clustering in
response to multivalent targets has been shown to be a prerequisite in the signaling of
phagocytic and efferocytic receptors11,70,82. In fact, all phagocytic receptors are activated
through clustering, induced by their immobilization by a single multivalent particle.
Receptor diffusion may therefore affect their ability to initiate signaling pathways. A
question that has yet to be answered is whether receptor mobility may reflect the
transduction of mechanical forcers generated by actin polymerization and the motion of
myosin motors during engulfment.
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1.5 Receptor Diffusion in the Picket Fence Membrane Model
A recent paradigm shift in our view of the plasma membrane structure has called
our current understanding of receptor mobility during phagocytosis and its interplay with
actin-driven force-generation into question3,17,151. In the classical “fluid-mosaic model” of
the membrane, described in the 1970s by Singer and Nicholson, the cell membrane was
treated as a two-dimensional, oriented, viscous solution of randomly-distributed
transmembrane proteins in a solvent of phospholipids1. The proteins were assumed to
undergo Brownian motion so long as they did not collide with other proteins. Accordingly,
individual FcγR phagocytic receptors were believed to be distributed evenly throughout
the membrane, undergoing Brownian motion until they encountered their ligands172. Some
current models of phagocytic engulfment still utilize the concept of freely-diffusing
receptors164,167. A series of observations which could not be explained by the SingerNicholson model, however, have necessitated a newer treatment of the plasma membrane
in the picket fence membrane model pioneered by Kusumi et al.3.
The Singer-Nicholson fluid mosaic model fails to address two fundamental issues
that have puzzled researchers for almost thirty years3. The first is that the diffusion
coefficients measured for proteins and lipids in artificial lipid bilayers and liposome
membranes are 5-50 times larger than their equivalent coefficients in the cell
membrane3,173. The compositional similarity of these membranes precludes their specific
contents from being responsible for such drastic differences. The fluid mosaic model,
however, does not provide an alternative explanation. The second issue is that molecular
oligomerization or the formation of complexes results in a dramatic decrease in their
diffusion rate in the cell membrane relative to individual monomers3. For example, the
crosslinking of DOPE (L-alpha-dioleoylphosphatidylethanolamine), an unsaturated
phospholipid believed to be fairly unaffected by the presence of transmembrane proteins
or sterols that alter membrane fluidity, reduces its diffusion rate by approximately five
times174. A mathematical treatment of the plasma membrane according to the SingerNicholson model, however, predicts the translational diffusion coefficient to be minimally
dependent on the size of the diffusing molecule175. Increasing a molecule’s radius by a
factor of ten, for example, is expected to result in a diffusion rate reduced by only a factor
of 1.43. The oligomerization-induced changes in the diffusion coefficient are therefore
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incompatible with the fluid mosaic model.
The Picket Fence Model of Membrane Compartmentalization
To provide an explanation for the confined diffusion and oligomerization-induced
trapping observed for molecules within the cell membrane, Kusumi and colleagues have
developed an alternative view of the plasma membrane, which has since been supported
by various experimental results3,173. In their model, the entire cell membrane is partitioned
into individual compartments, also referred to as confinement zones, thought to be formed
by the cortical cytoskeleton that lines the cytosolic surface of the cell membrane3,18. Bound
to this “fence” are transmembrane proteins that span the entirety of the membrane and
anchor it to the cytoskeleton, forming “pickets”. A schematic of the picket fence model is
presented in Fig. 1.4.
The fence is believed to consist of a mesh of cortical actin for the majority of cell
types18. Examples of other biological fences do, however, exist. Both actin and an unrelated
cytoskeletal protein called spectrin have been shown to form the fence in erythrocytes and
both are suggested to be responsible for the confined diffusion of MHC (major
histocompatibility complex) class I molecules176,177. Septins, proteins responsible for
coordinating cell division in yeast, may also be involved in partitioning the plasma
membrane in some cases178,179. Possible candidates for the protein pickets include the ERM
proteins, ezrin, radixin, and moesin, which have a C-terminal actin-binding domain and
simultaneously bind to the membrane phospholipid phosphatidylinositol-4,5-bisphosphate
(PI(4,5)P2) with their N-terminal domain18.
Numerous experimental observations support the role of the cytoskeleton in
modulating diffusion3. In blebbed membranes, which lack an underlying cytoskeleton,
molecules have been observed to diffuse freely and at a greater rate than in the cell
membrane3. Molecular crowding by membrane proteins and cholesterol were previously
invoked to explain the reduced diffusion rates observed for plasma membrane
molecules180,181. Since blebbed membranes, however, contain the same concentrations of
cholesterol and membrane proteins as the original cell membrane, molecular crowding
alone cannot account for the observed changes in mobility173. Extensive research into the
diffusion of band 3, a transmembrane protein found in the spectrin-cytoskeleton-supported
membrane of erythrocytes, also supports the picket fence model. An early study by Sheetz
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Figure 1.4. The Picket Fence Model of Membrane Compartmentalization.
The figure shows a schematic cross-section of the cell membrane, with embedded
transmembrane proteins. Inside the cell, the actin cytoskeleton forms fences that run
adjacent to the inner membrane leaflet, partitioning the membrane into
compartments and restricting the diffusion of confined transmembrane proteins.
Specialized transmembrane proteins that anchor the cytoskeleton to the membrane
act as stationary “pickets”. As indicated, confined membrane molecules are capable
of escaping from a compartment or hopping between compartments. Trajectories
show the path taken by the transmembrane proteins over time.
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et al. showed the diffusion coefficient of band 3 to be approximately fifty times greater in
mutant cells lacking the spectrin meshwork182. Treating healthy cells with spectrindisrupting chemical agents likewise resulted in a greater diffusion coefficient for
translational, but not rotational, diffusion183. The cytosolic domain of band 3 was shown to
be involved in restricting its diffusion due to steric interactions with the cytoskeleton183. In
1998, Tomishige et al. used optical tweezers to drag the cytoskeleton network along the
membrane and observed diffusing band 3 molecules to be laterally translated in the same
direction as the cytoskeleton184. Optical tweezers have also been used to laterally
translocate transferrin receptor molecules within the plasma membrane185. When the
dragged transferrin receptors escaped the tweezers, these transmembrane proteins
rebounded to their original positions, suggesting the cytoskeletal confinement zone
boundaries to be elastic in nature.
More recently, electron tomography with 3D reconstruction of the actin
cytoskeleton in fibroblast and keratinocyte cells showed that the actin filaments line the
inner side of the membrane, less than 0.85 nm below the cytosolic surface186. The mesh
sizes of the observed actin network matched the confinement zone dimensions determined
by diffusion analysis173,186. The presence of a cytoskeletal fence is therefore thought to
prevent the transmembrane proteins from easily crossing the compartment barrier due to
steric interactions between the cytoskeleton and their cytosolic domains3,183,187. The pickets
are suggested to provide further regulation and to even enable the actin cytoskeleton to
restrict the diffusion of lipids in the outer membrane leaflet186,188. While steric hindrance
created by these pickets contributes to regulating phospholipid diffusion, it is not itself
enough to account for the confinement of phospholipids173,189. Instead, the slower diffusion
rate of molecules in the vicinity of the pickets is believed to result from the friction-like
effects of these immobile pickets, propagated over several nanometers due to the high
viscosity of the phospholipid bilayer190,191. Together, the corralling effect of the
cytoskeleton and the hydrodynamic friction effect of the transmembrane pickets are held
responsible for slowing down protein and lipid diffusion within the cell membrane3.
The membrane proteins and lipids therefore have both a fast micro-diffusion
coefficient, 𝐷𝑚𝑖𝑐𝑟𝑜 , and a slower macro-diffusion coefficient, 𝐷𝑚𝑎𝑐𝑟𝑜 173. As suggested by
Kusumi et al., 𝐷𝑚𝑖𝑐𝑟𝑜 corresponds to the diffusion of proteins and lipids within
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confinement zones, wherein they diffuse freely. Since these confinement zones are tens to
hundreds of nanometers across, depending on the molecule and cell type in question, they
are large enough for the diffusant not to encounter the barrier on the shorter time
scales3,173,174. 𝐷𝑚𝑖𝑐𝑟𝑜 coefficients of various molecules have been shown to closely match
their diffusion coefficients in artificial, blebbed and liposomal membranes, which lack a
cytoskeletal structure3,173,174,188,192. The macro-diffusion coefficient of a molecule is
typically an order of magnitude lower than 𝐷𝑚𝑖𝑐𝑟𝑜 . The µ-opioid G-protein-coupled
receptor studied by Suzuki et al., for example, has a 𝐷𝑚𝑎𝑐𝑟𝑜 of 0.2 μm2/s and a 𝐷𝑚𝑖𝑐𝑟𝑜 of
5 μm2/s, which is twenty-five times greater192. 𝐷𝑚𝑎𝑐𝑟𝑜 is reflective of the plasma membrane
environment probed by the molecule on greater time scales, over which it may successfully
move from one compartment to another3. In the context of the molecules studied by
Kusumi et al., such motion between compartments was called “hop diffusion”.
The residence time within a confinement zone for a molecule moving by hop
diffusion is frequently very short, with hops occurring every 1-50 ms3. As such, the time
scales employed in studying receptor diffusion prior to the implementation of high-speed
single-molecule imaging were too long to reveal the existence of such hops directly173. To
illustrate the importance of frame rate, Kusumi et al. have compared the diffusion of goldparticle-tagged DOPE phospholipids imaged with a temporal resolution of 33 ms and
25 μs. They found the observed trajectories at 33 ms to be Brownian in nature. At 25 μs,
however, DOPE appeared to move by a series of hops from one compartment to another,
interspersed by Brownian motion in the confines of each compartment. Such hop diffusion
has been observed for numerous transmembrane proteins, including transferrin receptor,
α2-macroglobulin receptor, E-cadherin, band 3, and µ-opioid receptor184,192–194. More long
term confinement, lasting 1-10 s and thus detectable at a lower frame rate, has also been
reported for several receptors, including B cell receptor (BCR) and the phagocytic Fcε and
Fcγ receptors55,58,72.
Different residence times of molecules within compartments suggest different
potential means of escape from confinement18. On the scale of milliseconds, relevant to
hop diffusion, the actin cytoskeleton is fairly stable. Cytoskeletal remodeling is believed
to take place on the longer timescale of around 10 s58,72,195. A hop may occur when the
actin meshwork undergoes a transient local dissociation from the plasma membrane or the
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protein pickets, resulting in the formation of a gap18,184. Alternatively, a slight temporary
shift in the position of an anchored picket with some limited mobility might likewise allow
a molecule to pass through. Finally, hop diffusion may result from a transient alteration in
the links between actin filaments within the network. The release of molecules from more
long term confinement, on the other hand, may be attributed to cortical actin turnover or to
specific re-arrangements triggered by a signaling cascade18. Signaling may also result in
the formation of protein complexes, which can then get trapped in the same confinement
zone where the external signal was transduced196. A much slower rate of intercompartment-motion for the entire complex results due to the relative inability of all the
molecules in a complex to simultaneously move to a different compartment, when
compared to single molecules197. The picket fence model therefore accounts for observed
oligomerization-induced trapping.
The membrane microenvironments experienced by diffusing proteins and
phospholipids result in behavior patterns closely related to that of particles in other
biophysical systems. Microrheology is a method for measuring the viscoelastic properties
of a medium with both solid and fluid characteristics by video-tracking the trajectories of
submicron-sized tracer particles in the medium198. Pioneered by Mason and Weitz in 1995,
it relies on the generalized Stokes-Einstein equation to describe the motion of a particle in
a viscoelastic material199. Bulk rheological characterization of materials is performed using
rheometers198. Microrheology requires a smaller volume of material and is capable of
probing heterogeneous environments. Passive microrheology tracks the thermally-driven
diffusion of tracers, while active microrheology measures tracer motion in response to
forces applied to the particles. In either approach, the particle tracks provide information
about the local microstructure of the complex fluid.
In 2006, Oppong et al. used fluorescence microscopy to track the diffusion of
particles in Carbopol ETD 2050, a polymer gel200. They found the microrheological
viscous and elastic moduli of the gel computed from the particle tracks to be significantly
different from moduli of the bulk material200. The Carbopol gel was inferred to have a
highly expanded polymer network, with concentration-dependent overlaps between the
polymer chains leading to the entrapment of particles201. The particles diffusing in
Carbopol were further found to sample a range of microenvironments, moving sub-
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diffusively in cages of various size202. Similar behavior has been observed by Weeks and
Weitz for particles diffusing in colloidal systems near the glass transition203–205. Oppong et
al. have employed particle tracking to study the gelation of colloidal Laponite clay
suspensions, finding the microenvironments explored by the particles to be more
heterogeneous later in the gelation process206. The analysis tools employed in these
microrheological studies may prove valuable for further characterizing the plasma
membrane microstructure.
Cytoskeletal Regulation of Receptor Diffusion in Phagocytosis
Cytoskeleton-governed long-term confinement has been observed for several
immune system receptors on the scale of seconds55,58,70,72. For unengaged receptors,
membrane partitioning has been suggested to both act as a safety mechanism, preventing
undue clustering, and to enhance the likelihood of interactions between co-confined
receptors151. The increased receptor mobility required for efficient signaling is thought to
arise from cytoskeletal remodeling, changing a rigid actin meshwork to a more flexible,
branched structure151. Such rearrangements may be triggered by synergistic priming of the
signaling response or by the initial binding of ligand151. The binding and engulfment of
targets in FcγRIIA-mediated phagocytosis has been shown to rely on differential receptor
mobility in various regions of the phagocytic cup55. Cytoskeleton-governed mobility may
therefore form the basis of efficient target capture and force transduction for other
phagocytic and efferocytic receptors.
Analysis of steady-state diffusion of a number of immune system receptors has
shown at least a portion of them to be confined to cytoskeleton-based membrane
compartments. In 2008, Andrews et al. studied the motion of FcεRI, a phagocytic receptor
for the IgE antibody58. They found a portion of FcεRI receptors to be confined to submicron
regions of the membrane, with another portion of receptors that moved in a Brownian
fashion. A similar result was found by Treanor et al. in 2010 for the B cell receptor, with
populations of both confined and freely-diffusing proteins72. A recent study of FcγRIIA
mobility in human monocytes likewise reported a third of these phagocytic receptors to be
confined under rest conditions55. Such heterogeneity is believed to be the result of variable
actin density and fence strength in different regions of the underlying cytoskeleton.
In support of this proposition, Jaumouille et al. have found FcγRIIA confinement
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to be independent of phosphorylation-induced association with downstream signaling
molecules55. Neither was it mediated by cholesterol-containing lipid rafts, with a
chemically-induced cholesterol depletion resulting in a greater degree of confinement. The
treatment of the cytoskeleton with an actin-disrupting agent latrunculin A, however,
resulted in an increased portion of freely diffusing receptors. Enhanced receptor mobility
and elevated signaling have likewise been observed following actin depolymerization,
induced by cytochalasin D or latrunculin A, for BCR and FcεRI molecules58,72. The
generalized effects of these chemical disruptors on the cell at large, however, make the
results of such treatments somewhat difficult to interpret. As such, Jaumouille et al. have
also demonstrated actin-dependent FcγRIIA confinement through an alternative method,
by showing receptor diffusion to be much faster in actin-depleted membrane blebs than in
the cell membrane55.
Confinement of unengaged membrane receptors in a resting cell can have several
potential functions. First, reduced mobility may provide a safety mechanism by preventing
the spontaneous clustering and signaling of receptors in absence of an appropriate
ligand72,207.
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compartmentalization effectively curtails the spontaneous signaling of BCR molecules by
spatially separating them into different confinement zones72. Monte Carlo simulations of
FcγRIIA motion have also shown a greater frequency of collisions between freely-diffusing
receptors than between confined ones55. The effect of receptor confinement on collision
rate was, however, reduced at a greater FcγRIIA density55.
While membrane partitioning limits inter-compartment collisions, it can also result
in higher collision frequencies for receptors present within the same compartment, leading
to a “reaction burst”151,173. The co-confinement of CD36 molecules in cytoskeleton-defined
linear troughs has been shown to result in enhanced clustering of unengaged receptors 70.
Temporary co-confinement was likewise found to promote dimerization for epidermal
growth factor receptor (EGFR) molecules208. Cytoskeleton-based fences were also found
to govern the lifetime of major histocompatibility complex (MHC) class I membrane
clusters, further illustrating the role of actin in governing oligomerization71. The existence
of some receptors in transient pre-formed clusters may be responsible for a basal, “tonic”
level of signaling in absence of a ligand18,55. Alternatively, the presence of multiple
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receptors within the same compartment may also improve their simultaneous association
with an encountered multivalent target, resulting in more efficient binding18,58,70
The complete capture and engulfment of targets by phagocytic cells is believed to
involve cytoskeletal rearrangements, which may enhance or otherwise alter receptor
mobility151. Such rearrangements are thought to include a transition from a more rigid
fence, largely made up of linear actin filaments with minimal branching, to a more flexible
mesh with Arp2/3-promoted actin branching and greater gaps151. The actin monomers
released in this process may be a necessary source of actin for the phagocytic cup
protrusions. The mesh gaps and general actin disassembly may, in turn, result in improved
receptor mobility. Treatment with an actin-filament stabilizing agent, jasplakinolide, for
instance, has been shown to decrease target binding efficiency209. This effect may be
attributed to reduced diffusion in the overly stable confinement zones that result from such
a treatment17. Enhanced receptor diffusion in response to actin-disrupting agents does not,
however, lead to improved particle binding. The effects of these chemicals are more
complex, owing to the dependence of continuous membrane ruffles, employed by
macrophages and dendritic cells for the efficient binding of targets, on the dynamic
remodeling of actin17,36,151.
In general, cytoskeletal remodeling required for phagocytosis may be the result of
“priming” or may arise from the initial binding of select ligands151. The initial engagement
of a few receptors has been suggested to act as a signal for re-arrangements, which free up
more receptors, initiating a positive feedback loop. In priming, engaging one kind of
receptor associated with the phagocytic response may improve the mobility of another.
Such synergistic crosstalk has been reported for integrins and FcγR receptors55,151,210.
Approximately 80% of αMβ5 integrins exist in a confined state in resting cells210. Jongstra
et al. found a portion of these molecules to be liberated upon FcγR stimulation210. Integrinmediated attachment of cells to a substratum has likewise been suggested to influence
FcγRIIA confinement, priming the cells for phagocytosis55.
Following initially enhanced receptor mobility during target binding, patterns of
receptor diffusion during phagocytosis remain poorly understood. Knowledge of the
associated mobility patterns, however, would greatly aid in the development of better
computational models of phagocytosis, in place of models that assume free receptor
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diffusion in the phagocytic cup. In their recent study of FcγRIIA, Jaumouille et al. have
first found a portion of the receptors to be confined in resting cells and then tracked
FcγRIIA motion in actively-phagocytizing cells55. They did so in the context of frustrated
phagocytosis, wherein the cells are engaged by a ligand-coated substrate and the entire area
of contact becomes a phagocytic cup. Jaumouille et al. found the mode of receptor diffusion
to be dependent on the location of the molecule within the phagocytic cup membrane. The
leading edge of the cup, which would correspond to tips of the membrane protrusions
wrapping around a target, was found to have more freely diffusing receptors. The actinrich areas near the center of the cup had more confined receptors. The authors rationalized
such differential mobility in terms of a positive feedback on the leading edge, where
receptors were more likely to cluster in encountering new binding sites, and negative
feedback in the actin-rich areas, where the sufficient levels of signaling left no receptor
recruitment to be desired. Whether such behavior is true of other phagocytic and efferocytic
receptors is yet to be determined.

1.6 Literature Review of CD93
CD93 is a transmembrane glycoprotein of interest to our lab, with a putative
physiological role as a phagocytic/efferocytic receptor in the regulation of inflammation7,8.
A protein expressed in a variety of cell types, it has been observed on the surface of
endothelial cells, stem cells, platelets and select leukocytes, including monocytes and
neutrophils, but not on tissue macrophage cells211–216. Its predominant site of expression is
the vascular endothelium and CD93 has been detected in the endocardium and vascular
endothelium during embryogenesis213,217,218. A soluble form of the protein, shed off the
surface of cells, has also been detected in human plasma214. Complete CD93 consists of
652 amino acids and contains five distinct domains, illustrated in Fig. 1.5

219

. Its N-

terminal C-type lectin-like domain shares homology with carbohydrate-binding proteins,
though, to date, its ligands remain unidentified. It is followed by an epidermal growth factor
(EGF)-like domain, with five EGF-like repeats, a mucin domain rich in serine and
threonine amino acids, a transmembrane helix, and a distinct cytosolic domain of unknown
signaling capacity. In its soluble form, sCD93 retains the C-type lectin-like and EGF-like
domains, with some cleavage forms retaining a portion of the mucin domain214.
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Figure 1.5. Structure of CD93. CD93 is composed of five distinct domains,
including an N-terminal C-type lectin-like domain (CTLD), five epidermal growth
factor (EGF)-like repeats, a mucin domain rich in serine and threonine amino acids,
a transmembrane domain (TM) and a short cytosolic tail (Cyto-tail).
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CD93 was originally identified as a receptor for C1q, a protein complex in the
complement cascade of the innate immune system219,220. Accordingly, CD93 was believed
to enhance phagocytosis in a C1q-dependent manner220–224. In an early 1994 study, Guan
et al. reported that blocking the receptor with R3, a CD93-specific antibody, decreased the
phagocytic efficiency of monocyte cells plated a C1q-coated surface221. Further studies
suggested that CD93 acted as a receptor for the structurally related proteins C1q, mannosebinding lectin (MBL) and surfactant protein A (SPA), which are known to recognize
pathogen-associated molecular patterns (PAMPs)222,224,225. The association of CD93 with
C1q has since then been disproven101,217. Instead, the observed involvement of CD93 in
diseases with impaired apoptotic cell clearance, such as atherosclerosis and systemic lupus
erythematosus, points to a role for CD93 as an efferocytic receptor129,226,227.
Studies of CD93 suggest that it may contribute to efferocytosis in one of two
potential ways. First, membrane-bound CD93 may act as an efferocytic receptor,
recognizing and binding to eat me signals on the surface of apoptotic cells, directly or
through an opsonin. Indeed, in 2004, CD93-deficient mice were shown to have impaired
clearance of apoptotic cells in vivo, with no corresponding effects on phagocytosis101. The
specific eat me signals or bridging molecules recognized by CD93, however, have not yet
been identified. The intracellular signaling cascade that would follow is likewise unknown.
GIPC (G-alpha-interacting protein (GAIP) Interacting Protein, C terminus) and moesin are
two intracellular molecules known to interact with the cytosolic domain of CD93, so they
may be involved in the resulting signaling pathway228,229. Moesin, however, has no reported
role in receptor internalization; it is instead more likely to be involved in mediating CD93
immobilization in the plasma membrane, perhaps by forming pickets18. In contrast, GIPC
is known to be involved in the internalization of other receptors230. It may therefore be part
of CD93’s efferocytic signaling pathway, or, alternatively, by involved in the normal
turnover of the receptor. More recently, the soluble form of CD93 has itself been suggested
to act as an opsonin, bridging a yet unknown efferocytic receptor to an unidentified eat-me
signal102,214.
Stimulation of protein kinase C (PKC) using phorbol dibutyrate (PDBu), a plantderived phorbol ester, has been shown to induce rapid CD93 shedding from the surface of
human monocyte and neutrophil cells214. Phorbol 12-myristate 13-acetate (PMA), another
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phobol ester, induced CD93 shedding from neonatal umbilical cord blood cells and human
monocyte-like cells216,231,232. CD93 shedding has also been observed in response to
physiologically-relevant stimulants, specifically following the treatment of monocytes
with inflammatory molecules such as TNF-α and LPS, and in response to CD93
crosslinking214. The molecule responsible for cleaving full-length CD93 into its soluble
and membrane-bound components has not yet been identified, but is believed to be a zincdependent proteinase belonging to the metalloproteinase family. Phobol esters have been
reported to induce metalloproteinase-based cleavage of cell surface proteins233.
Furthermore, CD93 shedding has been shown to be absent following treatment with 1,10phenanthroline, a metalloproteinase inhibitor that chelates zinc214. Importantly, the same
study determine that TNFα-converting enzyme (TACE), a metalloprotease responsible for
the shedding of numerous transmembrane proteins on immune cells, has no role in CD93
shedding214.
The shedding of CD93 observed in these experiments reflects a physiologicallyrelevant phenomenon. sCD93 has been detected in normal human serum and has been
linked to several cardiovascular and autoimmune diseases8,214. Elevated serum levels have
been associated with coronary artery disease and systemic sclerosis226,234. Furthermore,
serum sCD93 is valid biomarker of acute myocardial infarction, while the P541S single
nucleotide polymorphism of CD93 is one of the greatest genetic risk factors for
atherosclerotic disease, with an odds ratio of 1.26235,236. Elevated sCD93 has likewise been
observed in the synovial fluid of people with rheumatoid arthritis237. A 2009 study by
Greenlee et al. examined the role of sCD93 in efferocytosis more directly, utilizing a
mouse model of induced sterile peritonitis, which is an inflammation of the tissue that lines
the inner abdominal wall102. sCD93 levels were determined to be approximately nine times
greater in the peritoneal lavage fluid of mice with peritonitis. Greenlee and colleagues then
found sCD93-containing lavage fluid to enhance the engulfment of apoptotic T cells by
CD93-deficient macrophages in vitro, with no corresponding effect for lavage fluid of
CD93-deficient animals.
Numerous clinical studies point to a potential role for CD93 in apoptotic cell
clearance226,227,234,235,237. A more complete understanding of the involvement of CD93 and
sCD93 in efferocytosis is yet to be achieved. Questions yet to be addressed include the

41

identification of its binding partners as a putative efferocytic receptor and the
metalloprotease responsible for its cleavage. Differential receptor mobility within the
membrane, discussed at length in Section 1.5, is now believed to play a significant part in
regulating cellular engulfment of particles3,17. Furthermore, recent observations of 𝐶𝑋3 𝐶𝐿1
chemokine shedding suggest that membrane compartmentalization into a series of
confinement zones may regulate the shedding of transmembrane molecules238.
Characterizing the motion of CD93 within the plasma membrane may therefore yield
valuable clues to the means of its shedding and help to investigate its role as an efferocytic
receptor.
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Chapter 2
CD93 Diffusion: Theory and Methods
2.1 Theory of Diffusion
In this section, we present the theory of diffusion. Brownian motion is first
introduced. We then examine normal diffusion in the context of the Langevin equation,
discussing the origins of and assumptions inherent in this equation. The relationship of the
mean squared displacement with time is then derived, using both the diffusion equation
and the Langevin equation and leading to the Einstein-Stokes law. The ergodicity of
Brownian motion is then discussed. The section is concluded with a brief discussion of
anomalous diffusion in the context of a continuous time random walk.
Particles in a Random Walk
The behavior of freely-diffusing particles undergoing Brownian motion can be
described by the simple, stochastic process of a random walk239. Suppose a particle is
engaged in a random walk beginning at the origin. Let 𝑡 be the time taken for the particle
to make a single step of length 𝑙, in a randomly chosen direction indicated by the unit vector
𝑛̂. The position of the particle after 𝑁 steps, corresponding to an elapsed time of 𝑁𝑡, can
be written as
𝑁

𝑟𝑁 = ∑ 𝑛̂𝑘 𝑙 ,
⃗⃗⃗⃗

(2.1)

𝑘=1

where 𝑛̂𝑘 is the direction of the 𝑘th step. Since the direction of any step is selected at
random, the temporal average of 𝑛̂ after 𝑁 steps, written as 〈𝑛̂〉, approaches zero for large
𝑁. The mean particle displacement from the origin is therefore
lim 〈𝑟⃗⃗⃗⃗𝑁 〉 = 0,

𝑁→∞

(2.2)

for any chosen 𝑡. The mean squared displacement (MSD) of the particle is, however, nonzero.
The probability density function (PDF) of the particle displacement is easily
determined with the aid of the central limit theorem (CLT)239,240. The classical CLT
considers a random sample of 𝑁 independent random variables {𝑋1 , 𝑋2 , … 𝑋𝑁 }, drawn from
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identical distributions with a mean of 𝜇 and a finite variance of 𝜎 2 . According to the
theorem, for a sufficiently large 𝑁, the sample average 〈𝑋〉 behaves like a normallydistributed variable with a mean of 𝜇 and a variance of 𝜎 2 /𝑛, regardless of the probability
distribution of {𝑋1 , 𝑋2 , … 𝑋𝑁 }. Since the displacement of a freely-diffusing particle in an
isotropic medium is described by a sum of many independent, identically-distributed
random steps, the CLT dictates that it will follow a Gaussian distribution.
In the one-dimensional case, the PDF of the particle displacement 𝑥, following
many steps, is given by
(𝑥 − 𝜇𝑥 )2
𝑓(𝑥) =
exp (−
),
2𝜎𝑥2
√2𝜋𝜎𝑥2
1

(2.3)

where 𝜇𝑥 = 〈𝑥〉 is the mean displacement and 𝜎𝑥2 = 〈𝑥 2 〉 is the mean squared displacement
of the particle239. Since the particle is equally likely to move in the positive and negative
𝑥-directions, 𝜇𝑥 = 0. The MSD can be shown to be related to the one-dimensional
diffusion coefficient of the particle through
〈𝑥 2 〉 = 2𝐷𝑡,

(2.4)

where 𝑡 is the time239.
The description is easily extended to the three-dimensional case, since the motion
in each direction is independent. In an isotropic medium, 𝜎𝑥2 = 𝜎𝑦2 = 𝜎𝑧2 = 𝜎 2 and 𝜇𝑥 =
𝜇𝑦 = 𝜇𝑧 = 0. Accordingly, the probability 𝑃 of finding a particle somewhere between
(𝑥, 𝑦, 𝑧)

and

(𝑥 + 𝑑𝑥, 𝑦 + 𝑑𝑦, 𝑧 + 𝑑𝑧)

is

𝑃(𝑥, 𝑦, 𝑧) =

1 2
𝑥2 + 𝑦2 + 𝑧2
𝑃(𝑥, 𝑦, 𝑧) = (
)
exp
(−
) 𝑑𝑥𝑑𝑦𝑑𝑧.
2𝜋𝜎 2
2𝜎 2

(2.5)

following

many

steps

𝑃(𝑥)𝑃(𝑦)𝑃(𝑧), or
3

The probability of a Brownian particle travelling a distance 𝑟 from the origin is given by
3

1 2
𝑟2
2
𝑃(𝑟) = (4𝜋𝑟 ) (
) exp (− 2 ) 𝑑𝑟
2𝜋𝜎 2
2𝜎

(2.6)

in spherical coordinates. The three-dimensional mean-squared displacement of the particle
is
〈𝑟 2 〉 = 6𝐷𝑡,
with the linear dependence on time characteristic of normal diffusion.

(2.7)
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The Langevin Equation
The Langevin equation is an equation of motion for a particle in a fluid that was
originally developed to describe Brownian motion239,241. It provides an alternative,
equivalent way of treating diffusion. For simplicity, consider a particle of mass 𝑚 engaged
in a three-dimensional random walk that begins at the origin. An equation of motion for
the particle must take into account both its interactions with numerous fluid molecules and
the effect of any external forces. Let the effect of the particle’s interactions with fluid
molecules be expressed through some fluctuating net force, 𝐹 (𝑡). In the absence of external
forces, Newton’s second law then has the form
𝑑𝑣
𝑚 ( ) = 𝐹 (𝑡).
𝑑𝑡

(2.8)

An exact expression for the dependence of 𝐹 (𝑡) on 𝑡 is difficult to obtain, since it depends
on the positions of many fluid molecules at any given moment. We therefore resort to a
statistical treatment.
Let 𝐹 (𝑡) consist of a slowly-varying term 𝐹𝑠𝑙𝑜𝑤 and a rapidly-fluctuating noise term
⃗⃗⃗
𝐹 ′ , with
𝐹 = 𝐹𝑠𝑙𝑜𝑤 + ⃗⃗⃗
𝐹′,

(2.9)

where ⃗⃗⃗
𝐹 ′ has a time average of zero. A particle moving through a fluid is subject to a
hydrodynamic drag, acting against its direction of motion. This drag force depends on the
velocity of the particle relative to the fluid, with
𝐹𝑑𝑟𝑎𝑔 = −𝜆𝑣 (𝑡),

(2.10)

where 𝜆 is the drag coefficient241. For a sphere with a radius 𝑎 moving in a fluid with a
dynamic viscosity 𝜇, the drag coefficient is given by the Stokes law as 𝜆 = 6𝜋𝜇𝑎. At any
given moment, the drag force is responsible for slowing the particle down. The constant
change in direction exhibited by the particle in a random walk, however, cannot be
attributed to 𝐹𝑑𝑟𝑎𝑔 . Instead, the particle is also subject to a random fluctuating force due to
its collisions with the fluid molecules, designated by 𝜂(𝑡)241. Since the motion of the fluid
molecules is random, 𝜂 has a mean of zero. The drag force and collision force correspond
to the slowly varying and rapidly fluctuating terms of 𝐹 (𝑡) respectively239,241.
The equation of motion for the particle can therefore be written as
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𝑑𝑣
𝑚 ( ) = −𝜆𝑣 (𝑡) + 𝜂(𝑡).
𝑑𝑡

(2.11)

In this form, with an explicitly decomposed 𝐹 (𝑡), Newton’s second law is known as the
Langevin equation. A solution to Eq. (2.11) can be obtained with the aid of an integrating
factor, and can be written as
𝑡 (𝑠)
𝜆𝑡
𝜂
𝜆(𝑡 − 𝑠)
𝑣(𝑡) = 𝑣 (0) exp (− ) + ∫
exp (−
) 𝑑𝑠 .
𝑚
𝑚
0 𝑚

(2.12)

The applicability of the Langevin equation relies on two fundamental
assumptions239,241. The first assumption is that 𝜂(𝑡) and 𝐹𝑑𝑟𝑎𝑔 are independent. For values
of 𝑡 > 0, the random collision force and the drag force are uncorrelated, with a time
average of
〈𝑣(0) ∙ 𝜂 (𝑡)〉𝑡>0 = 0.

(2.13)

The same assumption cannot be made for 𝑡 < 0, since prior values of the collision force
contribute to determining the velocity at 𝑡 = 0.
The second assumption involves the time scales in the system. Since the fluid
molecules move much faster than the particle, the correlation time 𝜏 ∗ over which the
correlations between the fluid molecules must be taken into account is much smaller than
the characteristic time scale for significant changes in particle velocity. As such, the
collision forces experienced by the particle at time 𝑡 and some later time 𝑡 ′ can be assumed
to be completely uncorrelated as long as (𝑡 ′ − 𝑡) ≫ 𝜏 ∗ . In this case, their correlation
function can therefore be written as,
〈𝜂(𝑡) ∙ 𝜂(𝑡 ′ )〉 = 𝛽𝛿̃(𝑡 − 𝑡 ′ ),

(2.14)

where 𝛽 is a specific constant and 𝛿̃ represents the Dirac delta function.
The mean squared velocity of a particle of mass 𝑚 in thermal equilibrium in a threedimensional system is given by
〈𝜈 2 〉 =

3𝑘𝐵 𝑇
,
𝑚

(2.15)

where 𝑇 is the system temperature and 𝑘𝐵 the Boltzmann constant240. This fact, together
with equations (2.12), (2.13) and (2.14), can be used to show that
𝛽 = 6𝜆𝑘𝐵 𝑇.
The correlation function for 𝜂 can therefore be written as

(2.16)
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〈𝜂(𝑡) ∙ 𝜂 (𝑡 ′ )〉 = 6𝜆𝑘𝐵 𝑇𝛿̃(𝑡 − 𝑡 ′ ).

(2.17)

Thus written, equation (2.17) is known as the fluctuation-dissipation theorem241. It
illustrates the relationship between the mean-squared fluctuating force, 〈𝜂(𝑡)2 〉, and the
friction factor. The more energy is dissipated by friction, the more energy is restored back
to the particle by the collision force. The random force is therefore necessary for keeping
the particle’s mean kinetic energy constant.
Derivation of MSD from the Diffusion Equation
In this section, we derive an expression for the mean squared displacement of a
particle using the diffusion equation. For simplicity, we treat the 1D case and show that
〈𝑥 2 〉 = 2𝐷𝑡, as in Eq. (2.4). The 1D diffusion equation may be written as
𝜕𝑓(𝑥, 𝑡)
𝜕 2 𝑓(𝑥, 𝑡)
=𝐷
,
𝜕𝑡
𝜕 2𝑥

(2.18)

where 𝑓(𝑥, 𝑡) is the mean number of particles per unit volume found at position 𝑥 at time
𝑡 239.
Let 𝑀 be the total number of particles in the system. Since the total number of
particles must be conserved,
∞

∫ 𝑓(𝑥, 𝑡)𝑑𝑥 = 𝑀.

(2.19)

−∞

The solution for f is assumed to be bounded, with no particles found infinitely far away,
such that, in the limit that 𝑥 → ±∞, 𝑓 → 0 and 𝜕𝑓/𝜕𝑥 → 0.
The MSD is by definition given by
〈𝑥 2 〉 =

1 ∞ 2
∫ 𝑥 𝑓(𝑥, 𝑡)𝑑𝑥 .
𝑀 −∞

(2.20)

We may arrive at an expression for 〈𝑥 2 〉 by multiplying the Eq. (2.18) through by 𝑥 2 and
integrating both sides to yield
∞

∞
𝜕𝑓(𝑥, 𝑡)
𝜕 2 𝑓(𝑥, 𝑡)
2
∫ 𝑥
𝑑𝑥 = 𝐷 ∫ 𝑥
𝑑𝑥 .
𝜕𝑡
𝜕 2𝑥
−∞
−∞
2

(2.21)

The left-hand side may be simplified by
𝐿𝐻𝑆 =

𝜕 ∞ 2
𝜕
∫ 𝑥 𝑓(𝑥, 𝑡)𝑑𝑥 = 𝑀 〈𝑥 2 〉
𝜕𝑡 −∞
𝜕𝑡

The right-hand side, in turn, is simplified by successive integration by parts to

(2.22)
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∞
𝜕𝑓 ∞
𝜕𝑓
𝑅𝐻𝑆 = 𝐷 ( [𝑥
] − 2 ∫ 𝑥 𝑑𝑥)
𝜕𝑥 −∞
−∞ 𝜕𝑥
2

∞

= 𝐷(

−2[𝑥𝑓]∞
−∞

+ 2 ∫ 𝑓 𝑑𝑥) = 𝐷(2𝑀)

(2.23)

−∞

If the two sides are then equated and integrated over time, with the assumption that
〈𝑥(0)2 〉 = 0 since all the particles start at the origin, we see that
𝜕 2
〈𝑥 〉 = 2𝐷
𝜕𝑡
〈𝑥 2 (𝑡)〉 = 2𝐷𝑡.

(2.24)

The same process can be carried out for any number of dimensions, starting with
the general diffusion equation
𝜕𝑓(𝑟, 𝑡)
= 𝐷∇2 𝑓(𝑟, 𝑡) .
𝜕𝑡

(2.25)

The MSD then has the value
〈𝑟 2 (𝑡)〉 = 2𝑑𝐷𝑡 ,

(2.26)

where 𝑑 is the dimensionality.
Derivation of MSD from the Langevin Equation
A value for the MSD may likewise be derived using the Langevin equation, for a
particle in thermal equilibrium in a one-dimensional system. For an ensemble of particles,
𝑥̅ = 0 in absence of an external force, where the over-bar denotes an ensemble average.
Let 𝑣 = 𝑥̇ and 𝑑𝑣/𝑑𝑡 = 𝑥̈ . If we multiply the Langevin equation through by 𝑥, we get
𝑚𝑥

𝑑𝑥̇
= −𝜆𝑥𝑥̇ + 𝑥𝜂(𝑡).
𝑑𝑡

(2.27)

Since
𝑑(𝑥𝑥̇ )
𝑑𝑥̇
=𝑥
+ 𝑥̇ 2 ,
𝑑𝑡
𝑑𝑡
the ensemble average of Eq. (2.27) may be written as
̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
𝑑(𝑥𝑥̇ )
̅̅̅̅̅̅̅.
̅̅̅) + 𝑥𝜂(𝑡)
𝑚(
− 𝑥̇ 2 ) = −𝜆(𝑥𝑥̇
𝑑𝑡

(2.28)

(2.29)

To simplify this, we first apply the equipartition theorem, wherein
𝑚𝑥̇̅̅̅2
𝑘𝐵 𝑇
=
.
2
2

(2.30)
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Furthermore, since 𝑥 and 𝜂(𝑡) are uncorrelated and the mean of the fluctuating force is
zero regardless of 𝑥,
̅̅̅̅̅̅̅ = 0 .
𝑥𝜂(𝑡)

(2.31)

Finally, since differentiation with respect to time and ensemble-averaging are commuting
operations,
̅̅̅̅̅̅̅̅) 𝑑(𝑥𝑥̇
̅̅̅)
𝑑(𝑥𝑥̇
=
.
𝑑𝑡
𝑑𝑡

(2.32)

Eq. (2.29) therefore becomes a simple differential equation,
𝑚

̅̅̅)
𝑑(𝑥𝑥̇
̅̅̅ ) = 𝑘𝐵 𝑇 .
+ 𝜆(𝑥𝑥̇
𝑑𝑡

(2.33)

It is easily solved to give
̅̅̅ ) = 𝐶𝑒𝑥𝑝(−𝛾𝑡) + (
(𝑥𝑥̇

𝑘𝐵 𝑇
),
𝜆

(2.34)

where 𝛾 = (𝜆/𝑚) and 𝛾 −1 is the characteristic time of the system. If all the particles are
found at the origin at 𝑡 = 0,
0=𝐶+(

𝑘𝐵 𝑇
).
𝜆

(2.35)

Recall that
̅̅̅2 )
𝑑(𝑥
̅̅̅) .
= 2(𝑥𝑥̇
𝑑𝑡

(2.36)

Eq. (2.34) can therefore be written as
̅̅̅2 )
1 𝑑(𝑥
𝑘𝐵 𝑇
=(
) (1 − exp(−𝛾𝑡))
2 𝑑𝑡
𝜆

(2.37)

and integrated with respect to time to yield a general expression for the MSD as
2𝑘𝐵 𝑇
̅̅̅
𝑥2 = (
) (𝑡 − 𝛾 −1 (1 − exp(−𝛾𝑡))).
𝜆

(2.38)

Two limiting cases may now be examined. In the regime of very short times, 𝑡 ≪
𝛾 −1, the exponential may be expanded as exp(−𝛾𝑡) ≈ 1 − 𝛾𝑡 + (𝛾 2 𝑡 2 )/2. In this case, the
MSD may be approximated as
𝑘𝐵 𝑇 2
̅̅̅
𝑥2 ≈ (
)𝑡 .
𝑚

(2.39)

For 𝑡 ≪ 𝛾, the particle therefore behaves like a free particle, moving with a constant
thermal velocity of 𝑣 = √(𝑘𝐵 𝑇/𝑚).
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At much longer time scales, 𝑡 ≫ 𝛾 −1, the exponential instead tends to zero. The
expression for the MSD then simplifies to
2𝑘𝐵 𝑇
̅̅̅
𝑥2 ≈ (
)𝑡
(2.40)
𝜆
and the particle moves diffusively, with ̅̅̅
𝑥 2 ∝ 𝑡. A comparison of Eq. (2.40) with
Eq. (2.24), the expression for the MSD derived using the diffusion equation, yields a value
for the diffusion coefficient of
𝐷=

𝑘𝐵 𝑇
.
𝜆

(2.41)

For a spherical particle with radius 𝑎 moving in a fluid with viscosity 𝜇, 𝜆 = 6𝜋𝜇𝑎
according to Stokes’ law241. The diffusion coefficient can thus be expressed as
𝑘𝐵 𝑇
𝐷=(
).
6𝜋𝜇𝑎

(2.42)

Eq. (2.42) is known as the Stokes-Einstein equation for a spherical particle undergoing
Brownian motion239.
Ergodicity of Brownian motion
The MSD of particles undergoing Brownian motion can be evaluated in one of two
equivalent ways242. For the purposes of clarity, let angular brackets denote a time average
and an overbar denote an ensemble average when discussing ergodicity. Suppose we have
a system of 𝑁 normally-diffusing particles with 𝑁 ≫ 1 and let ⃗⃗⃗
𝑟𝑛 (𝑡) determine the position
of the 𝑛th particle at some experimental time 𝑡. All the particles are found at the origin at
𝑡 = 0, so ⃗⃗⃗
𝑟𝑛 (0) = 0 for all 𝑛. The MSD can be determined by averaging over the squared
displacements of all particles at each desired 𝑡. The ensemble-averaged MSD is defined by
𝑁

1
̅̅̅̅̅̅̅
𝑟 2 (𝑡) = ∑(𝑟𝑛 2 (𝑡)) .
𝑁

(2.43)

𝑛=1

Alternatively, the MSD can also be evaluated for each individual particle by finding
the time-averaged mean of 𝛿 2 (𝜏), the square of its displacement over some lag time, 𝜏. For
the 𝑘 𝑡ℎ particle,
2

𝛿𝑘 2 (𝜏) = (𝑟⃗⃗⃗𝑘 (𝑡 ′ + 𝜏) − ⃗⃗⃗
𝑟𝑘 (𝑡 ′ )) .

(2.44)

A single sufficiently long particle trajectory, i.e., with (𝜏 ≪ 𝑇) where 𝑇 is the overall
measurement time over which the particle is tracked, can therefore yield many 𝛿𝑘 2 (𝜏)
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values, depending on the chosen start time 𝑡 ′ . The temporally averaged MSD of one
particle is then formally given by
〈𝛿 2 (𝜏, 𝑇)〉 =

𝑇−𝜏
1
2
∫ (𝑟(𝑡 ′ + 𝜏) − 𝑟(𝑡 ′ )) 𝑑𝑡 ′ ,
(𝑇 − 𝜏) 0

(2.45)

with a corresponding discrete version applying to experimental data.
In a Brownian process, the two definitions of MSD are equivalent and
lim 〈𝛿 2 (𝜏, 𝑇)〉 = ̅̅̅̅̅̅̅̅̅̅̅̅
𝑟 2 (𝑡 = 𝜏)

𝑇→∞

(2.46)

when the measurement time 𝑡 is equal to the lag time 𝜏. The motion of freely-diffusing
particles is therefore said to be an ergodic process, characterized by the equivalence of
ensemble and temporal averages at long measurement times242.
Anomalous Diffusion
Particles in a variety of biological and physical systems have been observed to
undergo anomalous diffusion242,243. Anomalous diffusion is characterized by a non-linear
dependence of the ensemble-averaged MSD, ̅̅̅̅̅̅̅
𝑟 2 (𝑡), on time 𝑡. This dependence can often
be described by a power-law form over a limited range of t, with
̅̅̅̅̅̅̅
𝑟 2 (𝑡) ≈ 2𝑑𝐾𝛼 𝑡 𝛼 ,

(2.47)

over that range242. Here 𝛼 is the anomalous diffusion exponent and 𝐾𝛼 is the generalized
diffusion coefficient, with units of 𝑚2 𝑠 −𝛼 . Processes for which 𝛼 < 1 and 𝛼 > 1 are said
to be subdiffusive and superdiffusive respectively.
Diffusion of particles in single-particle tracking studies is frequently analyzed using
the time-averaged MSD. Such an analysis must, however, be performed with caution, since
there is no reason to expect anomalous diffusion processes to be ergodic. Many processes
instead exhibit weak ergodicity breaking with
〈𝛿 2 (𝜏, 𝑇)〉 ≠ ̅̅̅̅̅̅̅
𝑟 2 (𝜏) ,

(2.48)

even in the limit of 𝑇 → ∞. Moreover, the temporal averages of such processes are
frequently irreproducible, even over long measurement time scales. In practice, timeaveraged MSDs of individual particles are therefore frequently averaged across the entire
ensemble, with sufficiently many trajectories242. The ensemble-averaged, time-averaged
MSD (EA-TAMSD) is given by
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𝑁

1
̅̅̅̅̅̅̅̅̅̅̅̅
〈𝛿 2 (𝜏, 𝑇)〉 = ∑〈𝛿𝑘 2 (𝜏, 𝑇)〉 .
𝑁

(2.49)

𝑘=1

Several processes, such as subdiffusive continuous time random walks (CTRWs) and
scaled Brownian motion, exhibit a linear lag time dependence reminiscent of normal
〈𝛿 2 (𝜏, 𝑇)〉 ∝ 𝜏
diffusion, with ̅̅̅̅̅̅̅̅̅̅̅̅

242,244,245

. In the absence of a comparison with ̅̅̅̅̅̅̅
𝑟 2 (𝑡) , it is

easy to mistake them for Brownian motion.
The degree of variability in the time-averaged MSDs of individual particles may be
described by the distribution 𝜙(𝜉) of an associated dimensionless quantity,
𝜉𝑘 =

〈𝛿𝑘 2 (𝜏)〉
,
̅̅̅̅̅̅̅̅̅
〈𝛿 2 (𝜏)〉

(2.50)

computed for each particle242. For a fully ergodic, ideal process with completely
reproducible particle tracks, as 𝑇 → ∞, 𝜉𝑘 = 1 and
𝜙(𝜉) = 𝛿̃(𝜉 − 1),

(2.51)

where 𝛿̃ is a Dirac delta function.
In general, variability in 〈𝛿𝑘 2 (𝜏, 𝑇)〉 can be characterized by the ergodicity breaking
parameter
𝐸𝐵 = lim (〈𝜉 2 〉 − 〈𝜉〉2 ).

(2.52)

𝑇→∞

The form of the dependence of ̅̅̅̅̅̅̅
𝑥 2 (𝑡) and 〈𝛿 2 (𝜏, 𝑇)〉 on experimental time and lag
time is known for several anomalous diffusion models242. The scatter of time averages has
also been characterized for a number of processes. A detailed investigation of both
ensemble-averaged and time-averaged MSDs, along with 𝜙(𝜉), can therefore allow for an
anomalous diffusion process to be more easily spotted and, often, described in terms of a
particular mathematical model.
Subdiffusive Continuous Time Random Walk
The continuous time random walk is a model originally developed by Montroll and
Scher to study the diffusion of charge carriers in amorphous inorganic semiconductors246.
In this model, the motion of a particle is characterized by a series of random jumps 𝛿𝑥, in
between which the particle is trapped for a random waiting time 𝜏𝑤

242

. The waiting time

and length of each jump are independent of those of the previous jumps.
Let 𝜓(𝜏𝑤 ) and 𝜆(𝛿𝑥) be the probability density functions of the jump lengths and
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waiting times, respectively. Suppose 𝜆(𝛿𝑥) is symmetric, with 〈𝛿𝑥〉 = 0 – corresponding
to an unbiased CTRW – but with a finite jump length variance 〈𝛿𝑥 2 〉. If the characteristic
waiting time of the system, defined by 〈𝜏𝑤 〉, is finite, the process converges to Brownian
motion in the long time diffusion limit of 𝑇 ≫ 𝜏 247. If 〈𝜏𝑤 〉 is infinite, however, as is the
case for waiting time PDFs with non-exponential tails, subdiffusive CTRWs arise242. In
such CTRWs, the waiting times are power-law distributed, with
𝜓(𝜏𝑤 ) ∝

1
𝜏𝑤 (1+𝛼)

,

0 < 𝛼 < 1.

(2.53)

The system is therefore subject to aging, wherein, in the absence of a characteristic time,
longer and longer waiting times can be observed as the system evolves and particles get
caught in deeper energy traps242,248. The number of particles perceived as immobile
consequently depends on the real time of the process and the extent of prior ageing.
The ensemble-averaged time-averaged MSD for subdiffusive CTRWs has been
shown to depend on the total measurement time 𝑇, with
𝜏
2 (𝜏, 𝑇)〉 ∝
̅̅̅̅̅̅̅̅̅̅̅̅
〈𝛿
𝑇 1−𝛼

(2.54)

for 𝜏 ≪ 𝑇 249. Its variation with lag time 𝜏 is linear. The ensemble-averaged MSD, on the
other hand, has a power-law time-dependence of ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 𝛼 , illustrating the non-ergodic
behavior of subdiffusive CTRWs242.
The behavior of particles in a subdiffusive CTRW further deviates from that of
Brownian particles in the case of physical confinement242,244. The MSD of a Brownian
particle confined to some finite interval or subject to an external harmonic potential will
eventually evolve to a plateau, with ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 0 . The ensemble-averaged MSD of a
particle undergoing a subdiffusive CTRW in the presence of an external potential likewise
reaches a plateau242. Due to ergodicity breaking, however, the ensemble-averaged timeaveraged MSD continues increasing sublinearly with increasing 𝜏 244,250. The EA-TAMSD
of confined subdiffusive CTRWs has been shown to be related to lag time and total
measurement time through
1−𝛼

𝜏
̅̅̅̅̅̅̅̅̅̅̅̅
〈𝛿 2 (𝜏, 𝑇)〉 ∝ ( )
𝑇

(2.55)

for 𝜏 ≪ 𝑇 250.
If the particle is initially found in the center of a harmonic potential well or in the
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middle of a finite interval, its EA-TAMSD first exhibits linear scaling with lag time,
characteristic of unconfined diffusion, and then switches to sublinear scaling for larger 𝜏
244,250

. Such behavior is preserved even if the power-law scaling of 𝜓(𝜏𝑤 ) is terminated at

some specific cutoff, with an associated characteristic time 𝜏𝑤 ∗ and
𝜓(𝜏𝑤 ) =

𝑑
𝐶𝛼
𝜏𝑤
[1 −
exp (− ∗ )],
𝛼
(𝐶 + 𝜏𝑤 )
𝑑𝜏𝑤
𝜏𝑤

(2.56)

where 𝐶 is some scaling constant244,251. In this case, the walk exhibits all the features of a
confined subdiffusive CTRW for 𝜏 ≪ 𝜏𝑤 ∗ .
The time-averaged MSD values determined from trajectories of individual particles
undergoing CTRWs exhibit a significant degree of scatter and lack reproducibility242. The
extent of their scatter is characterized by the distribution 𝜙(𝜉), with 𝜉 given by Eq. (2.50).
As 𝑇 → ∞,
1

𝜙(𝜉) =

Γ(1 + 𝛼)𝛼
𝛼𝜉

1+

1
𝛼

1

Γ(1 + 𝛼)𝛼
𝑙𝛼 (
),
1
𝛼
𝜉

(2.57)

where 𝑙𝛼 (𝑧) is a one-sided Lévy stable distribution249. For 𝛼 ≤ 0.5, the maximum of the
distribution is found at 𝜉 = 0. In the specific case of 𝛼 = 0.5, 𝜙(𝜉) reduces to a halfGaussian. For 𝛼 > 0.5, the maximum of the distribution is found at 𝜉 = 1. Particle
confinement is reported not to have a significant effect on 𝜙(𝜉) 244. The introduction of a
waiting time cutoff, as well as system noise, can, however, drastically alter the shape of
𝜙(𝜉), which then resembles a Gaussian centered at 𝜉 = 1 observed for ergodic systems at
a finite 𝑇 244,251,252. In a biological context, such noise may arise from the diffusion of a cell
on a coverslip, so care must be taken when interpreting 𝜙(𝜉) 252.

2.2 Single-Particle Tracking Methods
Detection and Tracking of Particles
The diffusion of molecules in the plasma membrane of living cells can be captured
by labelling the particles with a fluorescent marker and imaging each cell over a period of
time using fluorescence microscopy. The series of images obtained is then used to track
the motion of each particle from frame to frame. A good single-particle tracking (SPT)
method must be capable of successfully determining the position of each particle in each
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video frame for the accurate reconstruction of particle tracks. The positions of
fluorescently-labelled particles can be determined to sub-pixel accuracy by fitting a
Gaussian kernel to the point spread function (PSF) of each fluorophore253. Reliably linking
the particle tracks from frame to frame is, however, more challenging.
High particle density, the presence of multiple modes of diffusion, temporary
merging of particles, and particle disappearance all compromise the accuracy of the
tracking and increase the post-acquisition analysis time. Some SPT methods seek to
circumvent these challenges by tracking particles only at a low density. Reduced particle
density, however, reduces the amount of data available from an experiment, making
infrequent events more difficult to detect and increasing the statistical uncertainty in the
data obtained. Furthermore, it does not eliminate the problems caused by particle
disappearance due to fluorophore blinking, photobleaching, or motion out of the focal
plane of the imaging system
The most rigorous approach to SPT is to determine all the tracks possible for each
particle, across all surveyed space and time, and then to select the best ensemble of particle
trajectories from these possible solutions. This method, known as multiple hypothesis
tracking (MHT), therefore yields a globally optimal solution254. Since it makes concurrent
use of all particle locations at all available times, the solution is globally optimized with
respect to both space and time. In practice, however, MHT is very computationally
intensive and inapplicable to more than a few select situations. Most particle tracking
algorithms therefore rely on linking the particles frame-by-frame, wherein locally optimal
choices approximate a globally optimal solution. Such algorithms are said to be spatially
global but temporally “greedy”, with a temporally local solution which is not guaranteed
to match a temporally global one.
An SPT algorithm developed in 2008 by Jaqaman et al. is a two-step, spatially
global approximation to MHT that identifies tracks by means of a linear assignment
problem67. In the first step, track segments are assigned to particles in a temporally greedy
manner by linking the particles frame-by-frame. Each particle in each frame is linked to at
most one particle in the preceding or the following frame, generating partial tracks. In the
second step, track segments are linked in a temporally global manner, accounting for
temporary particle disappearances and merges. The linear assignment problem is
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formulated by characterizing all potential links of particles or tracks with an associated
linkage-specific cost. The cost of closing a gap between two track segments, for example,
depends on the distance between them. The cost of merging or splitting events is, in turn,
a function of both distance and fluorophore intensity. At each step, the problem is then
solved by identifying a set of linkages that minimizes the total imposed cost. In the past,
this algorithm has been used successfully to look at the lifetimes of clathrin-coated pits and
CD36 diffusion67. In the present work, it is employed to characterize the diffusion of CD93.
Classification of Particle Tracks
Following the reconstruction of the particle tracks, the SPT software of Jaqaman et
al. classifies the motion of each particle as free, directed or confined67. Their classification
relies on the moment spectrum scaling (MSS) analysis developed by Ferrari et al. in 2001
and employed in a biological context by Ewers et al. in 2005196,255. The analysis is
performed separately for each track. Briefly, the time-averaged moments of the 𝑘th track,
defined by
𝑇−𝜏
1
𝑣
〈𝛿𝑘 (𝜏)〉 =
∫ (𝑟⃗⃗⃗𝑘 (𝑡 ′ + 𝜏) − ⃗⃗⃗
𝑟𝑘 (𝑡 ′ )) 𝑑𝑡 ′ ,
(𝑇 − 𝜏) 0
𝑣

(2.58)

are calculated for 𝑣 = 0,1, … 6. Assuming that each moment exhibits a power-law
dependence on the lag time, i.e., that
〈𝛿𝑘 𝑣 (𝜏)〉 ∝ 𝜏 𝛾𝑣 ,

(2.59)

linear regression analysis of log-transformed data is then used to find the power-law index
𝛾𝑣 of each moment.
According to Ferrari et al., the power-law index 𝛾𝑣 is expected to be linearly
dependent on the order of the moment 𝑣 for all strongly self-similar diffusion processes,
with
𝛾𝑣 = 𝑆𝑀𝑆𝑆 𝑣.

(2.60)

A plot of 𝛾𝑣 as a function of 𝑣, known as an MSS plot, is therefore a line. The slope of this
line, 𝑆𝑀𝑆𝑆 , provides information about the mode of diffusion. For Brownian motion, 𝛾𝑣 is
one and 𝑆𝑀𝑆𝑆 = 1/2. Other values of 𝑆𝑀𝑆𝑆 correspond to anomalous diffusion. Particles
are generally classified as confined if they exhibit subdiffusive motion, with 𝑆𝑀𝑆𝑆 < 1/2.
Particles with 𝑆𝑀𝑆𝑆 > 1/2 are superdiffusive and are said to be directed. Despite these
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classifications, however, no inference is made about the nature or cause of their
subdiffusive or superdiffusive behavior. The labels “confined” and “directed” are merely
used in place of “subdiffusive” and “superdiffusive” respectively.
For each free track, the software computes an estimate of the free diffusion
coefficient by fitting a line through the first five points computed for the second moment.
For each confined track, it determines an estimate of the so-called confinement zone size.
To do so, the two-dimensional position of the particle as a function of time is used to
generate a matrix which contains the variances and covariances of the 𝑥 and 𝑦 components
of the position. The confinement radius is then estimated from twice the mean positional
standard deviation extracted from the variance-covariance matrix, 2𝜎𝑚 . The algorithm also
determines the uncertainty in the position of each particle, confined or otherwise, at every
point along its track, in both the 𝑥 and 𝑦 directions. When a Gaussian kernel is fitted to the
PSF of a point, the residuals of the fit are used to estimate the uncertainties 𝑑𝑥 and 𝑑𝑦 for
that point. The mean localization uncertainty of each particle in the 𝑥 direction, 〈𝑑𝑥〉, is
just the average of 𝑑𝑥 along its track. An equivalent procedure is used to find 〈𝑑𝑦〉. The
greater of 〈𝑑𝑥〉 and 〈𝑑𝑦〉 is referred to as the positional accuracy of the track in the software.

2.3 Materials and Biological Methods
CHO Cell Culture and Transfection
Chinese Hamster Ovary (CHO) cells were cultured at 37 ℃ and 5% CO2 in Roswell
Park Memorial Institute (RPMI) media (Wisent) with 10% FBS (Invitrogen). The cells
were split upon reaching 80% of confluency. For imaging experiments, the cells were
cultured on sterile, 18 mm round coverslips housed in 12-well plates. GenJet Plus In Vitro
DNA Transfection Reagent (SignaGen Laboratories) was used to transfect the cells with a
human-CD93-GFP construct previously prepared in our lab by J. Ellins. In this construct,
enhanced green fluorescent protein (GFP) was attached to the C-terminal end of the
cytosolic tail of human CD93. Transfection complexes were prepared in serum-free
Dulbecco’s Modified Eagle’s Medium (DMEM, Wisent). The transfection was carried out
in accordance with the manufacturer’s recommendations. The cells were used within 24 h
of transfection.
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Isolation and Culture of Human Monocytes
The collection of blood from healthy donors for the isolation of human monocytes
was approved by the Health Science Research Ethics Board of the University of Western
Ontario. The procedure was performed in accordance with the guidelines of the Tri-Council
Policy Statement on human research. Butterfly blood collection needles were used to draw
the blood into 10 ml BD Vacutainer plastic collection tubes with Sodium Heparin
(ThermoFisher Scientific). The blood was then carefully layered on top of an equal volume
of pre-warmed Lympholyte-poly cell separation media (Cedarlane) in bacterial culture
tubes, with 5 ml of media and 5 ml of blood per tube. The tubes were centrifuged at
1500 rpm for 35 min at 22 ℃ and allowed to come to a complete rest without braking. The
top band of cells, containing peripheral blood mononuclear cells (PBMCs), was then
collected from each tube. The PBMCs were washed with phosphate-buffered saline (PBS)
in a 50 ml falcon tube, which was then centrifuged for 6 min at 1500 rpm. The cell pellet
was re-suspended in pre-warmed RPMI-1640 media with 10% FBS and 1% Corning
antibiotic-antimycotic solution.
The cells were then pipetted onto sterile 18 mm round coverslips, with 250 μl of
solution per coverslip, and incubated for 1 h at 37 ℃ and 5% CO2 to allow the monocytes
to adhere to the coverslip surface. A 10 ml volume of blood typically yielded enough
monocytes for 12 coverslips, at a density appropriate for single particle tracking (~40%
confluency). Non-adherent cells were then removed by a triple wash with PBS. Fresh
PRMI media with 10% FBS and 1% antibiotic-antimycotic solution was then added to the
monocytes at 1 ml per well. The cells were kept at 37 ℃ and 5% CO2 and used within
24 h.
Immunoblotting for PMA-induced CD93 Shedding
Equal numbers of cells were pre-seeded in the wells of a 6-well plate at
approximately 80% confluency and transfected with CD93-GFP or empty vector as
described above. The following day, the cells were treated with 0.1 μg/ml phorbol 12myristate 13-acetate (PMA) for either 5 h or 45 min, to determine whether PMA induces
the shedding of CD93 in transfected CHO cells. Cells transfected with an empty vector and
untreated cells were used as negative controls. Immediately following PMA treatment, the
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cell supernatants were collected. The cells were washed with PBS and lysed with
Laemmli’s buffer containing protease and phosphate inhibitors (ThermoScientific), with
250 μl buffer per well. Cell lysates were boiled for 5 min at 95 ℃ and then vortexed to
shear the genomic DNA. The lysates were run on a non-reducing 10% SDS-PAGE gel and
transferred to a nitrocellulose membrane. The membrane was blocked overnight in 5%
skim milk in TBST (Tris-buffered saline and Tween 20) buffer.
To test for the presence of CD93, the membrane was incubated with primary
mouse-anti-human CD93 (1: 1000, eBioscience) in TBST with 5% skim milk for 2 h. To
check for equivalent loading of samples, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was simultaneously probed for with a monoclonal mouse anti-GAPDH antibody
(EMD Millipore). After three 5 min washes with TBST, the membrane was incubated with
anti-mouse IR700 secondary antibody (1: 10,000, Jackson ImmunoResearch) for 1 h.
Following three 5 min washes with TBST, the membrane was imaged using the LI-COR
Odyssey Infrared Imaging System.
Live-Cell Labelling for Single Particle Tracking
CD93 molecules endogenous to human monocyte cells or transfected into CHO
cells were fluorescently labelled. The labelling was performed in living cells for subsequent
single particle tracking. All incubations in the protocol were performed at 10 ℃. The cells
were first incubated in blocking solution consisting of 4% human serum in HEPESbuffered RPMI (HPMI) for 20 min. They were then labelled with a primary monoclonal
mouse-anti-human CD93 antibody (eBioscience) diluted in the blocking solution by
incubating for 20 min. A range of primary antibody dilutions was tested. The dilution of
primary antibody used is indicated in the results of each specific experiment. Following a
series of washes with the blocking solution, the cells were then incubated for 10 min with
Cy3-conjugated rabbit-anti-mouse Fab (Fragment of antigen binding) fragments
(1: 1000, Jackson ImmunoResearch), which served as the secondary antibody. The Cy3
probe has maximum excitation wavelength of 550 nm, with a maximum emission at
570 nm. After another series of washes, the cells were labelled for 10 min with goat-antirabbit-Cy3 Fab (1: 1000, Jackson ImmunoResearch), which acted as the tertiary antibody.
The cells were then washed and kept at 10 ℃ in HPMI prior to imaging.
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Cellular Imaging and Single Particle Tracking
Cells were imaged using a Leica DMI6000B microscope equipped with a
Photometrics Evolve-512 Delta EM-CCD camera and a Chroma Sedat Quad filter set.
During the imaging, the cells were kept at 37℃ and 5% CO2 in an imaging buffer. For all
SPT-related imaging, the microscope was focused on the flatter, bottom surface of the cells,
adjacent to the coverslip. Movies for SPT analysis were taken using the Sedat Cy3 (Ex:
550 ± 25 nm, Em: 605 ± 52 nm) channel at a magnification of 113x (100x objective
with 1.2x magnification, followed by a camera reducer). Each movie was 30 s long, with
a system-defined frame rate of 10 frames per second. CHO cells were confirmed to express
CD93-GFP by imaging them in the GFP channel (Ex: 490 ± 20 nm, Em: 535 ± 36 nm).
To test the immediate effect of treatment with PMA on CD93 diffusion, movies of
CD93 diffusion in cells on one coverslip were first collected. PMA was then added to the
imaging buffer, to a final concentration of 0.1 μg/ml or 0.2 μg/ml, as indicated. More cells
from the same coverslip were then imaged.
In all cases, images were prepared for SPT analysis by cropping around the area of
the cell and saving them as TIFF stacks using ImageJ software. Single particle tracking and
preliminary analysis of diffusion were done using the software of Jaqaman et al., described
in Section 2.2, for several dilutions of the primary antibody, as indicated in the results.

2.4 Diffusion Analysis
Following a preliminary analysis of CD93 diffusion with the SPT software
developed by Jaqaman et al., reconstructed particle tracks were used to perform further
analysis on the various sub-populations of particles, grouped together based on their
software-generated diffusion classification or confinement zone size67. All analysis was
performed using software written in MATLAB (7.10.0, The MathWorks Inc., Natick, MA,
United States, R2010a). The data were first filtered to remove tracks with a positional
accuracy worse than a maximum uncertainty cutoff. The uncertainty cutoff was chosen to
be 25 nm, unless otherwise specified. At least 1,000 tracks were left in each data set after
the filtering process.
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Extended MSD Curves and Van Hove Functions
To compare the diffusion behavior of CD93 molecules from different subpopulations or cell types, the ensemble-averaged time-averaged MSD was calculated for
each group for 𝜏 in the range of 0.1 to 10 s. These MSDs were determined without
accounting for the length of individual tracks, i.e., 𝑇, and are referred to as “extended” due
to their longer range of lag times relative to time-averaged MSD curves grouped by specific
total measurement time. The extended 2D EA-TAMSD was defined as
2
2
̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
̅̅̅̅̅̅̅̅̅
〈𝑟̃ 2 (𝜏)〉 = 〈(𝑥(𝑡 ′ + 𝜏) − 𝑥(𝑡 ′ )) + (𝑦(𝑡 ′ + 𝜏) − 𝑦(𝑡 ′ )) 〉 .

(2.61)

A comparison of the one-dimensional MSD in the 𝑥 and 𝑦 directions showed no significant
anisotropy. For each curve, a lag-time-dependent diffusion exponent, 𝛾, was estimated
using a sliding window approach, in order to better identify the range of 𝜏 in which the
diffusion of the molecules may be Brownian.
The particle tracks were also used to plot normalized histograms of particle
displacements in the 𝑥 and 𝑦 directions for each desired lag time and population. These
histograms served as approximations of the normalized probability density functions,
otherwise known as van Hove self-correlation functions. Each PDF was fitted to a Gaussian
distribution as well as to a family of general Lévy alpha-stable distributions, of which the
Gaussian, Cauchy and Lévy distributions are all examples256. A third-party MATLAB
algorithm was used to perform the alpha-stable distribution fits257. PDFs for the magnitude
of the 2D particle displacement were also fitted to the distribution expected for Brownian
diffusion,
𝑓(𝑟̃

2)

𝑟̃ 2
= 𝐶1 (𝑟̃ exp (− )),
𝐶2

(2.62)

where 𝐶1 and 𝐶2 were treated as fitting parameters.
Cage Effect Analysis
To determine whether the particles classified as confined by the SPT software were
indeed caged and to assess the strength of their cages, an algorithm developed by Doliwa
and Heuer in 1998 was used to perform a cage effect analysis203. In this method, the
microstructure of the fluid in which the particles diffuse is probed by examining
correlations between two successive displacements.
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For each lag time 𝜏 and each particle in a given ensemble, the positions of the
particle at three successive time points, 𝑟(𝑡0 ), 𝑟(𝑡0 + 𝜏), and 𝑟(𝑡0 + 2𝜏), were used to find
two successive steps made by the particle, 𝑟01 and 𝑟12. The projection 𝑥12 of the second
step along the direction of the first step was then determined, with 𝑥12 = 𝑟12 ∙ 𝑟̂01 . The
projection of 𝑟12 in a direction perpendicular to that of the first step, represented by 𝑦12 ,
was also found. This procedure was done for all the particles in the ensemble and all values
of 𝑡0 . The 𝑥12 values were then grouped according to the magnitude of the first step 𝑟01 of
their associated step pair.
𝑝(𝑥12 |𝑟01 ), the conditional probability distribution of the particle travelling a
specific distance 𝑥12 in the direction of the first step during the second step, given a first
step of a specific length 𝑟01 , was next examined to obtain its variance 𝜎||2 (𝑟01 ). The
conditional probability distribution 𝑝(𝑦12 |𝑟01 ) and its variance, 𝜎⊥2 (𝑟01 ), were also
determined. The mean of the 𝑝(𝑥12 |𝑟01 ) distribution was then evaluated for each specific
𝑟01 , resulting in mean 𝑥12 as a function of the initial step size, ⟨𝑥12 (𝑟01 )⟩. Equivalent
averaging was performed to obtain ⟨𝑦12 (𝑟01 )⟩. The dependence of

⟨𝑥12 (𝑟01 )⟩ and

⟨𝑦12 (𝑟01 )⟩ on 𝑟01 was then determined.
The relationship between ⟨𝑥12 (𝑟01 )⟩ and 𝑟01 provides information about the
microenvironment of the diffusing particles. No correlation is expected for the successive
steps of particles diffusing in a Brownian fashion, in which case ⟨𝑥12 ⟩ ≈ 0 for all 𝑟01 . The
successive displacements of caged particles are, however, expected to exhibit a negative
correlation, with ⟨𝑥12 ⟩ < 0 203,204. A caged particle moving in one direction during the first
step is, on average, expected to move in the opposite direction during the second step due
to interactions with the perimeter of the cage. ⟨𝑥12 ⟩ has been reported to be become more
negative as 𝑟01 increases, with ⟨𝑥12 ⟩ = A − 𝑐𝑥 𝑟01. The magnitude of the slope 𝑐𝑥 is a
measure of the cage strength, since stronger cages are expected to result in greater anticorrelation. The value of 𝑟01 at which the negative correlation starts to break down, 𝑟𝑐 , is a
measure of the cage size, which is approximately 2𝑟𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 + 𝑟𝑐 . Motion perpendicular to
the direction of the previous step was expected to be completely independent, with
⟨𝑦12 (𝑟01 )⟩ ≈ 0, and was utilized as a negative control. Differences in 𝜎||2 (𝑟01 ) and 𝜎⊥2 (𝑟01 )
were assessed to probe for system anisotropy.
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Ensemble-Averaged and Time-Averaged MSDs in Anomalous Diffusion
To perform a thorough comparison of ensemble-averaged and time-averaged
MSDs, one population of CD93 tracks from CHO cells, labelled with primary antibody at
a 1: 10,000 dilution, was selected. Ensemble-averaged 2D MSDs were then calculated
according to Eq. (2.43), for the sub-populations of free particles and particles in
confinement zones of various size. For each track, the time of onset was treated as 𝑡 = 0.
The ensemble-averaged time-averaged MSDs were calculated for each of the subpopulations. When the EA-TAMSD was calculated for the extended MSD curves as
described earlier in this section, no distinction was made based on the total measurement
time (i.e., the length of the tracks 𝑇). Here, however, the calculations were performed
differently to allow an evaluation of the dependence of the ensemble-averaged timeaveraged MSDs on both 𝜏, the lag time, and 𝑇, the total measurement time. For each 𝑇, a
selection of trajectories tracked for a total time greater than or equal to this measurement
time was made. All the tracks were then cut off at this chosen 𝑇, generating a set of
trajectories with the same total measurement time258. The time-averaged MSD was then
computed for each trajectory in the set, according to Eq. (2.45), for 𝜏 ≤ (𝑇/3). The timeaveraged MSD values were then ensemble-averaged according to Eq. (2.49), yielding EA2 (𝜏, 𝑇)〉. These were used to examine the dependence of EA̅̅̅̅̅̅̅̅̅̅̅̅
TAMSD values of the form 〈𝛿

TAMSD on 𝑇 and 𝜏, and compared with the predictions of existing models of anomalous
diffusion.
Mean maximal excursion (MME) analysis, a tool developed by Tejedor et al. to
determine whether unconfined particles move in accordance with the CTRW diffusion
model, was performed on the free CD93 receptor ensemble from CHO cells259. The regular
ensemble-averaged fourth moment of particle motion was calculated according to
𝑁

1
̅̅̅̅̅̅̅
𝑟 4 (𝑡) = ∑(𝑟𝑛 4 (𝑡)) ,
𝑁

(2.63)

𝑛=1

while the regular second moment corresponded to the previously found ensemble-averaged
MSD. The second and fourth MME moments were determined by first finding 𝑟𝑀 (𝑡) – the
maximum distance travelled by a particle away from its original position at 𝑡=0 in the span
of a measurement time 𝑡 – and then calculating the ensemble-averaged moments, with
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𝑁

1
̅̅̅̅̅̅̅̅
𝑟𝑀 2 (𝑡) = ∑(𝑟𝑀 2 (𝑡))𝑛
𝑁

(2.64)

𝑛=1

and
𝑁

1
4
𝑟̅̅̅̅̅̅̅̅
∑(𝑟𝑀 4 (𝑡))𝑛 .
𝑀 (𝑡) =
𝑁

(2.65)

𝑛=1

Moment ratios of the fourth to the squared second moment were calculated for both regular
and MME moments, with
𝑅𝑒𝑔𝑢𝑙𝑎𝑟 𝑅𝑎𝑡𝑖𝑜 =

̅̅̅̅̅̅̅
𝑟 4 (𝑡)

(2.66)

2
2 (𝑡)]
[𝑟̅̅̅̅̅̅̅

and
𝑀𝑀𝐸 𝑅𝑎𝑡𝑖𝑜 =

̅̅̅̅̅̅̅̅
𝑟𝑀 4 (𝑡)
2
[𝑟̅̅̅̅̅̅̅̅
𝑀 (𝑡)]

2

,

(2.67)

and compared with the cutoff values of 2 (regular ratio) and 1.49 (MME ratio) above which
the particle motion corresponds to a CTRW.
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Chapter 3
CD93 Diffusion: Results
3.1 CD93 Diffusion in CHO Cells and Human Monocytes
CD93-GFP Diffusion in CHO cells
In this study, we sought to characterize the diffusion of endogenously-expressed
CD93 in human monocyte cells, before and after the cells were treated with a sheddinginducing agent. Owing to the greater availability of immortalized cell lines over primary
cells, the mobility of CD93 receptors was first assessed in a heterologous system. Chinese
hamster ovary (CHO) cells were transfected with CD93-GFP, a construct that allowed for
the easy selection of CD93-expressing cells for receptor tracking, as shown in Fig. 3.1(a).
As expected, ectopically expressed CD93-GFP is distributed throughout the cell’s plasma
membrane and the associated protrusions, and throughout the endo-membranes of the
secretory system. To confirm that CD93-GFP was indeed on the cell surface, cells
ectopically expressing CD93-GFP were immunostained with anti-CD93 and a Cy3
secondary antibody, as shown in Fig. 3.1(b). This co-staining of CD93 confirmed that the
attachment of GFP to the cytosolic tail of CD93 did not interfere with the trafficking of the
receptor to the cell surface and was compatible with single particle tracking (SPT). The
density of immunolabelled CD93-GFP was lower than the overall density of these
receptors and they lacked the distribution typical of endo-membranes, confirming that this
protocol was labelling cell-surface CD93 alone.
To find an appropriate density of Cy3-tagged CD93-GFP molecules for single
particle tracking, several dilutions of the primary antibody were tested, since its
concentration was the limiting factor in the labelling process. Dilutions of 1: 1,000,
1: 2,500, and 1: 5,000 resulted in a labelled receptor density that was too high for the
tracking software to detect individual tracks. SPT was performed successfully for dilutions
of 1: 7,500 and 1: 10,000, whereas the 1: 20,000 dilution was too dilute, resulting in fewer
obtained tracks (e.g. ~122 accuracy-filtered tracks/cell vs ~713 accuracy-filtered
tracks/cell obtained on the same day at the 1: 10,000 dilution).
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a)

b)

Figure 3.1. A representative image of a CHO cell transfected with CD93-GFP
and immuno-labelled with Cy3.
a) CHO cells were transfected with human CD93-GFP. The cell presented here is
imaged (113X magnification) in the GFP channel, with a peak excitation at 488 nm
and a peak emission at 507 nm. The microscope is focused on the bottom surface
of the cell. CD93-GFP appears to be distributed throughout the cell membrane, with
some endomembrane localization. b) CD93-GFP-transfected CHO cells were
labelled with a primary anti-CD93 antibody at a 1: 7,500 dilution, followed by
labelling with Cy3-conjugated secondary and tertiary antibodies. The same cell as
in (A) is imaged in the same focal plane (113X magnification) in the Cy3 channel,
with a peak excitation at 550 nm and a peak emission at 570 nm. The distribution
of labelled receptors is distinct from that of CD93-GFP at large. Their lower density
allows for successful single particle tracking.
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All particle tracks from all data sets were classified as free, confined, or
directed/linear by the SPT software, developed by Jaqaman et al., using moment spectrum
scaling analysis, as described in Section 2.267. The mean confinement radius of each
confined track and the early-time diffusion coefficient of each free track were then
determined by the software, as described. Representative CD93 trajectories for tracks of
different classification and confinement size, randomly selected from a set of CHO cells
(1: 10,000 antibody dilution), are shown in Fig. 3.2. The distinction between free and
confined receptors is visually evident in most cases, with receptors confined to larger
confinement zones generally exploring a greater area than those confined to smaller zones.
Following preliminary analysis with the SPT software, all particle tracks were
filtered, such that only tracks with a mean position uncertainty of less than 25 nm were
retained for further analysis. A cutoff of 35 nm was applied to all relevant track populations
when analyzing the effect of PMA on CD93 diffusion, since the nature of those
experiments had the potential of limiting the number of available tracks. Fig. 3.3 illustrates
the filtering process for a population of CD93-GFP tracks from CHO cells (𝑛 = 12)
labelled at 1: 10,000. A total of 8,972 trajectories, corresponding to 42.6% of the total
tracks, passed the accuracy cutoff of 25 nm in this cell population.
Fig. 3.3(a) shows the accepted population of confined tracks, i.e., 40.6% of all
confined tracks, by plotting the confinement size of each trajectory against its mean
localization uncertainty. As shown in Fig. 3.3(b), filtering did not significantly alter the
normalized distribution of the confinement zone radii of confined receptors. It did,
however, modestly decrease the size of a small peak at low confinement radius, which
likely corresponds to largely immobile particles or endocytosed receptors. The normalized
distribution of early-time diffusion coefficients of free tracks is presented in Fig. 3.3(c).
The filtering process did not significantly alter this distribution.
Once all software-reconstructed trajectories were filtered, we sought to determine
whether the density of labelled receptors could influence the extracted SPT parameters. A
comparison of SPT data from cell samples labelled with different concentrations of primary
anti-CD93 was therefore performed, using samples labelled at 1: 7,500, 1: 10,000 and
1: 20,000. The mean fraction of confined, free and directed receptors observed at each
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Figure 3.2. Representative CD93 trajectories for tracks of different
classification and confinement size.
Trajectories of CD93-GFP motion in the plasma membrane of transfected CHO
cells (𝑛𝑐𝑒𝑙𝑙𝑠 = 12), immunolabelled with a 1: 10,000 dilution of primary anti-CD93
antibody, were reconstructed from movies of receptor diffusion using the SPT
software and classified as free, confined/subdiffusive, or lineardirected/superdiffusive using moment spectrum scaling analysis. Confined tracks
were grouped into sub-ensembles; trajectories with a mean confinement radius
between 50-150 nm were placed into the 100 nm sub-ensemble and so forth. Free
tracks and confined tracks from the 100 nm, 200 nm and 300 nm sub-ensembles
were then randomly selected for plotting in this figure. Since directed tracks were
rare, one directed track was selected for comparative purposes. The plotted
trajectories are representative of the track collections of their respective
classification and confinement size.
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Figure 3.3. The effect of positional accuracy filtering on CD93 tracking data
from transfected CHO cells. Reconstructed trajectories of CD93-GFP motion in
the plasma membrane of transfected CHO cells (𝑛𝑐𝑒𝑙𝑙𝑠 = 12), immunolabelled with
a 1: 10,000 dilution of primary anti-CD93 antibody, were analyzed by the SPT
software and subject to positional accuracy filtering. Tracks for which the mean
positional uncertainty was greater than 25 𝑛𝑚 were rejected. a) Accuracy-filtered
confined tracks, presented on a scatter plot of mean positional uncertainty vs. mean
confinement radius. b) The effect of the filtering process on the normalized
distribution of confinement zone radii of confined receptors. Black lines overlaying
each histogram represent locally-averaged bar heights, smoothed over 15 bins to
show the data trend of each distribution. Each distribution was treated as an
approximation to the probability density function and normalized to yield a total
area of one under the curve, corresponding to a total probability of one when
integrating across the entire domain. c) The effect of the filtering process on the
normalized distribution of early-time diffusion coefficients of free receptors. As in
(b), black lines overlaying each histogram represent the overall trend in the data,
smoothed over 5 bins.
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a)

b)

c)
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dilution is plotted in Fig. 3.4. The fraction of confined receptors observed at 1: 7,500 was
not significantly different from that at 1: 10,000, according to a two-tailed t-test. Likewise,
no significant difference was observed for the free receptors at 1: 7,500 and 1: 10,000.
Overall, 76 ± 5 % of CD93-GFP receptors in CHO cells were found to be confined and
22 ± 5 % were found to be free, when averaged across all runs.
The effect of labelled receptor density on the confinement size distribution is
presented in Fig. 3.5(a). Although some distributions were more asymmetrical than others
and spanned a greater range of sizes, no significant differences were observed between the
confinement size distributions of different runs at the same labelling density. The small
variations observed were attributed to differences between the cells used in each run. No
replicates were performed for the 1: 20,000 dilution since it was judged ill-suited for single
particle tracking owing to its low density of labelled receptors. The mean confinement radii
of the 1: 7,500 and 1: 10,000 dilutions were 189 ± 23 nm and 218 ± 11 nm respectively
and, therefore, there was no significant effect of receptor labelling density on the mean
confinement size. Based on the standard deviations, the extent of the run-to-run variations
was, however, lower at the 1: 10,000 dilution.
The effect of labelled receptor density on the early-time diffusion coefficients of
free receptors is shown in Fig. 3.5(b). No significant differences were observed between
the distributions of different runs of a fixed labelling density, or between the 1: 7,500 and
1: 10,000 dilutions, which both had a mean diffusion coefficient of 0.07 ± 0.01 μm2/s.
Labelling density was therefore found not to have a significant effect on the mean earlytime diffusion coefficient of free CD93-GFP receptors in CHO cells.
CD93 Diffusion in Monocytes
After characterizing the motion of CD93-GFP in CHO cells, we sought to compare
it with the diffusion of endogenously-expressed CD93 in human monocytes. The relative
proportions of freely diffusive, confined and linearly-directed CD93 receptors in human
monocytes are presented in Fig. 3.6, for three different dilutions of the primary antibody
(1: 2,500, 1: 5,000, and 1: 7,500). Lower antibody dilutions were required for these cells,
as they express less CD93 than the CHO cells in our ectopic CD93-GFP expression system.
The density of the labelled receptors did not influence their classification; 70 ± 3 % of the
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Figure 3.4. The effect of receptor labelling density on the types of CD93
diffusion in CHO cells.
Types of CD93-GFP diffusion in the plasma membrane of transfected CHO cells,
determined at different densities of antibody labelling. Trajectories were classified
based on the results of the moment spectrum scaling analysis employed by the SPT
software. A minimum of 11 cells were assessed per run, with 𝑛𝑟𝑢𝑛𝑠 (1: 7,500) = 7,
𝑛𝑟𝑢𝑛𝑠 (1: 10,000) = 6 and 𝑛𝑟𝑢𝑛𝑠 (1: 20,000) = 1. Based on the results of a twotailed 𝑡-test, no significant differences were observed between the 1: 7,500 and
1: 10,000 dilutions, with 𝑝 > 0.05 for both confined and free receptors. 76±5% and
22±5% of CD93-GFP receptors in CHO cells were found to be confined and free
respectively, when averaged across all runs.
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Figure 3.5. The effect of receptor labelling density on CD93 diffusion in
transfected CHO cells.
The diffusion of CD93-GFP in the plasma membrane of transfected CHO cells was
assessed by the SPT software at different densities of antibody labelling, with a
minimum of 11 cells per run and 𝑛𝑟𝑢𝑛𝑠 (1: 7,500) = 7, 𝑛𝑟𝑢𝑛𝑠 (1: 10,000) = 6 and
𝑛𝑟𝑢𝑛𝑠 (1: 20,000) = 1. (a) Confinement size distributions. (b) Early-time free
diffusion coefficient distributions. Each box plot presents the data from a single run,
showing the 25th , 50th (median) and 75th percentiles, with whiskers corresponding
to 1.5x the interquartile range and a mean indicated by *. Labelling density had no
significant effect on the mean confinement radius or the mean early-time diffusion
coefficient of the receptors, based on a comparison of means(±s.d.).
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b)
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Figure 3.6. The effect of receptor labelling density on the types of CD93
diffusion in human monocytes.
Types of CD93 diffusion in the plasma membrane of human peripheral blood
monocytes, determined at different densities of antibody labelling. Trajectories were
classified based on the results of the moment spectrum scaling analysis employed
by the SPT software. A minimum of 13 cells were assessed per run, with
𝑛𝑟𝑢𝑛𝑠 (1: 2,500) = 3, 𝑛𝑟𝑢𝑛𝑠 (1: 5,000) = 2 and 𝑛𝑟𝑢𝑛𝑠 (1: 7,500) = 1, with the
exception of 7 cells at 1: 7,500. 70±3% of CD93 receptors in human monocytes
cells were found to be confined, while 26±2% were classified as free, when averaged
across all runs. A two-tailed t-test was used to compare the percentages of confined
and free receptors between the 1: 2,500 dilution in monocytes and the 1: 10,000
dilution in CHO cells. There was no significant difference between the two
dilutions, with 𝑝 > 0.05 for both confined and free receptors.
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molecules were classified as confined and 26 ± 2 % were found to diffuse freely.
Importantly, there was no significant difference in the percentages of confined and free
receptors observed for the monocyte and CHO cells.
The effects of receptor labelling density on the confinement sizes of confined CD93
molecules and early-time diffusion coefficients of free CD93 receptors are shown in Fig.
3.7. Neither the confinement size (a) nor the diffusion coefficient (b) distributions
exhibited any significant variations between runs of a fixed labelling density. The mean
confinement radii for the 1: 2,500 and 1: 5,000 dilutions were 252 ± 15 nm and 237 ±
11 nm respectively, with a dilution-independent mean of 242 ± 7 nm. The mean free
diffusion coefficients for these dilutions were 0.07 ± 0.01 μm2/s and 0.06 ± 0.02 μm2/s.
Receptor labelling density therefore has no significant effect on either the mean
confinement radius of confined CD93 or the free early-time diffusion coefficient of free
CD93 in human monocyte cells. The diffusion parameters estimated by the SPT software
for CD93 in monocytes were further equivalent to those of CD93-GFP in CHO cells,
demonstrating the relevance of the CHO cell heterologous system.
Extended MSD Curves and van Hove Functions
Following a preliminary analysis of CD93 diffusion with the SPT software, we
sought to determine whether the behavior of confined receptors depended on the sizes of
their confinement zones. The motion of CD93 in CHO and monocyte cells was therefore
further examined with the aid of mean square displacement (MSD) curves and van Hove
functions. Accuracy-filtered trajectories extracted from the SPT software were first used
to plot extended MSD curves for the various receptor sub-populations. As described in
Section 2.4, lag-time-specific MSD values were found by first temporally-averaging the
squared displacements of each particle trajectory and then averaging across the particle
ensemble. Confined receptors were classified into various subpopulations: receptors
having a confinement radius 𝑅𝑐𝑜𝑛𝑓 of 50-150 nm were placed in the 100 nm ensemble,
receptors confined to zones of 150-250 nm in the 200 nm ensemble, and so on.
Two-dimensional MSD curves for the various CD93 sub-populations in monocyte
and CHO cells are plotted in Fig. 3.8(a) and Fig. 3.8(b), over an extended lag time range
of 0.1 to 10 s. As expected, the monocyte MSD curve for directed tracks has a slope of
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Figure 3.7. The effect of receptor labelling density on CD93 diffusion in human
monocytes.
The diffusion of CD93 in the plasma membrane of human peripheral blood
monocytes was assessed by the SPT software at different densities of antibody
labelling, with 𝑛𝑟𝑢𝑛𝑠 (1: 2,500) = 3, 𝑛𝑟𝑢𝑛𝑠 (1: 5,000) = 2 and 𝑛𝑟𝑢𝑛𝑠 (1: 7,500) =
1. A minimum of 13 cells were assessed per run, with the exception of 7 cells at
1: 7,500. (a) Confinement size distributions. (b) Early-time free diffusion
coefficient distributions. Each box plot presents the data from a single run, showing
the 25th , 50th (median) and 75th percentiles, with whiskers corresponding to 1.5x
the interquartile range and a mean indicated by *. Labelling density had no
significant effect on the mean confinement radius or the mean early-time diffusion
coefficient of the receptors, based on a comparison of means(±s.d.).
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Figure 3.8. Extended ensemble-averaged time-averaged MSD curves for CD93
receptors in human monocytes and CHO cells.
(a) Extended MSD curves for CD93 in human monocyte cells, labelled at 1: 5,000.
(b) Extended MSD curves for CD93-GFP in transfected CHO cells, labelled at
1: 10,000. Separate sub-populations of receptors were generated according to their
SPT software classification, with molecules of a confinement radius of 50-150 nm
placed in the 100 nm confined ensemble and so forth. Extended MSD values were
calculated as described in Section 2.4, without accounting for the total measurement
time of each trajectory. Local log-log slopes, γ, of the MSD curves were estimated
for τ of 0.2-1.5 s using linear least squares.
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1.48 ± 0.01 on a log-log plot, corresponding to superdiffusive motion. A similar
superdiffusive value of 1.20 ± 0.05 was obtained for directed tracks in CHOs. Receptors
classified as free yield a log-log curve with a slope of 0.88 ± 0.01 in monocytes and a
slope of 0.87 ± 0.01 in CHOs, values close to, but slightly smaller than, that for Brownian
motion. Such values are compatible with their classification as free by the SPT software,
since the moment spectrum scaling analysis relies on multiple orders of moments to
classify the tracks and does not require an exponent of exactly 𝛾2 = 1 for the second
moment of free particles. The slightly sub-linear exponents of the free receptors are,
however, indicative of their non-Brownian behavior, as further illustrated later in this
chapter. The MSD curves of all confined receptors have log-log slopes of much less than
one, corresponding to subdiffusive motion. In both CHO and monocyte cells, however,
receptors confined in zones of different 𝑅𝑐𝑜𝑛𝑓 have MSD curves with significantly different
slopes, which generally increase with increasing confinement radius. One-dimensional
MSD curves were found to be equivalent in the 𝑥 and 𝑦 directions, reflecting system
isotropy.
To further examine the motion of free and confined CD93 receptors, we determined
the self-correlation van Hove functions of receptors sorted into the free and 100, 200, and
300 nm confined sub-populations. The self-part of the van Hove correlation function
quantifies the probability 𝑃(∆𝑥) of a particle moving a distance ∆𝑥 in a given lag time 𝜏,
presenting it as a normalized PDF. The van Hove functions of particles undergoing
Brownian motion are Gaussian in shape. Fig. 3.9 presents the normalized one-dimensional
van Hove functions of CD93 molecules in monocyte cells on both a linear (a) and a semilogarithmic plot (b). As shown for a lag time of 1.5 s, the van Hove functions were found
to be different for different receptor sub-populations. Their distinction persisted over the
entire examined range of lag times, from 0.1-7 s (data not shown).
To numerically compare the functions of different CD93 sub-populations and to
determine whether they are reflective of normal diffusion, we first attempted to fit them to
Gaussian distributions. In all cases, including that of the free receptors, the van Hove
functions required narrower curves with a greater peak height than their best-fit Gaussians,
indicating motion potentially dominated by spatial heterogeneity or anomalous diffusion.
Instead, the functions were fitted to general Lévy alpha-stable distributions, 𝑆(𝛼, 𝛽, 𝛾, 𝛿),
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a)

b)

Figure 3.9. Normalized van Hove functions for CD93 sub-populations in
human monocytes.
Normalized van Hove functions of free and confined CD93 receptors from human
monocytes labelled at 1: 5,000, determined for a lag time 𝜏 of 1.5 s and presented
on (a) a linear plot and (b) a semi-logarithmic plot. Separate sub-populations of
receptors were generated according to their SPT software classification, with
molecules of a confinement radius of 50-150 nm placed in the 100 nm confined
ensemble and so forth. Lines of best fit were determined by non-linearly fitting each
van Hove function to a general alpha-stable distribution. The gamma values
presented in the legend correspond to the scale of the distributions, 𝛾. Their
characteristic exponents were 𝛼100 = 1.62, 𝛼200 = 1.77, 𝛼300 = 1.84, and 𝛼𝑓𝑟𝑒𝑒 =
1.44. For all distributions, the skewness (𝛽) and location parameters (𝛿) were close
to zero.
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where 𝛼 is the characteristic exponent, 𝛽 is skewness and 𝛾 and 𝛿 stand for scale and
location. Alpha-stable distributions include the Gaussian distribution, 𝑆(2, 𝛽, 𝜎⁄√2 , 𝜇),
where 𝜎 and 𝜇 are the standard deviation and the mean, as well as both Cauchy 𝑆(1,0, 𝛾, 𝛿)
and Levy 𝑆(1⁄2 , 1, 𝛾, 𝛿) distributions. The characteristic exponent determined the overall
shape of the distribution. The scale parameter 𝛾, also known as the dispersion parameter,
is reflective of the spread of the distribution around its location parameter. For particles
engaged in Brownian motion, whose van Hove function is a Gaussian, it is a measure of
the mean squared particle displacement, with 𝛾 2 = 〈𝑥 2 〉⁄√2. For non-Gaussian
distributions, the scale parameter can be loosely thought of as a standard-deviation-like
measure of the mean squared particle displacement.
Alpha-stable distributions provided good fits to the van Hove functions of CD93
sub-populations in monocytes, as shown in Fig. 3.9. As expected, the skewness and
location parameters of the distributions were close to zero in all cases, since all the van
Hove functions were fairly symmetric and centered around zero, indicating a lack of
directional bias. The characteristic exponents of the functions were in the range of 1 < 𝛼 <
2, between the values expected for Cauchy and Gaussian distributions. For all ensembles,
a characteristic exponent of 𝛼 < 2 was indicative of heavy-tailed distributions, with tails
that decay non-exponentially. For the confined receptors, 𝛼 was seen to decrease with
decreasing confinement size. Since a smaller 𝛼 is indicative of tails that decay at a slower
rate, the van Hove functions of receptors confined to zones of a smaller size had heavier
tails. Interestingly, the van Hove function of the free receptor ensemble has the smallest
characteristic exponent, indicative of the greatest deviation away from a Gaussian shape.
For the confined receptors, the scale parameter increased with increasing 𝑅𝑐𝑜𝑛𝑓 , with the
smallest 𝛾 for the 100 nm confined ensemble, corresponding to the narrowest van Hove
function. The free particle ensemble has the largest 𝛾, corresponding to the greatest
probability of taking large steps in a given amount of time. Overall, the van Hove function
of the 300 nm ensemble was similar to that of the free ensemble.
The same trends were observed for the van Hove functions in both the 𝑥 and 𝑦
directions, for 𝜏 ≤ 7 s. Movies illustrating the dependence of the van Hove functions of
the free and 200 nm confined monocyte CD93 ensembles on lag time are presented in the
digital Supplementary Content (Mov. 1, Mov. 2). The effects of lag time on the
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characteristic exponent and scale of the stable alpha distributions fitted to the van Hove
functions of the free and confined CD93 particles are presented in Fig. 3.10. As shown,
the width of the van Hove function of the free CD93 ensemble increased with increasing
lag time, from 𝛾 = 0.06 at 𝜏 = 0.1 s to 𝛾 = 0.30 at 𝜏 = 7.0 s, as the distribution became
more spread out. In contrast, the width of the van Hove function of the 200 nm confined
ensemble remained nearly constant, increasing from 𝛾 = 0.06 at 𝜏 = 0.1 s to a fixed
plateau at 𝛾 = 0.1 and reflecting the confined nature of the particles. The same was true of
other confined ensembles, which plateaued at 𝛾(100 nm) = 0.06 and 𝛾(300 nm) = 0.18.
The characteristic exponent of the free ensemble fluctuated around a mean value of 𝛼 =
1.54 ± 0.06, with no defined dependence on lag time. For the 200 nm confined ensemble,
𝛼 decreased from 1.80 at 𝜏 = 0.1 s to 1.52 at 𝜏 = 7.0 s, showing that the distribution
became more non-Gaussian with increasing lag time.
The normalized van Hove functions of CD93-GFP receptors in CHO cells were
determined for a range of lag times and plotted in Fig. 3.11 for a representative time lag of
3.0 s. Stable-alpha distributions provided only a moderately accurate fit to these functions,
visibly underestimating the central peaks and tails of the data. Nonetheless, the van Hove
functions for CHO cell receptors displayed trends similar to those observed for CD93 in
monocytes. Alpha stable distributions of subdiffusive receptors confined to larger zones
had a larger corresponding scale parameter, which was greatest for free receptors, reflective
of their inherent ability to travel farther unhindered. The smaller characteristic exponent
determined for the ensemble van Hove functions of receptors confined to smaller zones
meant their functions were more non-Gaussian in nature. As for monocytes, similar trends
were observed over a range of lag times, in both the 𝑥 and 𝑦 directions. In both CHOs and
monocytes, the non-Gaussian van Hove functions may be indicative of system
heterogeneity or anomalous diffusion, as discussed in greater detail in Chapter 4. The
distinct van Hove functions observed for particles confined to zones of a different size,
together with their specific MSD curves, may be reflective of the different environments
experienced by receptors confined to zones of a different size.
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Figure 3.10. The effect of lag time on the alpha-stable distribution parameters
of the normalized van Hove functions of CD93 in monocytes.
Normalized van Hove functions of free and confined CD93 receptors from human
monocytes labelled at 1: 5,000, were non-linearly fitted to general alpha-stable
distributions with characteristic exponents 𝛼 and scale parameters 𝛾 for a range of
lag times. Separate sub-populations of receptors were generated according to their
SPT software classification, with molecules of a confinement radius of 50-150 nm
placed in the 100 nm confined ensemble and so forth.
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Figure 3.11. Normalized van Hove functions for CD93 sub-populations in CHO
cells.
Normalized van Hove functions of free and confined CD93-GFP receptors from
transfected CHO cells labelled at 1: 10,000, determined for a lag time 𝜏 of 3.0 s and
presented on (a) a linear plot and (b) a semi-logarithmic plot. Separate subpopulations of receptors were generated according to their SPT software
classification, with molecules of a confinement radius of 50-150 nm placed in the
100 nm confined ensemble and so forth. Lines of best fit were determined by nonlinearly fitting each van Hove function to a general alpha-stable distribution. The
gamma values presented in the legend correspond to the scale of the distributions,
𝛾. Their characteristic exponents were 𝛼100 = 1.56, 𝛼200 = 1.82, 𝛼300 = 1.84, and
𝛼𝑓𝑟𝑒𝑒 = 1.44. For all distributions, the skewness (𝛽) and location parameters (𝛿)
were close to zero.
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3.2 Cage Effect Analysis
Cage effect analysis, developed by Doliwa and Heuer and described in Section 2.4,
was performed on the reconstructed, accuracy-filtered trajectories of free and confined
CD93 receptors. Using this analysis, we sought to detect the presence of particle caging by
evaluating the extent of negative correlation between successive particle steps, as well as
to assess the cage strength of confined particles and system isotropy. The analysis was
conducted for CD93 receptors tracked in both CHO and monocyte cells, labelled with a
primary antibody at dilutions of 1: 10,000 and 1: 5,000 respectively.
Representative Plots for Subdiffusive CD93 in CHO cells
Fig. 3.12 presents the results of the cage effect analysis for a population of
subdiffusive CD93 receptors found in zones with a confinement radius of 90-110 nm,
tracked in CHO cells. As shown in Fig. 3.12(a) for a lag time of 0.1 s, the normalized
distribution of step magnitudes of the first step, 𝑝(𝑟01 ), differs from the distribution
predicted for 2D Brownian motion and has a mode of approximately 40 nm. Fig. 3.12(b)
presents 𝑝(𝑥12 |𝑟01 = 40), the distribution of the projection, {𝑥12 }, of the second step along
the direction of the first step, for a first step with a magnitude of 40 nm. Unlike 𝑝(𝑟01 ),
𝑝(𝑥12 |𝑟01 ) is fairly symmetric and can be approximated by a Gaussian distribution with a
mean 〈𝑥12 〉 of (−0.01) µm, showing negative correlation. Receptor caging detected
through the presence of negative correlation between successive steps is shown in Fig.
3.12(c), which presents plots of the mean parallel ⟨𝑥12 ⟩ and perpendicular ⟨𝑦12 ⟩ projections
as functions of 𝑟01 . Negative correlation is observed for ⟨𝑥12 ⟩, with ⟨𝑥12 ⟩ < 0, implying
that, in any pair of two successive steps, the second step of the receptor has a component
anti-parallel to the direction of the first step. As expected, the magnitude of the first step
has no effect on the perpendicular projection of the second step, with ⟨𝑦12 ⟩ ≈ 0.
The magnitude of the negative correlation between successive steps increases
linearly with increasing 𝑟01 for the 90-110 nm confined CD93 ensemble. Receptors that
move further during the initial step are therefore more likely to step further backwards
during the following step, since they approach closer to the “wall” of the cage. How much
they are repelled by the cage wall is reflected in the absolute value of the slope of the
⟨𝑥12 ⟩ plot, 𝑐𝑥 = 0.42 ± 0.01, which provides a measure of the cage strength. The specific
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Figure 3.12. Cage effect analysis of subdiffusive CD93 receptors with a 90-110
nm confinement radius in CHO cells.
Cage effect analysis for a sub-population of confined CD93-GFP receptors from
transfected CHO cells labelled at 10: 000, with a confinement radius of 90-110 nm.
The analysis was performed as described in Section 2.4, for a lag time of 0.1 s. In
the plots, 𝑟01 stands for the magnitude of the first step in any step pair (𝑟01 , 𝑟12).
𝑥12 stands for the projection of the second step in the direction of the first step,
indicated by a unit vector 𝑟̂01 , with 𝑥12 = 𝑟12 ∙ 𝑟̂01 . The projection of the second
step in a direction perpendicular to that of the first step, indicated by a unit vector
𝑢̂01 , is given by 𝑦12 = 𝑟12 ∙ 𝑢̂01 . (a) The normalized probability distribution of step
magnitudes, 𝑝(𝑟01 ). A normalized probability distribution expected for 𝑟01 in a twodimensional normal diffusion model is plotted for comparison. (b) The normalized
probability distribution of the projections of the second step in the direction of the
first step, 𝑝(𝑥12 |𝑟01 ), for 𝑟01 = 40 nm. The data is fitted to a Gaussian distribution.
(c) Parallel and perpendicular correlation plots, showing the effect of step magnitude
𝑟01 on ⟨𝑥12 ⟩ and ⟨𝑦12 ⟩ respectively, with ⟨𝑥12 ⟩ < 0 and ⟨𝑦12 ⟩ ≈ 0. The data was
fitted to ⟨𝑥12 ⟩ = A − 𝑐𝑥 (𝑟01 ) with a fit cutoff at 100 nm and a similar fit for ⟨𝑦12 ⟩.
𝑐𝑥 was treated as a measure of the cage strength. (d) The effect of initial step
magnitude 𝑟01 on the standard deviation of the parallel and perpendicular
projections of the second step, where 𝜎∥ is the standard deviation of 𝑝(𝑥12 |𝑟01 ) and
𝜎⊥ is the standard deviation of 𝑝(𝑦12 |𝑟01 ).
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value of 𝑟01 at which the correlation begins to break down, given by 𝑟𝑐 , is a measure of the
size of the cages, 𝑅𝑐𝑎𝑔𝑒 203. The correlation breaks down at 𝑟𝑐 because the particles that step
further that 𝑟𝑐 during their initial step have left the cage and are no longer subject to its
effects.
The particles in the confined ensemble of Fig. 3.12 are predicted by the SPT
software to have 𝑅𝑐𝑜𝑛𝑓 = 90-110 nm. There is no change in the slope of the graph in Fig.
3.12(c) observed at 𝑟01 values around this range, however. The correlation may start to
break down around 200 nm, though it is difficult to distinguish this breakdown from noise
in the data due to the smaller number of steps analyzed at large lag times. Since the SPT
software and the cage effect analysis utilize two conceptually distinct quantities as a
measure of confinement zone size, the estimates provided by these two techniques may not
be equivalent. Alternatively, the lack of a distinct observed 𝑅𝑐𝑎𝑔𝑒 may suggest a range of
cage sizes. A discussion of whether or not the cages detected by the cage effect analysis
correspond to the compartments defined by 𝑅𝑐𝑜𝑛𝑓 is left for the following chapter.
The standard deviations of 𝑝(𝑥12 |𝑟01 ) and 𝑝(𝑦12 |𝑟01 ), represented by 𝜎∥ and 𝜎⊥
respectively, are plotted in Fig. 3.12(d). The behavior of 𝜎∥ and 𝜎⊥ was found to be
identical, indicating that the system is isotropic, in agreement with our observations based
on the one-dimensional MSD plots. Both 𝜎∥ and 𝜎⊥ increase with increasing 𝑟01 as
particles which travelled further during the first step were, in turn, more likely to cover a
greater distance during the successive step. Such behavior is reflective of a heterogeneous
system of particles with different diffusion coefficients.
Comparison of Subdiffusive and Free CD93 in CHO cells
To compare the behavior of free and confined CD93 receptors in CHO cells, we
plot their representative correlation plots in Fig. 3.13 for a lag time of 1.0 s. For receptors
confined to zones of 190-210 nm, presented in Fig. 3.13(a), successive steps were
negatively correlated, with ⟨𝑥12 ⟩ < 0. As ⟨𝑥12 ⟩ decreased with increasing 𝑟01 , CD93
receptors that took a longer initial step stepped further backwards in the anti-parallel
direction during the following step, repelled by the cage wall. A potential breakdown of
correlation was observed at approximately 400 nm, though it is difficult to distinguish it
from noise. The perpendicular correlation ⟨𝑦12 ⟩, which acted as a negative control,
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Figure 3.13. Comparison of correlation plots in the cage effect analysis of
confined (190-210 nm) and free CD93 receptors in CHO cells.
CD93-GFP receptor tracks from CHO cells labelled at 1: 10,000 were analyzed
with the SPT software, extracting an ensemble of free particles and an ensemble of
particles confined to 190-210 nm zones. The representative results of the cage
effect analysis performed for both ensembles are shown for a lag time of 1.0 s. (a)
Correlation plots for the confined (190-210 nm) ensemble. (b) Correlation plots for
the free ensemble. In the plots, 𝑟01 stands for the magnitude of the first step in any
step pair (𝑟⃗⃗⃗⃗⃗
𝑟12). 𝑥12 stands for the projection of the second step in the direction
01 , ⃗⃗⃗⃗⃗
of the first step, with 𝑥12 = ⃗⃗⃗⃗⃗
𝑟12 ∙ 𝑟01 . The projection of the second step in a
perpendicular direction, is given by 𝑦12 = ⃗⃗⃗⃗⃗
𝑟12 ∙ 𝑢01 . The data was fitted to ⟨𝑥12 ⟩ =
A − 𝑐𝑥 (𝑟01 ), with a fit cutoff at 200 nm for the confined ensemble and no cutoff for
the free ensemble.
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remained close to zero for all values of 𝑟01 . The confined ensemble had a cage strength 𝑐𝑥
of 0.40 ± 0.01, estimated with a cutoff at 200 nm to match the 𝑅𝑐𝑜𝑛𝑓 predicted by the SPT
analysis for this ensemble. The control 𝑐𝑦 of this ensemble had a significantly smaller
magnitude than 𝑐𝑥 and was close to zero.
The free particle ensemble shown in Fig. 3.13(b), conversely, exhibited little
correlation between successive steps. In absence of a predicted confinement radius or an
obvious correlation breakdown point, the full data set was fitted to a line. The cage strength
of the free ensemble was estimated to be 0.03 ± 0.01, significantly lower than that of the
confined ensemble. The 𝑐𝑥 and control 𝑐𝑦 of this ensemble were similar in magnitude and
close to zero. CD93 receptors classified as free therefore appeared to experience no caging
at this lag time.
The Relationship between Confinement Radius and Cage Lifetimes
The relationship between cage strength, 𝑐𝑥 , and lag time, for receptors in both CHO
and monocyte cells, is presented in Fig. 3.14(a) and Fig. 3.14(b) respectively. The analysis
was performed over a range of lag times from 0.1 s to 3.5 s, for free particles and particles
confined to zones with 𝑅𝑐𝑜𝑛𝑓 of 50-150, 150-250, 250-350, 350-450, and 450-550 nm.
The error bars in Fig. 3.14(a) are much smaller than those in Fig. 3.14(b) because a greater
number of tracks was gathered for the CHO cells, in which the receptors were easier to
track. The same general trends are, however, observed for both cell populations.
Receptors confined to zones of a smaller size generally exhibited stronger caging
than those in larger zones. This trend was present in both populations across a range of lag
times. While little distinction was observed between the 100 nm and 200 nm ensembles
in CHO cells, the 100 nm ensemble of monocyte cells generally had a significantly greater
cage strength than the 200 nm ensemble. Receptors classified as free by the SPT software
appeared caged at lag times smaller than 0.5 s. The rapid decay of their cage strength with
increasing 𝜏 was indicative of the transient nature of their cages. In general, the cage
strength determined for all ensembles of confined receptors decreased with lag time, owing
to the eventual re-arrangement of the cages. In both CHO and monocyte cells, the cages
were more short-lived for receptors confined to zones of a larger size.
When the data in Fig. 3.14(a) were fitted to straight lines, the slopes for each of the

93

Figure 3.14. The relationship between confinement radius, cage strength and
cage lifetimes for CD93 receptors in CHO and monocyte cells.
The relationship between confinement size, cage strength and cage lifetimes for
(a) CD93-GFP in CHO cells labelled 1: 10,000 and (b) CD93 in monocytes labelled
at 1: 5,000. Receptors were analyzed by the SPT software, extracting free and
confined particle ensembles, with molecules with a 50-150 nm confinement radius
placed in the 100 nm ensemble and so forth. All ensembles were subject to the cage
effect analysis, for lag times from 0.1 s to 3.5 s. The absolute value of the slope of
each ⟨𝑥12 ⟩ correlation plot, 𝑐𝑥 , was treated as a measure of the cage strength.
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CHO cell ensembles were 𝑚100 = −0.026 ± 0.003, 𝑚200 = −0.026 ± 0.002, 𝑚300 =
−0.039 ± 0.002, 𝑚400 = −0.069 ± 0.005, and 𝑚500 = −0.074 ± 0.005, all in units of
s-1. The cage strength of receptors confined to larger zones, such as those with 𝑅𝑐𝑜𝑛𝑓 of
350-450 nm, is therefore predicted to reach zero at a lag time of ~5 s. The monocyte data
in Fig. 3.14(b) was similarly fitted, albeit for 𝜏 of 0.1-2.5 s to minimize the impact of noise,
yielding slopes of 𝑚100 = −0.06 ± 0.01, 𝑚200 = −0.08 ± 0.01, 𝑚300 = −0.07 ± 0.01,
𝑚400 = −0.11 ± 0.01, and 𝑚500 = −0.15 ± 0.01, also in units of s-1. The cages generally
appeared to be more short-lived in in monocyte cells.
An alternative means of visualizing the effect of lag time on the cage strength is
presented in Fig. 3.15, for 𝜏 of 0.1, 0.5, 1.5 and 2.5 s. As shown for CHO (Fig. 3.15(a))
and monocyte (Fig. 3.15(b)) cells, significant differences in the cage strengths of different
confined ensembles are observed even at 𝜏 = 0.1 s. These differences become more
apparent at intermediate lag times (0.5 and 1.5 s), with weaker cages observed for confined
ensembles of a greater 𝑅𝑐𝑜𝑛𝑓 and no significant caging for the free receptors. The cage
strength of each individual ensemble is, in turn, significantly smaller at 𝜏 = 2.5 s than at
shorter lag times, owing to the gradual re-arrangement of the cages. The different strength
and lifetimes of the cages detected for receptors confined to zones of a different size are
indicative of the distinct environments experienced by these receptors.

3.3 Effects of PMA on CD93 Diffusion
Effects of PMA in Human Monocytes
Phorbol esters, such as PMA (phorbol 12-myristate 13-acetate), are known to
induce the shedding of endogenous CD93 from human monocyte cells in a matrixmetalloproteinase-dependent manner214,231. Once the diffusion of transfected CD93-GFP
and endogenous CD93 was characterized in CHO and monocyte cells respectively, the
capacity of PMA to alter CD93 diffusion and induce receptor shedding was evaluated.
Human monocytes with primary labelling dilutions of 1: 2,500 and 1: 5,000 were imaged
to obtain movies of endogenous CD93 diffusion prior to and immediately following the
addition of PMA. PMA was used at a concentration of at least 0.1 µg/ml, which has been
reported to induce CD93 shedding from monocyte cells231. Treating the monocytes with
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Figure 3.15. Temporal evolution of cage strength for CD93 receptors confined
to zones of different size in CHO and monocyte cells.
The effect of lag time 𝜏 on the cage strength of (a) CD93-GFP in CHO cells labelled
at 1: 10,000 and (b) CD93 in monocytes, labelled at 1: 5,000. Receptors were
analyzed by the SPT software, extracting free and confined particle ensembles, with
molecules with a 50-150 nm confinement radius placed in the 100 nm ensemble
and so forth. All ensembles were subject to the cage effect analysis, for lag times
from 0.1 s to 3.5 s. The absolute value of the slope of each ⟨𝑥12 ⟩ correlation plot,
𝑐𝑥 , was treated as a measure of the cage strength.
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PMA resulted in distinct changes in the distribution of CD93 on the cell membrane. As
shown in Fig. 3.16(a) for two representative cells labelled at 1: 2,500, untreated monocytes
exhibited a fairly uniform distribution of the receptor, with individual, trackable molecules.
Representative images of monocytes treated with 0.2 µg/ml PMA and 0.6 µg/ml PMA are
shown in Fig. 3.16(b) and (c) respectively. As shown in these images, cells treated with
PMA lost most of the CD93 signal almost instantaneously. The majority of remaining
CD93 molecules were localized in large bright patches. Cells treated with 0.1 µg/ml (data
not shown) and 0.2 µg/ml (Fig. 3.16(b)) PMA appeared equivalent.
The loss of CD93 signal, likely due to the shedding of CD93 from the monocyte
surface, made it challenging to track the motion of the remaining receptors following PMA
treatment214,231. Sufficient trajectories were nonetheless reconstructed by the SPT software
to allow analysis, albeit with larger error bars on the computed quantities, for 0.1 µg/ml
and 0.2 µg/ml PMA-treated cells. The percentages of free and confined receptors observed
in monocytes prior to and following 0.1 µg/ml or 0.2 µg/ml PMA treatment are shown in
Fig. 3.16(d). In cells labelled at 1: 2,500, 72 ± 14% of the receptors were confined
following a 0.1 µg/ml PMA treatment, and 74 ± 5% following a 0.2 µg/ml treatment. In
cells labelled at 1: 5,000 and treated with 0.2 µg/ml PMA, 70 ± 8% of the receptors were
classified as confined. PMA treatment did not have a significant effect on the fractions of
free and confined CD93 in monocytes, when compared to untreated cells.
The effects of PMA on the confinement zone size and early-time free diffusion
coefficient distributions are presented in Fig. 3.17(a) and Fig. 3.17(b) respectively. For the
confined receptors in cells labelled at 1: 5,000, the mean confinement radius was found to
be significantly larger following 0.2 µg/ml PMA treatment, according to a two-tailed t-test
(𝑝 < 0.01). No other significant differences were observed. Furthermore, the change in the
confinement zone size distribution induced by 0.2 µg/ml PMA in 1: 5,000 cells was of a
magnitude comparable with that of run-to-run variations observed for untreated cells (Fig.
3.7). It can therefore be concluded that PMA does not have a significant effect on the
motion of the remaining trackable CD93 molecules. While all the movies following PMA
treatments were gathered over a 20 min period, the small number of trackable receptors
prevented us from studying the temporal effects of the treatments.
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Figure 3.16. The effects of PMA on the distribution of CD93 on the membrane
of human monocyte cells and types of CD93 diffusion.
(a) Representative images (113X magnification) of untreated monocytes labelled at
1: 2,500 and imaged in the Cy3 channel, with a peak excitation at 550 nm and a
peak emission at 570 nm. The images were taken at an exposure time of 36 ms,
which was equivalent to the channel exposure time used for SPT movies.
(b) Representative image of 0.2 μg/ml PMA-treated monocytes, imaged with
specifications equivalent to those of untreated cells. (c) Representative image of
0.6 μg/ml PMA-treated monocytes, taken at an exposure time of 150 ms. (d) The
effect of PMA on the types of CD93 diffusion monocytes. Trajectories obtained
prior to and immediately following PMA treatment were accuracy-filtered with a
35 nm cutoff and classified based on the results of the moment spectrum scaling
analysis employed by the SPT software. Mean percentages presented on the bar
graph were obtained by averaged across the individual cells of each run, with a
minimum of 15 cells per run.
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Figure 3.17. The effects of PMA on the diffusion of CD93 in human monocytes.
The diffusion of CD93-GFP monocytes, labelled at 1: 2,500 or 1: 5,000, was
assessed by the SPT software prior to and following treatment with 0.1 μg/ml or
0.2 μg/ml PMA, with a minimum of 15 cells per run. Trajectories were accuracyfiltered with a 35 nm cutoff. (a) Confinement size distributions. (b) Early-time free
diffusion coefficient distributions. Each box plot presents the data from a single run,
showing the 25th , 50th (median) and 75th percentiles, with whiskers corresponding
to 1.5x the interquartile range and a mean indicated by *. For each sample, the effect
of the treatment was analyzed with a two-tailed t-text. The mean confinement size
was found to be significantly greater following a 2x PMA treatment for cells
labelled at 1: 5,000 (𝑝 < 0.01). No significant difference in the mean 𝐷𝑓𝑟𝑒𝑒 before
and after treatments was observed for any samples.
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Effects of PMA in CHO cells
We next tested the impact of PMA on CD93 diffusion in the ectopic CHO cell
model. CD93-GFP-transfected CHO cells were treated with PMA at a concentration of 0.1
µg/m for 45 min231. An immunoblot of cell lysates from PMA-treated cells as well as
untreated and untransfected controls is shown in Fig. 3.18(a). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was co-stained as a loading control, indicating successful lysate
preparation and equal loading of each lane in the gel. CD93 bands of the expected size are
observed for all samples except the negative (untransfected) controls. CD93 appears as a
trimer, perhaps indicating separate species of CD93 with differing post-translational
modifications. The same results were obtained in three separate experiments and following
a longer (5 h) PMA treatment (data not shown). Surprisingly, treatment with PMA
therefore did not alter the amount of CD93 present on the CHO cell surface, indicating that
CHO cells might not express the matrix-metalloproteinase required for CD93 cleavage214.
This finding enabled us to investigate the impact of potential PMA-mediated alterations to
the cytoskeleton, independent of PMA-induced shedding of CD93, on CD93 diffusion in
CHO cells.
Transfected CHO cells were labelled using 1: 7,500 and 1: 10,000 dilutions of
primary antibody. Movies of receptor motion were captured immediately prior to and
following the addition of PMA, to allow comparison of the diffusion of CD93 within the
same cell population before and after treatment. No changes in CD93 distribution were
observed following PMA exposure. The percentages of subdiffusive, free and
superdiffusive receptors prior to and following treatment with 0.1 µg/ml or 0.2 µg/ml PMA
are presented in Fig. 3.18(b). As shown, PMA at these concentrations had no significant
effect on the relative amounts of free, confined and linearly-directed CD93 molecules.
The effects of PMA on the distributions of the confinement radii of subdiffusive
receptors and the early-time diffusion coefficients of free receptors are shown in Fig.
3.19(a) and Fig. 3.19(b) respectively. The 𝑅𝑐𝑜𝑛𝑓 distributions of the confined receptors
before and after treatment with PMA at a concentration of 0.1 µg/ml were visually
identical, and their means were not significantly different according to a two-tailed t-test
(𝑝 > 0.01). Treatment with PMA at 0.2 µg/ml resulted in a significantly larger mean
confinement radius (𝑝 < 0.01), for both labelling dilutions. The mean early-time diffusion
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Figure 3.18. The effects of PMA on CD93-GFP receptor shedding and motion
classification in transfected CHO cells.
(a) The effect of a 45 min treatment with 0.1 μg/ml PMA on the amount of CD93
present on the CHO cell surface, shown on an immunoblot. Prepared lysates from
treated, transfected CHO cells were run on a non-reducing 10% SDS-PAGE gel and
transferred to a nitrocellulose membrane, which was blocked and simultaneously
probed with primary mouse-anti-human CD93 and GAPDH (loading control). The
bands were visualized with an anti-mouse IR700 secondary on a LI-COR Odyssey
Infrared Imaging System. Lysates from untransfected and untreated cells were
utilized as negative and positive controls respectively. (b) The effect of PMA on the
types of CD93-GFP diffusion CHO cells. Trajectories obtained prior to and
immediately following PMA treatment were accuracy-filtered with a 35 nm cutoff
and classified based on the results of the moment spectrum scaling analysis
employed by the SPT software. Mean percentages presented on the bar graph were
obtained by averaged across the individual cells of each run, with a minimum of 11
cells per run.
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Figure 3.19. The effects of PMA on the diffusion of CD93-GFP in transfected
CHO cells.
The diffusion of CD93-GFP in transfected CHO cells, labelled at 1: 7,500 or
1: 10,000, was assessed by the SPT software prior to and following treatment with
0.1 μg/ml or 0.2 μg/ml PMA, with a minimum of 11 cells per run. Trajectories were
accuracy-filtered with a 35 nm cutoff. (a) Confinement size distributions. (b) Earlytime free diffusion coefficient distributions. Each box plot presents the data from a
single run, showing the 25th , 50th (median) and 75th percentiles, with whiskers
corresponding to 1.5x the interquartile range and a mean indicated by *. For each
sample, the effect of the treatment was analyzed with a two-tailed t-text. The mean
confinement size was found to be significantly greater following a 2x PMA
treatment, for cells at both labelling densities (𝑝 < 0.01). No significant difference
in the mean 𝐷𝑓𝑟𝑒𝑒 before and after treatments was observed for the 0.2 μg/ml PMAtreated cells at the 1: 7,500 labelling dilution. In all other cases, the treatment
resulted in a significantly smaller mean 𝐷𝑓𝑟𝑒𝑒 (𝑝 < 0.01).
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coefficients of the free receptors were found to be significantly lower following a treatment
with PMA in the majority of cases, according to a two-tailed t-test (𝑝 < 0.01). Although
the changes in both the mean confinement radius and the mean early-time diffusion
coefficient were statistically significant, they lie within the range of the cell-to-cell
variations discussed above (see Fig. 3.5), and so are probably not biologically relevant.

3.4 Analysis of Anomalous Diffusion in CHO cells
Several existing models of anomalous diffusion have a well-defined dependence of
the ensemble-averaged MSD on the measurement time 𝑡 and of the ensemble-averaged
time-averaged MSD (EA-TAMSD) on the lag time 𝜏 and total measurement time 𝑇 5,242.
The ensemble-averaged MSD ̅̅̅̅̅̅̅
𝑟 2 (𝑡) is determined by taking an ensemble average of all
squared particle displacements 𝑟 2 (𝑡) at a measurement time 𝑡 relative to their initial
2 (𝜏, 𝑇)〉 is, conversely,
̅̅̅̅̅̅̅̅̅̅̅̅
positions at 𝑡 = 0. The ensemble-averaged time-averaged MSD 〈𝛿

found by ensemble-averaging the individual track-specific time-averaged MSDs of all
particles tracked for a specific total time 𝑇, which corresponds to the total measurement
time. To compare the effects of 𝑡, 𝜏, and 𝑇 on the ensemble-averaged MSD and the EA〈𝛿 2 (𝜏, 𝑇)〉 were
TAMSD in the context of CD93 diffusion, two-dimensional ̅̅̅̅̅̅̅
𝑟 2 (𝑡) and ̅̅̅̅̅̅̅̅̅̅̅̅
determined for the sub-populations of free and confined particles in CHO cells. The largest
set of CD93-GFP tracks from CHO cells, primary-labelled at 1: 10,000, was used for this
analysis. The calculations were performed as described in Section 2.4.
The dependence of ensemble-averaged MSD on the measurement time 𝑡 is shown
in Fig. 3.20 for free receptors and receptors with different confinement radii. The powerlaw indices 𝛼1 and 𝛼2 presented in the legend of Fig. 3.20 are obtained from fits of the data
to the form ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 𝛼 for early and later 𝑡. For receptors classified as free, ̅̅̅̅̅̅̅
𝑟 2 (𝑡) exhibits
close to a linear dependence on 𝑡 for 𝑡 < 2.0 s, with 𝛼1 = 0.96 ± 0.02. For 𝑡 > 2.0 s,
however, the free receptors behave subdiffusively, with a power-law index of 𝛼2 = 0.46 ±
0.02. The subdiffusive behavior of these receptors is characteristic of several models of
anomalous diffusion, including continuous time random walks (CTRWs), fractional
Brownian motion (FBM) and the diffusion on a fractal, three models previously applied in
a biological context5,242. Particles in all confined ensembles exhibit subdiffusive behavior
for small values of 𝑡, with 𝛼1 < 1. For 𝑡 > 3.0 s, however, the ensemble-averaged MSDs
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Figure 3.20. The effect of measurement time on the ensemble-averaged MSD
of CD93-GFP in CHO cells.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Confined receptors were split into ensembles, with molecules of a 50150 nm confinement radius in the 100 nm ensemble, and so forth. Ensembleaveraged MSDs of each ensemble were then calculated over a range of 𝑡, as
described in Section 2.4, and presented on a log-log plot. For each ensemble, the
power-law indices 𝛼1 and 𝛼2 were estimated by a linear regression, with ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 𝛼
in the indicated region of time. Lines of best fit for these regressions are presented
on the plot alongside the data points (dashed for 𝛼1 , continuous for 𝛼2 ).
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of the 100 nm, 200 nm and 400 nm confined ensembles plateau, with 𝛼2 = 0.00 ± 0.02,
𝛼2 = 0.03 ± 0.02 and 𝛼2 = 0.07 ± 0.03 respectively. In this region, ̅̅̅̅̅̅̅
𝑟 2 (𝑡) is almost
constant. In models of both Brownian and anomalous diffusion, such plateaus are
characteristic of particle confinement242,244,250. No transition to such a plateau is observed
at 𝑡 = 3.0 s for the 300 nm ensemble and its potential emergence for 𝑡 > 6.0 s is hard to
separate from system noise.
The effects of both measurement time and lag time on the ensemble-averaged timeaveraged MSD were examined for the free, 100 nm confined and 200 nm confined
ensembles. Not enough tracks were available to successfully perform this analysis for the
300 nm and 400 nm ensembles. Track-specific time-averaged MSDs 〈𝛿𝑘 2 (𝜏, 𝑇)〉 were
computed for each sub-population of particles for a total measurement time 𝑇 in the range
of 2.0 to 10.0 s and all available lag times. A corresponding power-law index 𝛼𝑘 was then
determined for each track by fitting the data to the form 〈𝛿𝑘 2 (𝜏, 𝑇)〉 ∝ 𝜏 𝛼𝑘 .
Fig. 3.21(a) shows the time-averaged MSDs of forty randomly-chosen tracks in the
free ensemble plotted as a function of lag time for 𝑇 = 2.0 s, while Fig. 3.21(b) shows data
for the 200 nm confined ensemble and 𝑇 = 5.0 s . The time-averaged MSDs of specific
tracks had a range of slopes, with a similar overall trend. The variation observed in the
time-averaged MSDs of individual tracks is consistent with the CTRW diffusion model
and is rarely observed for fractional Brownian motion, wherein individual trajectories
produce more reproducible results. The normalized distribution of the power-law indices
of the free tracks at 𝑇 = 2.0 s, shown in Fig. 3.21(c), peaked at 0.77 and was well described
by a normal distribution. The distribution of 𝛼𝑘 for the 200 nm confined tracks, shown for
𝑇 = 5.0 s, peaked at 0.14 and appeared to be skewed towards higher values of 𝛼𝑘 . Track̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
averaged mean indices of 𝛼
𝑘 (𝑇 = 2.0 𝑠) = 0.74 ± 0.38 and 𝛼𝑘 (𝑇 = 5.0 𝑠) = 0.23 ±
0.17, where uncertainties represent standard deviation, were determined for the free and
200 nm confined ensembles respectively.
The distribution of the power-law indices of the track-specific time-averaged MSDs
for the free ensemble had a strong dependence on measurement time. For short tracks, 𝛼𝑘
had a distribution that was approximately Gaussian in shape, as shown in Fig. 3.21(c). For
longer tracks with a greater 𝑇, however, the distribution developed a second distinct peak,
as shown in Fig. 3.22(a) for 𝑇 = 5.0 s and 6.0 s, suggestive of a change in the diffusion
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Figure 3.21. Time-averaged MSD curves of individual CD93-GFP particles in
the free and 200 nm confined ensembles.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Confined receptors were split into ensembles, with molecules of a
150-250 nm confinement radius in the 200 nm ensemble. Time-averaged MSDs of
individual tracks 〈𝛿𝑘 2 (𝜏, 𝑇)〉 were determined, as described in Section 2.4. A
corresponding power-law index 𝛼𝑘 was then found for each track, with
〈𝛿𝑘 2 (𝜏, 𝑇)〉 ∝ 𝜏 𝛼𝑘 . (a) Representative time-averaged MSDs of forty randomly
selected tracks in the free particle ensemble, calculated for a 𝑇 of 2.0 s and presented
on a log-log plot. (b) Representative time-averaged MSDs of forty randomly
selected tracks in the 200 nm confined particle ensemble, calculated for a 𝑇 of 5.0
s and presented on a log-log plot. (c) Distributions of track-specific power-law
indices of the free and 200 nm confined particles ensembles, for a 𝑇 of 2.0 s and 5.0
s respectively.
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Figure 3.22. The effect of total measurement time on the track-specific powerlaw exponent distribution of free CD93-GFP particles.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Time-averaged MSDs of individual tracks 〈𝛿𝑘 2 (𝜏, 𝑇)〉 were then
calculated, as described in Section 2.4. A corresponding power-law index 𝛼𝑘 was
then determined for each track, with 〈𝛿𝑘 2 (𝜏, 𝑇)〉 ∝ 𝜏 𝛼𝑘 . (a) Representative 𝛼𝑘
distributions of the free particle ensemble. Each of the lines of best fit was estimated
by fitting the data to a sum of two Gaussians using maximum likelihood estimation,
with 𝑃(𝛼) = 𝑝𝑁1 (𝜇1 , 𝜎1 ) + (1 − 𝑝)𝑁2 (𝜇2 , 𝜎2 ). (b) The effect of total measurement
time 𝑇 on the peak alpha values, 𝜇1 and 𝜇2 . Bold error bar lines indicate the standard
error in the maximum likelihood estimation of the parameters 𝜇1 and 𝜇2 . Dashed
lines indicate the standard deviations of the normal distributions, 𝜎1 and 𝜎2 . (c) The
effect of total measurement time 𝑇 on the fraction of subdiffusive receptors, 𝑝. Error
bar lines indicate the standard error in the maximum likelihood estimation of 𝑝.
(d) Representative distributions of the 200 nm confined particle ensemble.
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behavior exhibited by a fraction of the receptors classified as free. The presence of this
population first became evident at 𝑇 ≈ 5.0 s. To evaluate the evolution of 𝑃(𝛼𝑘 ) with T,
the distribution was fitted a sum of two Gaussians, with a PDF of 𝑃 = 𝑝𝑁1 (𝜇1 , 𝜎1 2 ) +
(1 − 𝑝)𝑁2 (𝜇2 , 𝜎2 2 ), where 𝑁(𝜇, 𝜎 2 ) denotes a normalized Gaussian distribution with a
mean 𝜇 and a variance 𝜎 2 . The fit was performed with maximum likelihood estimation.
The variation of 𝜇1 and 𝜇2 with T is shown in Fig. 3.22(b) for 𝑇 = 5.0-8.0 s, a
range of 𝑇 over which the peaks were visually distinct. No strong dependence of 𝜇1 and 𝜇2
on 𝑇 was observed. The two means were, however, always significantly different from
each other. The variation of 𝑝, the fraction of tracks included in 𝑁1 , with 𝑇 is shown in
Fig. 3.22(c) for all values of 𝑇 that resulted in algorithm convergence, i.e. 𝑇 = 2.1-8.0 s.
Despite the large error bars yielded by the fitting routine, a systematic linear increase of 𝑝
a rate of ~4.9 ± 3 % per s was observed for 𝑇 ≥ 6.4 s. The fraction of tracks included in
𝑁1 increased significantly from 4 ± 1% at 𝑇 of 2.1 s to 19 ± 6% at 𝑇 of 8.0 s. No second
population was detected for the confined ensembles, 𝑃(𝛼𝑘 ) distributions of which had a
single peak for all 𝑇, as shown for the 200 nm confined ensemble in Fig. 3.22(d) for a 𝑇
of 2.0, 6.0 and 8.0 s. The 𝑃(𝛼𝑘 ) distribution of the 200 nm ensemble, however, became
more narrow and skewed towards larger values of 𝛼𝑘 with increasing 𝑇.
To further evaluate the scatter between track-specific values of 〈𝛿𝑘 2 (𝜏, 𝑇)〉, the
extent of variability in the time-averaged MSDs of individual particles was characterized
by 𝜑(𝜉), the normalized distribution of 𝜉, where
〈𝛿𝑘 2 (𝜏, 𝑇)〉
𝜉𝑘 =
.
̅̅̅̅̅̅̅̅̅̅̅̅
〈𝛿 2 (𝜏, 𝑇)〉

(3.1)

For a fully ergodic, ideal process, in the limit of 𝑇 → ∞, 𝜉 has the form of a Dirac delta
function peaked at 𝜉 = 1 242,244. For a finite 𝑇 and small 𝜏, the scatter distribution of an
ergodic process is expected to be a Gaussian centered at 𝜉 ≈ 1, becoming narrower with
greater 𝑇. While significant deviations from this shape may be expected for comparatively
large lag times, 𝜑(𝜉) remains close to zero for small values of 𝜉 even for large values of 𝜏.
Deviations from such behavior at small 𝜉 reveal ergodicity breaking in the system.
The distributions of 𝜉(𝜏, 𝑇) for the free, 100 nm confined and 200 nm confined
ensembles are presented in Fig. 3.23. All the distributions of the free and 100 nm ensemble
are considerably skewed towards larger values of 𝜉, with non-zero 𝜑(𝜉) for 𝜉 close to zero.
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Figure 3.23. Variability in the time-averaged MSDs of individual CD93-GFP
particles.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells labelled at
1: 10,000. Confined receptors were split into ensembles, with molecules of a 50150 nm confinement radius in the 100 nm ensemble and molecules of a 150-250
nm confinement radius in the 200 nm ensemble. Time-averaged MSDs of individual
tracks 〈𝛿𝑘 2 (𝜏, 𝑇)〉 and the distribution of 𝜉 were then calculated as described in
2 (𝜏, 𝑇)〉, over a range of 𝑇 and 𝜏.
̅̅̅̅̅̅̅̅̅̅̅̅
Section 2.4, with 𝜉𝑘 = 〈𝛿𝑘 2 (𝜏, 𝑇)〉/〈𝛿
(a) Representative variability distributions 𝜑(𝜉) of the free particle ensemble.
(b) Representative variability distributions 𝜑(𝜉) of the 100 nm confined particle
ensemble. (c) Representative variability distributions 𝜑(𝜉) of the 200 nm confined
particle ensemble.
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The distribution for the 200 nm confined ensemble appears more symmetric for a lag time
of 0.1 s, with 𝜑(𝜉 = 0) ≈ 0. The total measurement time 𝑇 does not appear to have a
significant effect on the distributions of 𝜉, as shown in the comparison of 𝜑(𝜉) for 𝑇 of
2.0 s and 7.0 s. Increasing the lag time from 0.1 s to 2.0 s, however, causes a significant
shift to the left in the distribution of the 100 nm confined ensemble and makes the
distribution of the 200 nm confined ensemble more skewed.
Overall, the distributions of the free and 100 nm confined ensembles are indicative
of ergodicity breaking, which is observed for CTRWs, while 𝜑(𝜉) of the 200 nm confined
ensemble behaves in a more ergodic manner. For particles engaged in a CTRW, 𝜑(𝜉) is
known to peak at 𝜑 = 0 for waiting-time power-law 𝛼 values of 𝛼 ≤ 0.5 and at 𝜑 = 1 for
𝛼 values of 𝛼 > 0.5 244. The modes of the 100 nm confined and 200 nm confined 𝜑(𝜉)-s
occur at 𝜉 > 0, while the mode of the free ensemble 𝜑(𝜉) appears shifts to 𝜉 = 0 for higher
𝜏. The results of the scatter distribution analysis are therefore fairly inconsistent. Since
scatter distributions for CTRWs are, however, known to be highly sensitive to system noise
and waiting time cutoffs, the observed 𝜑(𝜉)-s do not contradict the CTRW model.
Once the track-specific time-averaged MSDs 〈𝛿𝑘 2 (𝜏, 𝑇)〉 were analyzed, they were
〈𝛿 2 (𝜏, 𝑇)〉. The effect of lag
used to calculate ensemble-averaged, time-averaged MSDs, ̅̅̅̅̅̅̅̅̅̅̅̅
time on the EA-TAMSDs of the free, 100 nm confined and 200 nm confined ensembles is
presented in Fig. 3.24. Specific EA-TAMSDs for a total measurement time of 𝑇 = 7.0 s
are shown in Fig. 3.24(a), for 𝜏 = 0.1-2.3 s. The EA-TAMSD curves of all three particle
sub-populations appear linear on a log-log plot over this range of lag times. Power-law
2 (𝜏, 𝑇)〉 ∝ 𝜏 𝛼𝜏 (𝑇) ,
̅̅̅̅̅̅̅̅̅̅̅̅
indices 𝛼𝜏 (𝑇) determined from fitting the EA-TAMSDs to the form 〈𝛿

are presented in Fig. 3.24(b) for 2 ≤ 𝑇 ≤ 10 s. Existing models of anomalous diffusion
treat the dependence of EA-TAMSD on 𝜏 as separable from its potential dependence on
𝑇

242

. We found 𝛼𝜏 (𝑇) to be independent of T for all three particle ensembles. The

〈𝛿 2 (𝜏, 𝑇)〉 on 𝜏 regardless of the total
ensembles exhibited the same dependence of ̅̅̅̅̅̅̅̅̅̅̅̅
measurement time over which the system was observed. The 𝑇-averaged 𝛼𝜏 values for the
free, 100 nm confined and 200 nm confined ensembles were 0.95 ± 0.01, 0.35 ± 0.01
and 0.27 ± 0.01 respectively. The nearly linear relationship of the EA-TAMSD with 𝜏
observed for the free CD93 ensemble is consistent with the CTRW model of motion, but
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a)
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Figure 3.24. The effect of lag time on the ensemble-averaged time-averaged
MSD of CD93-GFP in CHO cells.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Confined receptors were split into ensembles, with molecules of a 50150 nm confinement radius in the 100 nm ensemble and molecules of a 150-250
nm confinement radius in the 200 nm ensemble. Ensemble-averaged time-averaged
MSDs were then calculated for each sub-population, as described in Section 2.4,
over a range of 𝑇 and 𝜏. (a) Representative EA-TAMSDs of the free, 100 nm
confined and 200 nm confined ensembles as functions of lag time, presented on a
2 (𝜏, 𝑇)〉 ∝
̅̅̅̅̅̅̅̅̅̅̅̅
log-log plot for 𝑇 of 7.0 s. Lines of best in the data correspond to 〈𝛿
𝛼𝜏 (𝑇)
𝜏
, with power-law indices 𝛼𝜏 (𝑇) for the relationship of the EA-TAMSDs with
lag time estimated by linear regression. (b) The effect of measurement time on the
power-law indices 𝛼𝜏 (𝑇) for the relationship of the EA-TAMSDs with lag time,
over 𝑇 of 2.0 to 10.0 s. The free, 100 nm confined and 200 nm confined ensembles
had 𝑇-averaged 𝛼𝜏 values of 0.95 ± 0.01, 0.35 ± 0.01 and 0.27 ± 0.01
respectively.
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not with fractional Brownian motion or motion in a fractal environment. The sub-linear
2 (𝜏, 𝑇)〉 on lag time observed for confined CD93 is consistent with
̅̅̅̅̅̅̅̅̅̅̅̅
dependence of 〈𝛿

multiple models of anomalous diffusion, including that of a confined CTRW.
To further distinguish between several potential models of anomalous diffusion, we
〈𝛿 2 (𝜏, 𝑇)〉 on the total measurement time 𝑇 in each
next evaluated the dependence of ̅̅̅̅̅̅̅̅̅̅̅̅
2 (𝜏, 𝑇)〉 as a function of 𝑇 for a lag time of
̅̅̅̅̅̅̅̅̅̅̅̅
considered sub-population. Fig. 3.25 shows 〈𝛿
2
̅̅̅̅̅̅̅̅̅̅̅̅̅̅
0.1 s. For each ensemble, 〈𝛿
𝑘 (𝜏, 𝑇)〉 decreases approximately linearly with increasing 𝑇

on a log-log scale, corresponding to a negative power-law dependence. These curves were
2 (𝜏, 𝑇)〉 ∝ 𝑇 𝛼𝑇 , giving power-law indices of 𝛼 = −0.46 ± 0.01,
̅̅̅̅̅̅̅̅̅̅̅̅
fitted to the form 〈𝛿
𝑇

𝛼𝑇 = −0.297 ± 0.002, and 𝛼 𝑇 = −0.283 ± 0.002 for the free, 100 nm confined and
200 nm confined ensembles respectively at 𝜏 = 0.1 s. In ergodic models of anomalous
diffusion, the EA-TAMSD is expected to be independent of the total measurement time,
while a dependence on 𝑇 is indicative of non-ergodicity and system ageing. The negative
power-law indices observed for all the characterized ensembles are in line with the
behavior predicted for both CTRWs and confined CTRWs, but not for ergodic processes
such as fractional Brownian motion or motion in a fractal environment. The trend of a
〈𝛿 2 (𝜏, 𝑇)〉 with increasing 𝑇 was preserved for greater lag times, although we
decreasing ̅̅̅̅̅̅̅̅̅̅̅̅
had fewer data points at larger 𝜏 (data not shown). While the observed dependence of the
EA-TAMSD on 𝑇 is expected to be separable from its dependence on 𝜏, a larger data set
would be needed to determine whether the calculated 𝛼𝑇 indices are lag-time-independent.
〈𝛿 2 (𝜏, 𝑇)〉 is
A summary of the power-law indices determined for ̅̅̅̅̅̅̅
𝑟 2 (𝑡) and ̅̅̅̅̅̅̅̅̅̅̅̅
presented in Table 3.1. We find that free CD93 receptors, which would be classified as
moving in a Brownian fashion based on the 𝜏-dependence of the time-averaged MSDs ,
〈𝛿 2 (𝜏, 𝑇)〉 ∝ (𝜏/𝑇 1−𝛼 ), with 𝛼 ≈ 0.5. The dependence of these
have ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 𝛼 and ̅̅̅̅̅̅̅̅̅̅̅̅
quantities on the measurement time 𝑡, lag time 𝜏 and total measurement time 𝑇 is in good
agreement with the predictions of subdiffusive continuous time random walks242,249. The
motion of both the 100 nm and 200 nm confined receptors is approximately described by
̅̅̅̅̅̅̅
〈𝛿 2 (𝜏, 𝑇)〉 ∝ (𝜏⁄𝑇)𝛼 , with 𝛼 ≈ 0.3. This behavior resembles that of
𝑟 2 (𝑡) ∝ 𝑡 0 and ̅̅̅̅̅̅̅̅̅̅̅̅
particles engaged in a confined subdiffusive CTRW244,250.
The results of the mean maximal excursion (MME) analysis, a technique developed
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Figure 3.25. The effect of measurement time on the ensemble-averaged timeaveraged MSD of CD93-GFP in CHO cells.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Confined receptors were split into ensembles, with molecules of a 50150 nm confinement radius in the 100 nm ensemble and molecules of a 150-250
nm confinement radius in the 200 nm ensemble. Ensemble-averaged time-averaged
MSDs were then calculated for each sub-population, as described in Section 2.4,
over a range of 𝑡 and 𝜏. This figure shows EA-TAMSDs as a function of 𝑡 on a loglog plot for a lag time of 0.1 s, over a measurement time 𝑡 of 2.0-10.0 s. Lines of
〈𝛿 2 (𝜏, 𝑇)〉 ∝
best fit in the data, estimated by a linear regression, correspond to ̅̅̅̅̅̅̅̅̅̅̅̅̅̅
𝑘

𝑇 𝛼𝑇 , with power-law indices 𝛼 𝑇 (𝜏 = 0.1 s) for the relationship of the EA-TAMSDs
with measurement time. The free, 100 nm confined and 200 nm confined ensembles
had power-law indices 𝛼 𝑇 of −0.458 ± 0.005, −0.297 ± 0.002, and −0.283 ±
0.002 respectively.
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Table 3.1. Summary of the power-law exponents for the relationship of the
ensemble-averaged MSD and ensemble-averaged time-averaged MSD with
measurement time and lag time.
Separate sub-populations of particles were generated according to their SPT
software classifications for CD93-GFP receptors from CHO cells primary-labelled
at 1: 10,000. Confined receptors were split into ensembles, with molecules of a 50150 nm confinement radius in the 100 nm ensemble and molecules of a 150-250
nm confinement radius in the 200 nm ensemble. Ensemble-averaged and ensembleaveraged time-averaged MSDs were then calculated for each sub-population, as
described in Section 2.4. Linear regression analysis was used to determine the
power-law exponents.
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by Tejedor et al. to classify the diffusion of unconfined particles and performed here for
free CD93 receptors, are shown in Fig. 3.26259. The second and fourth MME moments
were calculated using 𝑟𝑀 (𝑡) = max{𝑟(𝑡 ′ ): 0 ≤ 𝑡 ′ ≤ 𝑡}, the maximum distance travelled
by each particle away from its original position at 𝑡=0 in the span of a measurement time
𝑡, as described in Section 2.4. As shown in Fig. 3.26(a), the second MME moment of the
receptors was greater than their ensemble-averaged MSD for all 𝑡 > 0.1 s, since, for each
receptor, 𝑟(𝑡) ≤ 𝑟𝑀 (𝑡). The moment ratios of both regular and MME moments, defined by
2
2 (𝑡)]2 and ̅̅̅̅̅̅̅̅
2
̅̅̅̅̅̅̅
𝑟 4 (𝑡)/[𝑟̅̅̅̅̅̅̅
𝑟𝑀 4 (𝑡)/[𝑟̅̅̅̅̅̅̅̅
𝑀 (𝑡)] , are presented in Fig. 3.26(b). For all 𝑡, the regular

moment ratio remained above the cutoff value of 2, while the MME moment ratio remained
above the cutoff of 1.49. Ratios above these cutoffs are expected for particles diffusing by
a CTRW and ratios below these cutoffs are expected for fractional Brownian motion. As
such, the results of this analysis for free CD93 receptors are in accordance with a
subdiffusive continuous time random walk. Since corresponding cutoffs for confined
CTRWs are yet to be derived, this analysis was not performed for confined CD93 receptors.
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Figure 3.26. Mean maximal excursion analysis of free CD93-GFP receptor
motion.
(a) The effect of measurement time on the ensemble-averaged MSD and second
MME moment of the free receptor ensemble of CD93-GFP from CHO cells
primary-labelled at 1: 10,000. (b) Regular and MME moment ratios for free
2
2 (𝑡)]2 and ̅̅̅̅̅̅̅̅
2
receptor motion, defined by ̅̅̅̅̅̅̅
𝑟 4 (𝑡)/[𝑟̅̅̅̅̅̅̅
𝑟𝑀 4 (𝑡)/[𝑟̅̅̅̅̅̅̅̅
𝑀 (𝑡)] . The analysis
was performed as described in Section 2.4. Lower (1.49) and upper (2) dashed lines
represent MME and regular moment ratio cutoffs above which particle motion is
described by a CTRW.
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Chapter 4
CD93 Diffusion: Discussion
The detection, engulfment and internal processing of cells undergoing programmed
cell death by efferocytic cell types is integral to the proper maintenance of homeostasis
within the body9,10. The failure of efferocytes to clear away the remnants of apoptotic cells
is thought to contribute to the development of numerous immune system-mediated
pathologies76–79. The biophysical mechanisms underlying efferocytosis, including the
interplay between actin-driven force generation and receptor diffusion, however, remain
poorly understood. In this study, we characterized the diffusion of CD93, a putative
efferocytic receptor reported to be involved in several cardiovascular and autoimmune
diseases8. Both free and confined CD93 molecules were observed in resting cells and found
to undergo anomalous diffusion that exhibited several features of a continuous time random
walk.
Seventy percent of endogenous CD93 molecules in human monocyte cells were
classified as confined using moment spectrum scaling analysis (Fig. 3.6)255. Several
immune receptors, including Fc𝛾RIIA, Fc𝜀RI and 𝛼𝑀 𝛽2 integrins, have been reported to
experience confinement mediated by the actin cytoskeleton in resting immune cells, with
confinement ranging from 80% for 𝛼𝑀 𝛽2 to 33% for Fc𝛾RIIA55,58,74,210. The fraction of
confined CD93 molecules falls within the upper end of this range. It has been proposed
that the percentages of confined and free Fc𝛾RIIA receptors reflects the rates of their
trapping by and escape from cytoskeleton-defined compartments, which have been
previously shown to exist in the plasma membrane55. In a steady-state system with
equivalent rates of capture and release, however, the relative fractions of free and confined
molecules are more likely to reflect the average time spend in each mobility state. The
observed high fraction of confined CD93 molecules in resting cells therefore suggests that
these receptors may spend more time confined within compartments than Fc𝛾RIIA.
Endogenous CD93 molecules classified as free were determined to have a mean
early-time diffusion coefficient of 0.07 ± 0.01 μm2/s (Fig. 3.7), in close agreement with
the coefficients reported for Fc𝜀RI receptors (median of 0.074 μm2/s) and Fc𝛾RIIA
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receptors, the latter of which were found to have a mean 𝐷𝑓𝑟𝑒𝑒 of 0.074 ± 0.004 μm2/s,
measured by the same software as utilized in our study55,58. Confined CD93 receptors were
found to have a mean confinement radius of 242 ± 7 nm (Fig. 3.7), close to the value of
199 ± 15 nm reported for confined Fc𝛾RIIA55.
According to the picket fence membrane model developed by Kusumi et al., the
motion of membrane molecules can be confined to compartments of various size3. The
“fences” of these compartments are believed to be made of cortical actin, which lines the
inner surface of the cell membrane. Transmembrane proteins that are anchored to the
cytoskeleton and span the membrane are thought to act as “pickets”. Such pickets are
capable of restricting the diffusion of even those molecules that do not directly encounter
the actin fences, such as the proteins and lipids in the outer membrane leaflet. The confined
diffusion of numerous transmembrane proteins, including Fc𝜀RI and Fc𝛾RIIA, has been
shown to be dependent on the cytoskeleton, with confined receptors diffusing in specific
actin-defined compartments3,55,58,74,151. Whether the confinement of CD93 is similarly
governed by actin is yet to be established. The similarity between our results and those for
other transmembrane proteins, however, suggests that the confinement of CD93 may also
be mediated by actin, as predicted by the picket fence membrane model.
The motion of endogenous CD93 in human monocyte cells was found to be similar
to the diffusion of transiently-expressed CD93-GFP in Chinese hamster ovary (CHO) cells
(Fig. 3.4-3.5), suggesting a similar mechanism of confinement between these cell types. A
prior study of the mobility of class I MHC molecules demonstrated diffusion to be affected
by the size and sequence of their cytosolic tails187. In contrast, the addition of GFP to the
intracellular domain of CD93 did not have a significant effect on CD93 diffusion, despite
its potential to sterically alter the interactions of the cytosolic tail of CD93 with its potential
binding partners, such as GIPC and moesin, or with the underlying actin cytoskeleton228,229.
As such, CD93 diffusion was either independent of these interactions or these interactions
were preserved following the addition of GFP tag. The CHO cell heterologous system was
therefore found to be a reasonable alternative for studying CD93 diffusion in experiments
not amenable to the use of primary human cells.
Endogenous CD93 has previously been reported to be shed from the plasma
membrane of immune cells in response to both phobol esters and physiologically-relevant
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stimulants, such as TNFα, with soluble sCD93 potentially acting as an opsonin for
apoptotic cell engulfment214,216,231,232. CD93 is known to be cleaved by a yet unidentified
zinc-dependent matrix metalloproteinase (MMP) other than TACE214. We observed the
expected shedding of CD93 from human monocyte cells induced by treatment with phorbol
myristate acetate (Fig. 3.16), a known stimulator of protein kinase C (PKC) activity and
CD93 cleavage232. No equivalent shedding was observed in PMA-treated CHOs (Fig.
3.18), indicating that these cells do not express the protease required for CD93 shedding.
The metalloproteinase responsible for the cleavage of CD93 might therefore be identified
by a comparative screen of MMPs expressed by monocytes but not by CHO cells.
A recent study of 𝐶𝑋3 𝐶𝐿1 chemokine diffusion, conducted in part in our lab, has
shown that actin cytoskeleton-based confinement of 𝐶𝑋3 𝐶𝐿1 regulates its cleavage from
the membrane by limiting its interactions with the protease ADAM10238. We therefore
sought to determine whether membrane compartmentalization may regulate the shedding
of CD93. A treatment with PMA, however, had no effect on the mobility of detected CD93
receptors in either CHO (Fig. 3.18-3.19) or monocyte (Fig. 3.16-3.17) cells, although the
monocytes shed most of their CD93 molecules almost instantaneously. The majority of the
remaining endogenous CD93 receptors were found in large bright patches, the significance
of which is yet unknown (Fig. 3.16). Since the majority of residual monocyte CD93 did
have an altered distribution pattern, with only a portion of the molecules retaining their
past diffusional characteristics, CD93 shedding likely proceeds in a cytoskeletondependent manner. The actin rearrangements and changes in CD93 mobility preceding its
cleavage, however, can be suggested to occur too quickly to be detected at the frame rate
used in our experiments.
The frame rate used in our study likewise precluded us from capturing any possible
motion of CD93 by hop diffusion, which occurs on the scale of milliseconds. Our
investigation was limited to motion on time scales of 0.1-10 s. Other receptors that have
been characterized by single particle tracking over equivalent time scales, such as Fc𝛾RIIA
and Fc𝜀RI, have been reported to undergo normal diffusion when not confined to a
compartment55,58,74. When confined, Fc𝜀RI and IgE-Fc𝜀RI receptors were found to
undergo Brownian motion in geometrically restricted domains, characterized by normal
diffusion on time scales shorter than the time between collisions with the domain walls and
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a plateau in the time-averaged(TA)-MSD at longer lag times58,74. Although confined
Fc𝛾RIIA receptors were not proven to undergo confined Brownian motion, they have been
treated as such and assigned a pseudo-linear diffusion coefficient55. Jaumouille et al.
classified these receptors using moment spectrum scaling analysis, which was also
employed in our study55,67. In this analysis, however, the trajectories of confined Fc𝛾RIIA
molecules would, by definition, have to have a power-law dependence on lag time, with
TA-MSD values proportional to 𝜏 𝛼 and 𝛼 < 1 196,255. A generalized diffusion coefficient,
with fractional units of μm2/sα, would therefore have been a more appropriate and
meaningful measure of confined Fc𝛾RIIA motion, since its units match the power-law
dependence5.
Neither free nor confined CD93 receptors were found to undergo purely Brownian
diffusion in our study, contrary to the results reported for Fc𝛾RIIA and Fc𝜀RI55,58.
Evidence of anomalous diffusion of CD93 in both CHO and monocyte cells was first
observed in the extended MSD plots (Fig. 3.8) and van Hove functions (Fig. 3.9-3.11) of
the receptors. While the extended MSD curves of the free receptors had log-log slopes
smaller than but close to that for Brownian motion, all particles classified as confined were
strongly subdiffusive, with power-law exponents 𝛼 < 1. Similar results were reported in a
microrheological study of microbead motion in reconstituted networks of F-actin,
conducted by Wong et al. in 2004260. Wong et al. found that when microbead size was
much smaller than the mesh size of the actin network, their extended MSD curve had a
linear dependence on lag time. When the size of the microbeads approached the size of the
actin mesh, however, their motion became subdiffusive, with 𝛼 < 1. Furthermore, the
power-law exponents of the beads, deduced from their extended MSD curves on time
scales of 0.1-10 s, were smaller for beads constrained by smaller mesh compartments260.
Consistent with these observations, we determined that CD93 molecules confined to zones
of smaller confinement radius 𝑅𝑐𝑜𝑛𝑓 were likewise found to be more subdiffusive, with
smaller 𝛼 (Fig. 3.8).
The ensemble van Hove functions of both confined and free CD93 receptors were
found to be non-Gaussian, with tails that decayed slower than expected for a normal
distribution (Fig. 3.9-3.11). This result was consistent with two possibilities – genuine nonBrownian diffusion of both confined and free CD93 receptors, or the Brownian diffusion
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of individual molecules in different microenvironments, the spatial heterogeneity of which
gives rise to non-Gaussian ensemble van Hove functions. The width of the free particle van
Hove functions increased with lag time, indicating the absence of physical barriers such as
corrals. The width of the confined receptor functions remained nearly constant and was
smaller for receptors confined to smaller confinement zones, confirming the presence of
barriers of a different characteristic size, consistent with the MSS analysis. The van Hove
functions of free particles were, surprisingly, found to be the most non-Gaussian in shape.
The van Hove functions for Brownian motion, as well as for some forms of
anomalous diffusion, have a normal distribution243. Non-Gaussian ensemble van Hove
functions can be indicative of both anomalous diffusion arising from motion in a spatially
heterogeneous system and anomalous diffusion of other origins, but do not themselves
prove that individual particles move in a non-Brownian fashion243,261. Examples of the
former include the motion of microparticles in Laponite suspensions, agarose, and
Carbopol ETD 2050 gels202,206,261. In 2008, Oppong et al. used microrheology to examine
the gelation of Laponite by tracking the motion of micron-sized particles within its
structure206. The MSDs values reported for these particles were calculated in a manner
equivalent to the extended MSDs reported in our study. Oppong et al. found the motion of
particles in Laponite to be subdiffusive, with non-Gaussian van Hove functions and more
pronounced deviations at later lag times206. In their system, such behavior was attributed
to the spatially heterogeneous structure of Laponite, with different micro-environments
sampled by different particles.
Similar non-Gaussian van Hove functions were also observed by Valentine et al.
for the motion of particles in agarose and actin networks261. Notably, while the ensemble
van Hove functions for particle diffusion in agarose were non-Gaussian even at short lag
times, the functions of individual particles retained a Gaussian shape indicative of
Brownian diffusion with different diffusion coefficients. Conversely, no such behavior was
observed for individual particles in actin networks. The difference was reflected in the
extended MSD curves of the particles in the two systems. In agarose, the log-log slope of
the extended MSD was linear at shorter lag times and transitioned to a plateau at longer
times, mirroring the behavior reported for confined Fc𝜀RI receptors58. In actin networks,
however, the motion of the particles was subdiffusive even at the shortest lag times, more
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closely resembling our results for the diffusion of CD93. The non-Gaussian behavior of
the ensemble van Hove functions of the particles in agarose was attributed to structural
heterogeneity. The motion of the particles in the actin network was treated as a more
complex phenomena, owing to the ability of individual particles to jump between
compartments and sample a range of environments over time. In our experiments, however,
even ensembles of CD93 molecules that remained confined in zones of a similar size had
non-Gaussian van Hove profiles, suggesting that either these molecules still probed a range
of different local microenvironments within their compartments or that they moved by
anomalous diffusion that was not the result of spatial heterogeneity.
To investigate the origin of the subdiffusive motion observed for CD93, we first
analyzed the microenvironments probed by free and confined receptors using the cage
effect analysis (Fig. 3.12-3.15) developed by Doliwa and Heuer203. Since receptors
confined to zones of smaller size had more subdiffusive extended MSD curves and
narrower van Hove functions, we determined whether molecules confined to zones of a
different size exhibited a different extent of caging, as determined by their cage strength.
All confined receptors exhibited caging, wherein the directions of two successive steps
were negatively correlated and receptors taking a larger initial step were more likely to
encounter the cage wall, then bouncing off in the opposite direction. Cages of greater
strength were observed for receptors confined to smaller zones, wherein the motion of the
molecules was more restricted. These results are similar to those reported for the diffusion
of tracer particles in Carbopol, where a greater cage strength was likewise correlated with
more subdiffusive motion202. CD93 receptors confined to smaller compartments were
found to be trapped in stronger cages with longer lifetimes.
The cages observed in our study lacked a clear characteristic size (Fig. 3.12-3.13).
It is therefore difficult to determine whether the cages of confined CD93 receptors are, in
fact, equivalent to the confinement zones assigned by the SPT software, the origin of which
has been attributed to actin fences3. Owing to the differences in the two analysis methods,
it is possible for 𝑅𝑐𝑎𝑔𝑒 determined by the cage effect analysis to be different from 𝑅𝑐𝑜𝑛𝑓
determined by the SPT software. Moreover, the characteristic cage size could be obscured
by system noise and may, in fact, be relatively close to the confinement radius. Several
observations, however, argue against such an interpretation. If receptor confinement in
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compartments of specific size was a consequence of caging, then caging would be evident
at all lag times for which the receptors remain confined and encounter the compartment
walls and cage lifetimes would be equal to the time required to escape the compartments.
Cage strength, however, decreased rapidly with increasing lag time, particularly for
particles confined to compartments of larger 𝑅𝑐𝑜𝑛𝑓 (Fig. 3.14-3.15). For such receptors,
the mean lifetime of the cages was smaller than the measurement time at which the majority
of the particles were still confined. In particular, for receptors confined to zones with 𝑅𝑐𝑜𝑛𝑓
equal to 350-450 nm, cage strength was extrapolated to zero at a lag time of ~5 s.
However, the ensemble-averaged MSD of these receptors (Fig. 3.20) still showed then to
be firmly confined at a measurement time of 5 s and beyond, with no evidence of escape.
Furthermore, if caging was completely equivalent with the entrapment of CD93 receptors
in their confinement zones, no directional anti-correlation would be observed in the motion
of free receptors. Even receptors classified as free, however, exhibited significant caging
at the shortest lag times (𝜏 < 0.5 s).
In prior studies, the absence of a characteristic 𝑅𝑐𝑎𝑔𝑒 has been attributed to the
presence of cages of various size within the system. No characteristic length scale was, for
example, observed for the cage effect experienced by microparticles in Laponite
suspensions, which are thought to possess a fractal-like structure202,206. In the plasma
membrane, a fractal-like structure has been shown to emerge when macromolecular
crowding approaches the percolation threshold262. Fractal geometry has also been
associated with the anomalous diffusion of voltage-gated potassium channels258. The cage
effect itself need not result from more stable barriers, such as cytoskeletal fences. In a
simulation study, Doliwa and Heuer have shown that caging in glass-forming systems may
be described by a model of Brownian motion of a particle in a harmonic potential
corresponding to a cage formed by other neighboring particles203. In their study, the cage
strength first increased with time as the particles encountered their cages, and then
decreased with time as more and more particles escaped. Similarly, Weeks and Weitz have
shown that, in a colloidal system near the glass transition, a particle is caged by other
surrounding particles, the movement of which eventually leads to cage re-arrangement204.
Longer-lasting cages were observed in systems with a greater volume fraction of
particles204.
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Given the different lifespans and lack of consistent cage sizes relative to their
confinement zone sizes, we do not believe the caging observed for CD93 molecules is
equivalent with their entrapment within confinement zones, which have previously been
suggested to be made of actin fences3. Instead, we postulate that both free and confined
CD93 receptors are temporarily captured in protein and/or lipid cages of various size that
arise due to macromolecular crowding. Since the cage strength of the free receptors
decreases very rapidly with time, their cages are very short-lived. Their transience could
be explained by a combination of weak cage-stabilizing forces and the rapid diffusion of
the cage-forming molecules away from CD93. The order-of-magnitude longer cage
lifetimes observed for confined CD93 molecules may be the result of their co-confinement
with other cage-forming molecules, wherein an increased local effective concentration of
molecules could then result in the formation of more stable cages of various sizes within
the larger actin compartments. In such a framework, CD93 receptors trapped in 350-450
nm confinement zones could escape their smaller molecular cages on the scale of 5 s, while
remaining confined within the larger, actin-defined compartments. Since longer-lived
cages were detected for confined CD93 with smaller 𝑅𝑐𝑜𝑛𝑓 , it is possible that smaller
confinement zones are associated with more molecular crowding, which leads to both
stronger, longer-lasting cages and more subdiffusive motion. Future experiments may help
to determine whether CD93 caging is the result of molecular crowding and whether
membrane compartmentalization can modulate the lifetimes of such cages.
Several models of anomalous diffusion have previously been employed to describe
the effects of macromolecular crowding and binding to molecular complexes or
cytoskeletal elements on the motion of proteins and lipids within the cell membrane5,242.
Geometrical inhomogeneities that can arise from macromolecular crowding and
cytoskeletal fences have been described by models involving diffusion on a fractal and
fractional Brownian motion (FBM)5,242,251,258. A particle diffusing on a fractal exhibits
subdiffusive motion governed by the dimension of the fractal5,242,263. Subdiffusive FBM
has been applied to characterize motion in a viscoelastic medium with long time
correlations5,242. Particles undergoing FBM revisit past locations, exhibiting antipersistence. Temporary immobilization of membrane molecules, conversely, has been
described with the aid of continuous time random walks (CTRWs)5,242. Each of these three

133

models exhibits a known characteristic dependence of the ensemble-averaged MSD on the
measurement time 𝑡 and of the ensemble-averaged time-averaged (EA-TA) MSD on the
lag time 𝜏 and total measurement time 𝑇242. By analyzing the ensemble-averaged MSDs
and EA-TAMSDs of CD93 receptors and evaluating system ageing, we found the diffusion
of free and confined CD93 to exhibit several features characteristic of free and confined
continuous time random walks.
CD93 receptors confined to small compartments (< 250 nm) were found to have
ensemble-averaged MSDs (Fig. 3.20) which plateaued to a constant value at 𝑡 > 2 s, with
̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 ~0 . In an ergodic system, their EA-TAMSDs would likewise reach a plateau, with
the temporal and ensemble averages converging in the limit of sufficiently long tracks. In
contrast, the measured EA-TAMSDs of the confined receptors continued increasing
sublinearly with lag time (Fig. 3.24), with 〈𝛿 2 (𝜏, 𝑇)〉 ∝ 𝜏 (1−𝛼) , and 𝛼 ≈ 0.7. Furthermore,
the system exhibited ageing, with a dependence of the EA-TAMSDs on the total
〈𝛿 2 (𝜏, 𝑇)〉 ∝ 1/𝑇 (1−𝛼) . The time-averaged MSDs of
measurement time (Fig 3.25), i.e. ̅̅̅̅̅̅̅̅̅̅̅̅
individual trajectories had a great deal of scatter (Fig. 3.21-3.23). All these observations
(Table 3.1) agreed with the expected behavior of particles engaged in confined subdiffusive
CTRWs244,250. Taken together, these observations were inconsistent with models of FBM
or diffusion on a fractal, both of which are known to be ergodic and not affected by total
measurement time 𝑇.
The motion of free CD93 molecules was likewise found to be non-ergodic and
subject to ageing. Their EA-MSD (Fig. 3.20) had a sublinear dependence on measurement
time for 𝑡 > 3 s, with ̅̅̅̅̅̅̅
𝑟 2 (𝑡) ∝ 𝑡 𝛼 , and 𝛼 ≈ 0.5, as expected for fractional Brownian motion
(FBM), motion in a fractal environment, and unconfined CTRWs. Their EA-TAMSD,
however, increased linearly with lag time (Fig. 3.24) and depended on total measurement
2 (𝜏, 𝑇)〉 ∝ 𝜏/𝑇 (1−𝛼) , consistent with the unconfined CTRW
̅̅̅̅̅̅̅̅̅̅̅̅
time (Fig. 3.25), with 〈𝛿

model242. As the total measurement time over which the particles were observed increased,
a greater fraction of the CD93 particles were captured by confinement zones, with
〈𝛿 2 (𝜏, 𝑇)〉 ∝ 𝜏 ~0.3, matching the exponent observed for confined particles (Fig. 3.22).
Nonetheless, since ~80% of the free receptors remained free for all observed 𝑇, the ageing
behavior of the system could not be attributed to particle confinement alone. The nonGaussian van Hove functions observed in our study were incompatible with the Gaussian
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functions expected for particles engaged in FBM243. Mean maximal excursion analysis
(Fig. 3.26), a technique developed to distinguish between FBM and CTRW models,
provided further evidence for the motion of free CD93 molecules according to a
subdiffusive continuous time random walk259,264.
Subdiffusive CTRWs arise when particles move by a series of random jumps
interrupted by “sticking” or “trapping” events with power-law distributed waiting times
𝜏𝑤 5,242. A waiting time distribution with a non-exponential tail, such as 𝜓(𝜏𝑤 ) ∝
1/𝜏𝑤 (𝛼+1) , 𝛼 < 1, results in the absence of a characteristic waiting time for the particles.
Accordingly, the system exhibits ageing. Increasing waiting times are seen the longer the
system is observed and a concordant decrease in the EA-TAMSD occurs with increasing
total measurement time 𝑇. The features of a CTRW are preserved even if the power-law
scaling of 𝜓(𝜏𝑤 ) is terminated at some maximum waiting time cutoff 𝜏𝑤 ∗ , as long as the
observations are limited to time scales much smaller than this cutoff

5,244,251

. The number

of CD93 tracks obtained in our experiments was unfortunately insufficient to extract a
reliable waiting time distribution for these receptors. Such an analysis may be performed
in the future, following the development of more stable fluorophores or photobleachingreducing conditions, to further test whether the motion of CD93 is compatible with the
model of a continuous time random walk.
The immobilization events underlying CD93 motion in the model of a continuous
time random walk may have several biological origins. In the plasma membrane, temporary
molecular immobilization is thought to arise from transient interactions with a
macromolecular complex or a cytoskeletal component5. Most interactions possess a
specific dissociation coefficient 𝑘, which results in an exponentially-distributed
dissociation time, with 𝜓(𝜏𝑤 ) = (𝑘)exp(−𝑘𝜏𝑤 ) for the waiting-time distribution5. Powerlaw distributed waiting times can, however, arise from non-stationary or heterogeneous
interactions5. If a particle binds to a growing macromolecular complex, its dissociation
coefficient may change with time. In cases where the probability of its escape decreases as
the complex grows, the particle dissociation times have been shown to become power-law
distributed, resulting in a time-evolution route to a CTRW5,265. Alternatively, a CTRW may
arise if a particle interacts with more than one binding partner or macromolecular complex,
resulting in a distribution of dissociation coefficients that leads to a heavy-tailed power-
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law 𝜓(𝜏𝑤 )5. Nothing precludes such interactions from occurring for CD93, both within
and outside of confinement zones. CD93 has been reported to interact with both moesin
and GIPC through its cytosolic tail228,229. Moesin is an actin-binding protein capable of
linking the actin cytoskeleton to the cell membrane18. It could therefore play a role in
temporarily immobilizing CD93 near the actin fences229. Alternatively, the binding of
CD93 to GIPC, a protein involved in the regulation of endocytosis, suggests that CD93
could get trapped as part of the internalization machinery, with an escape probability that
decreases with time230. In principle, the interactions of CD93 with its binding partners
could therefore result in the power-law distributed waiting times of a CTRW.
Particles engaged in a CTRW, with the associated power-law distributed waiting
times, have been observed in several biological systems242. In 2011, Weigel at al. studied
the diffusion of GFP-tagged Kv2.1 potassium channels in the plasma membrane of
transfected HEK cells258. They found a sublinear relationship for both the ensembleaveraged MSD with experimental time and for the EA-TAMSD with the lag time for these
molecules, similar to the observations made by us for confined CD93 particles. Akin to our
study, the channel motion was determined to be non-ergodic and the system was subject to
ageing, with a dependence of the EA-TAMSD on the total measurement time. Using first
passage statistics, wherein the time taken for each particle to travel a specified distance
from its original position is determined, they showed that the K+ channels had a powerlaw-based distribution of waiting times. Overall, the power-law exponents for the MSDs
were such that the diffusion of K+ channels was characterized by a mixed model of a
subdiffusive continuous time random walk in a fractal geometry258. The power-law-based
distribution of the channel waiting times was shown to be actin-dependent by treating the
system with an actin-disrupting toxin, while the fractal geometry was suggested to arise
due to macromolecular crowding. Kv2.1 potassium channels were subsequently found to
switch between mobile and stationary states by binding to clathrin-coated pits (CCPs),
which themselves had a range of lifetimes265. Their rate of escape from the CCPs gave rise
to a power-law waiting time distribution265.
A recent simulation study by Yamamoto et al. revealed a CTRW process in the
motion of water molecules on the cell membrane surface264. In 2014, Yamamoto et al.
investigated the source of the subdiffusion of water particles on the membrane surface,
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finding it to be a combination of a CTRW and fractional Brownian motion. Based on an
MME analysis, with results similar to those observed for CD93, and due to the aging
present in the system, the motion of the water molecules had a few characteristic features
of a CTRW. Furthermore, as was observed for confined CD93 molecules, the relationships
of the ensemble-averaged MSD with measurement time and of the time-averaged MSDs
with lag time were sublinear. The power-law exponents, however, did not agree with the
confined CTRW model, and were instead suggested to reflect a FBM process. In the
resulting mixed model, the CTRW was hypothesized to arise from the random binding of
the water particles to the membrane lipids, while FBM was suggested to originate from the
motion of the lipids themselves, which have been reported to diffuse in a manner consistent
with FBM264. Such complex forms of subdiffusive motion are not limited to the cell
membrane and have also been observed in the cytosol. Intracellular insulin granules, for
example, have been shown by Tabei et al. to move in accordance with fractional Brownian
motion subordinated to a CTRW, with an associated hybrid model266. The motion of lipid
granules in the cytosol of living fission yeast cells has been found to resemble a CTRW
with a truncated waiting-time distribution at short time-scales, but is governed by FBM at
longer time-scales251.
Attributing all the features of CD93 receptor motion to free and confined CTRWs
might not present a complete picture. Since CTRWs are assumed to be free of spatial
correlations, strict CTRW models cannot explain the correlations associated with caging
observed for both confined and free CD93 molecules242. From a mathematical standpoint,
a better description of CD93 motion might be developed using a combination of a CTRW
with another model of anomalous diffusion. Mixed models are, however, often situationspecific and are non-trivial to derive5,263,266. Since CD93 diffusion is a complex process,
affected by many physical and biological factors, there is no reason to expect that any
meaningful mathematical model may fully describe the motion of these molecules. Instead,
we therefore propose a three-tier conceptual model of CD93 diffusion, to be tested in future
studies with the long-term goal of better understanding its biological functions.
Our data are consistent with CD93 diffusion being affected by multiple distinct tiers
of regulation. On the first tier, we suggest that, like other immune cell receptors, CD93
undergoes relatively long-lasting confinement in membrane compartments of various sizes
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which depend on the structure of the actin cytoskeleton. On the second tier, both free and
confined CD93 receptors get trapped in cages, perhaps formed by other membrane proteins
and/or lipids due to macromolecular crowding. The short-lived cages of the free receptors
are only transiently detected and could potentially be formed by lipid rafts173,267. The
strength and lifetimes of the molecular cages of confined CD93 particles increase with
decreasing size of their actin-defined membrane compartments, due to the enhanced coconfinement of the cage-forming molecules. Finally, on the third tier, the random binding
of both free and confined CD93 particles to one or more macromolecular complexes and/or
the cytoskeleton itself leads to their temporary immobilization, resulting in diffusion
features consistent with a continuous time random walk.
Such a three-tier model of CD93 diffusion is reminiscent of the three-tier hierarchy
of membrane organization proposed by Kusumi et al. in 2012173,267. According to Kusumi
et al., the cell membrane is suggested to consist of actin-defined compartments (40-300
nm), lipid raft domains (2-20 nm) and dynamic protein complex domains (3-10 nm). On
the smallest scale, the membrane is simultaneously characterized by temporary proteinprotein interactions in dimers, oligomers and scaffolding-protein-induced complexes. Such
interactions may be responsible for the temporary immobilization of CD93 molecules
engaged in a continuous time random walk. On the largest scale, we found seventy percent
of CD93 molecules to be confined to relatively stable (≥ 8 s) membrane compartments,
the lifetimes and mean size of which are consistent with actin-defined corrals17,151,173.
The short-lived (≤ 0.5 s) caging observed for free CD93 molecules, conversely,
may be the result of their temporary association with small, cholesterol-rich mesodomains.
The measured lifetimes of lipid rafts are very dependent on the types of characterized lipid
rafts, i.e. lipid-only or protein-stabilized rafts, and affected by measurement system,
yielding values of nanoseconds to seconds267–271. The short caging times observed for free
particles are consistent with these measurements, falling in the upper end this range.
The caging observed for confined CD93 molecules was too short to be associated
with actin-based confinement. Whether or not it can be attributed to an association with
lipid rafts is unclear. It is possible that actin corrals exclude lipid rafts and we are observing
a novel level of membrane organization that results in the longer-lasting caging of confined
molecules by other co-confined molecules. Alternatively, some cholesterol-rich
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mesodomains have been proposed by Kusumi et al. to exist within the larger actin-defined
compartments, confined therein through the exclusion of cholesterol by protein pickets267.
The second possibility is, therefore, that lipid rafts are present in and somehow stabilized
by the actin corrals, resulting in the stronger caging of confined CD93. Finally, it is possible
that lipid rafts are present in the corrals, but the caging of confined CD93 is predominantly
mediated by the temporary cages formed by other molecules. The exact mechanism of
confined CD93 caging, and the means by which compartment size can influence the
strength and lifetimes of the cages, are yet to be determined.
A number of future experiments could be conducted to test the validity of our model
of CD93 diffusion. Investigating changes in CD93 diffusion in response to actin-disrupting
agents may help determine which aspects of its motion are governed by the cytoskeleton,
since both its confinement in membrane compartments and the CTRW features of its
motion may be actin-dependent. Treatment of CD93-expressing cells with a cholesteroldepleting chemical could establish whether CD93 associates with cholesterol-enriched
lipid mesodomains and whether or not these domains are responsible for its caging.
Investigating the interactions of CD93 with moesin and GIPC, as well as identifying its
other potential binding partners, may likewise shed light on both the origins of its caging
and on its temporary immobilization in the context of CTRW-based diffusion5,228,229. A
better understanding of CD93 diffusion can, in turn, lead to a more comprehensive picture
of its biological functions in efferocytosis.
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Chapter 5
TIRF-Compatible TFM Substrates
5.1 Overview of Chapter
In this project, we sought to characterize the diffusion of CD93, a putative
efferocytic receptor, and to develop a novel method for characterizing the forces involved
in efferocytosis. This chapter addresses the second of these two objectives – that of
developing a traction force microscopy (TFM) substrate compatible with total internal
reflection fluorescence (TIRF) microscopy, with the long term goal of simultaneously
studying receptor diffusion and the force-generating mechanisms involved in frustrated
efferocytosis. The chapter first presents the theory of TIRF and TFM microscopy. The
conceptual design of QGel920 TIRF-compatible TFM substrates, along with the materials
and methods involved in their manufacturing process, are then discussed. The chapter
concludes with the presentation and discussion of the preliminary results.

5.2 Total Internal Reflection Fluorescence Microscopy
Total internal reflection fluorescence (TIRF) microscopy is an imaging technique
that uses the optical phenomenon of total internal reflection, which occurs when the light
travels from a medium with a high refractive index to one with a lower one, to selectively
excite fluorophores in a thin region of the specimen near the interface61. As shown in Fig.
5.1, in conventional epifluorescence microscopy, light of a specific wavelength is used to
excite the fluorescent molecules of an entire cell62. The resulting image then includes the
collected emissions from all the fluorophores, found at the various cell depths. The
presence of such out-of-focus emissions is responsible for the blurred image quality and
the poor signal-to-noise ratio characteristic of epifluorescence microscopy.
In TIRF microscopy, the incident beam of light is directed at the sample such that
it undergoes total internal reflection at the boundary between the coverslip, which has a
higher refractive index of 1.52, and the cell, which has a lower refractive index of
approximately 1.3862. The basal surface of the cell is illuminated by an evanescent wave,
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Figure 5.1. Comparison of Epifluorescence and TIRF Microscopy.
In epifluorescence microscopy (top), the incident beam of light is perpendicular to
the sample and thus illuminates the entire cell, therefore exciting fluorescent
molecules throughout the cell regardless of depth. In TIRF microscopy (bottom),
the incident beam of light approaches the cell at an incidence angle greater than the
critical angle, 𝜃𝑖 > 𝜃𝑐 , and is thus totally internally reflected at the cell-coverslip
boundary. The transmitted evanescent field selectively excites the fluorophores in a
thin region of the cell, near the interface.
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which decays exponentially with distance from the boundary and thus excites the
fluorophores only in a thin region near the interface. This selective excitation of the basal
surface of the cell eliminates all out-of-focus emissions and provides the capacity to
visualize a thin (50-250 nm) segment of the cell with improved image contrast and, often,
enhanced resolution. As such, TIRF microscopy is frequently applied to study phenomena
at or near the cell membrane, including molecular distribution, co-localization and cellular
trafficking61,62,272.
Theory of Total Internal Reflection
To illustrate the basics of TIRF theory, let us treat the simplest case of a
monochromatic plane wave, incident upon an interface at some oblique angle273. The
electric and magnetic fields in a plane wave are uniform in any plane perpendicular to the
⃗ . They therefore take the form
direction of its propagation, specified by the wave vector, 𝑘
⃗ ∙ 𝑟 − 𝜔𝑡)) 𝑛̂
𝐸⃗̃ (𝑟, 𝑡) = 𝐸̃0 exp (𝑖(𝑘

(5.1)

and
1
1
⃗ ∙ 𝑟 − 𝜔𝑡)) (𝑘̂ × 𝑛̂) = (𝑘̂ × 𝐸⃗̃ ),
⃗̃ (𝑟, 𝑡) = 𝐸̃0 exp (𝑖(𝑘
𝐵
𝑐
𝑐

(5.2)

respectively, where 𝑟 is the position vector, 𝑛̂, the polarization vector, indicates the
direction of the electric field, 𝑐 is the speed of light, 𝜔 is the angular frequency of the wave
and 𝑡 stands for time.
Suppose the electromagnetic wave travels through a linear and homogenous
medium with a dielectric constant 𝜖𝑅 . Maxwell’s equations describing its propagation can
be written as
(𝑖) ⃗∇ ∙ 𝐸⃗ = 0,
⃗ ∙𝐵
⃗ = 0,
(𝑖𝑖) ∇

⃗ × 𝐸⃗ = −
(𝑖𝑖𝑖) ∇
⃗ ×𝐵
⃗ = 𝜇𝜖
(𝑖𝑣) ∇

⃗
𝜕𝐵
,
𝜕𝑡
𝜕𝐸⃗
𝜕𝑡

(5.3)
,

}

where 𝜖 and 𝜇 are the permittivity and permeability of the material, respectively. These
equations are identical to the equations in vacuum, but with 𝜖 and 𝜇 replacing 𝜖0 and 𝜇0 ,
the permittivity and permeability of free space. Accordingly, the wave travels though the
medium with a speed of
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𝜈=

1
𝑐
= ,
√𝜖𝜇 𝑛

(5.4)

where 𝑛 is the refractive index of the material, defined by
𝑛= √

𝜖𝜇
≈ √ 𝜖𝑅 .
𝜖 0 𝜇0

(5.5)

When a monochromatic plane wave encounters an interface between two materials,
it normally gives rise to a reflected wave and a transmitted wave. This is shown in Fig. 5.2
for 𝑝-polarized light, incident upon the interface at an angle 𝜃𝑖 , reflected at an angle 𝜃𝑅 and
transmitted at an angle 𝜃𝑇 . The wave’s behavior at the boundary is governed by the
electrodynamic boundary conditions
(𝑖) 𝜖1 𝐸1⊥ = 𝜖2 𝐸2⊥ ,
(𝑖𝑖) 𝐵1⊥ = 𝐵2⊥ ,

(𝑖𝑖𝑖) 𝐸⃗1∥ =
⃗ 1∥
𝐵
(𝑖𝑣)
=
𝜇1

𝐸⃗2∥ ,
⃗ 2∥
𝐵
𝜇1

.

}

(5.6)

We can write the equations for the electric fields of the incident, reflected and transmitted
waves as
⃗ 𝐼 ∙ 𝑟 − 𝜔𝑡)) ,
𝐸⃗̃𝐼 (𝑟, 𝑡) = 𝐸⃗̃0,𝐼 exp (𝑖(𝑘
⃗ 𝑅 ∙ 𝑟 − 𝜔𝑡)) ,
𝐸⃗̃𝑅 (𝑟, 𝑡) = 𝐸⃗̃0,𝑅 exp (𝑖(𝑘

(5.7)

⃗ 𝑇 ∙ 𝑟 − 𝜔𝑡)) .
𝐸⃗̃𝑇 (𝑟, 𝑡) = 𝐸⃗̃0,𝑇 exp (𝑖(𝑘
}
The corresponding magnetic fields all follow the form of Eq. (5.2), with 𝑐 replaced by the
speed of the wave in the relevant medium. It is worth noting that the frequencies of all three
waves are identical, with
𝑘𝐼 𝑣1 = 𝑘𝑅 𝑣1 = 𝑘𝑇 𝑣2 = 𝜔.

(5.8)

Eq. (5.8) and the boundary conditions in Eq. (5.6) allow for an easy derivation of Snell’s
law
sin(𝜃𝑇 ) 𝑛1
=
,
sin(𝜃𝑖 ) 𝑛2

(5.9)

𝜃𝑖 = 𝜃𝑅 ,

(5.10)

the law of reflection
and Fresnel’s equations for the relationships between 𝐸̃0,𝐼 , 𝐸̃0,𝑅 and 𝐸̃0,𝑇 . For 𝑝-polarized
light, with the electric field parallel to the plane of incidence, Fresnel’s equations are

143

Figure 5.2. Behavior of 𝑷-polarized light at the boundary of medium 1 and
medium 2.
⃗⃗⃗𝐼
𝑃-polarized light incident upon the interface with an angle 𝜃𝑖 and a wave vector 𝑘
has an electric field parallel to the 𝑥𝑧-plane. At the interface, a portion of the light
is reflected back into medium 1, with a wave vector ⃗⃗⃗⃗
𝑘𝑅 and an angle of reflection
equal to the angle of incidence. A portion of the light is transmitted into medium 2,
which has a different refractive index, 𝑛2 , and propagates with a wave vector ⃗⃗⃗⃗
𝑘𝑇 .
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𝑛1 cos(𝜃𝑇 ) − 𝑛2 cos(𝜃𝑖 )
) 𝐸̃ ,
𝑛1 cos(𝜃𝑇 ) + 𝑛2 cos(𝜃𝑖 ) 0,𝐼
2𝑛1 cos(𝜃𝑖 )
=(
) 𝐸̃ .
𝑛1 cos(𝜃𝑇 ) + 𝑛2 cos(𝜃𝑖 ) 0,𝐼 }

𝐸̃0,𝑅 = (
𝐸̃0,𝑇

(5.11)

For 𝑠-polarized light, with a polarization vector perpendicular to the plane of incidence,
they become
𝑛1 cos(𝜃𝑖 ) − 𝑛2 cos(𝜃𝑇 )
) 𝐸̃ ,
𝑛1 cos(𝜃𝑖 ) + 𝑛2 cos(𝜃𝑇 ) 0,𝐼
2𝑛1 cos(𝜃𝑖 )
=(
) 𝐸̃ .
𝑛1 cos(𝜃𝑖 ) + 𝑛2 cos(𝜃𝑖 ) 0,𝐼 }

𝐸̃0,𝑅 = (
𝐸̃0,𝑇

(5.12)

Total internal reflection occurs when the wave is travelling from a medium of a
high refractive index to a medium of a lower refractive index, at an angle of incidence
greater than the critical angle, given by
𝑛2
𝜃𝑐 = arcsin ( ).
𝑛1

(5.13)

For angles smaller than the critical angle, the wave transmitted through the boundary is a
sinusoidal plane wave. As the incidence angle approaches the critical angle, the period of
the transmitted wave increases and the wave vector bends towards the interface. At the
critical angle, the period of the wave becomes infinite and the wave vector points in a
direction parallel to the boundary. For 𝜃𝑖 greater than 𝜃𝑐 , the wave undergoes total internal
reflection. Nonetheless, the electric and magnetic fields in the second medium are non-zero
and are the source of the so-called evanescent wave60,61,274.
To illustrate this, we write the equation for the transmitted wave vector as
⃗⃗⃗⃗
𝑘𝑇 = (𝜔𝑛2 ⁄𝑐 )(sin(𝜃𝑇 ) 𝑥̂ + cos(𝜃𝑇 ) 𝑧̂ ),

(5.14)

in agreement with Eqs. (5.4) and (5.8) and the geometry of Fig. 5.2. As 𝜃𝑖 > 𝜃𝐶 , we
know that, according to Snell’s law, sin𝜃𝑇 > 1. The cosine of 𝜃𝑇 is therefore imaginary,
and can be written as
cos(𝜃𝑇 ) = 𝑖√sin(𝜃𝑇 )2 − 1.

(5.15)

The properties of the evanescent wave arise due to the presence of this imaginary
component in the wave vector.
The electric field of the transmitted wave can be shown to be
𝐸⃗̃𝑇 (𝑟, 𝑡) = 𝐸⃗̃0,𝑇 𝑒 𝑖(𝑘⃗𝑇 ∙𝑟−𝜔𝑡) = 𝐸⃗̃0,𝑇 𝑒 −𝑧/(2𝑑) 𝑒 𝑖(𝑘𝑥−𝑤𝑡) ,

(5.16)
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𝜔𝑛1

where 𝑘 = (

𝑐

) sin(𝜃𝑖 ). The characteristic penetration depth, 𝑑, is given by
𝑑=

𝜆0
((𝑛1 sin(𝜃𝑖 ))2 − 𝑛2 2 )−1/2 ,
4𝜋

(5.17)

where 𝜆0 is the vacuum wavelength of the incident light. The wave is therefore found to
be propagating in the 𝑥-direction, with an exponential attenuation in the 𝑧-direction. For
𝑝-polarized light, 𝐸⃗̃0,𝑇 itself is broken down into its components, according to the geometry
of Fig. 5.2, as
𝐸⃗̃0,𝑇 = 𝐸̃0,𝑇 [(cos(𝜃𝑇 ) 𝑥̂ − sin(𝜃𝑇 ) 𝑧̂ )],

(5.18)

with 𝐸̃0,𝑇 specified by Fresnel’s equations. Therefore, while the evanescent field retains its
𝑝-polarization, the electric field vector “cartwheels” along the interface with a non-zero
longitudinal component, resulting in a field elliptically polarized in the 𝑥𝑧 plane. For 𝑠polarized incident light, on the other hand, the electric field remains polarized purely in the
𝑦-direction, perpendicular to the plane of incidence.
The average energy transported by an electromagnetic wave per unit time and per
unit area can be found using the Poynting vector, which gives the energy flux density of
the wave as
𝑆=

⃗
𝐸⃗ × 𝐵
.
𝜇0

(5.19)

The temporal average of the Poynting vector is the intensity I, or the average power per
unit area carried by the wave, with 𝐼 = 〈𝑆〉. For the evanescent wave, the intensity can be
shown to be equal to
𝑧

𝐼(𝑧) = 𝐼(0)𝑒 −𝑑 ,

(5.20)

where 𝑧 is the distance from the interface and 𝑑 is the penetration depth defined in Eq.
(5.17) 274. The intensity at 𝑧 = 0 depends on the angle of incidence and the polarization
of the incident light. For 𝑝-polarized light,
𝐼𝑇

(0)∥

= 𝐼𝐼

(0)∥

4𝑐𝑜𝑠 2 𝜃𝑖 (2𝑠𝑖𝑛2 𝜃𝑖 − 𝛽 2 )
[ 4
],
𝛽 𝑐𝑜𝑠 2 𝜃𝑖 + 𝑠𝑖𝑛2 𝜃𝑖 − 𝛽 2

𝛽 = (𝑛2 ⁄𝑛1 ).

(5.21)

Alternatively, for 𝑠-polarized light,
𝐼𝑇

(0)⊥

= 𝐼𝐼

(0)⊥

4𝑐𝑜𝑠 2 𝜃𝑖
[
].
1 − 𝛽2

(5.22)
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In both cases, the intensity decays exponentially with 𝑧-distance from the boundary.
TIRF Imaging System
TIRF images in this study were taken using the Leica AM TIRF MC system with a
DMI6000-B inverted microscope, four integrated laser diodes with wavelengths of 405,
488, 561 and 635 nm and an EL-6000 metal halide fluorescence light source. The
excitation beam is focused onto the coverslip-sample interface through the microscope
objective, which is located below the sample. In this method, the achievable incidence
angles are governed by the numerical aperture of the objective, defined as
𝑁𝐴 = 𝑛𝑠𝑖𝑛(𝜃),

(5.23)

where 𝑛 is the refractive index of the medium in which the lens is immersed and 𝜃 is the
maximal half-angle of the illumination cone leaving the lens60. The HCX-PL-APO100𝑋/1.47-OIL-CORR-TIRF and the HCX-PL-APO-63𝑋/1.47-OIL-CORR-TIRF oilimmersion objectives with NA = 1.47 were used in this study.
In this imaging system, an internal sensor automatically controls the penetration
depth of the evanescent wave by detecting the returning TIRF beam. Several depths in the
range of 90-250 nm were available and used as indicated in each specific image. The
images were captured using a Hamamatsu C9100-02 EM-CCD camera. Images were
processed using ImageJ software.

5.3 Traction Force Microscopy
Theory of TFM
In traction force microscopy (TFM), the forces exerted on a substrate by a cell are
determined from the resulting displacements of marker particles embedded in the
substrate24. Suppose we have a system of 𝑁 particles, with initial positions
{𝑚
⃗⃗⃗⃗⃗1 𝑖 , ⃗⃗⃗⃗⃗
𝑚2 𝑖 , … , 𝑚
⃗⃗⃗⃗⃗⃗𝑁 𝑖 } within a known cell-substrate contact area, 𝐴. The displacement of the
⃗ (𝑟), defined as local
𝑘 𝑡ℎ particle, represented by 𝑑𝑘 , is a result of all the traction vectors 𝑇
⃗ (𝑟) = 𝐹 (𝑟)/𝑑𝐴, acting on the substrate. Specifically, the
forces per unit area, 𝑇
displacement of the 𝑘 𝑡ℎ particle in the 𝛼-direction due to traction vectors 𝑇𝛽 (𝑟) acting in
the 𝛽-direction can be given as
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𝑑𝑘,𝛼 = ∬ 𝑔𝛽𝛼 ( ⃗⃗⃗⃗⃗
𝑚𝑘 𝑖 − 𝑟)𝑇𝛽 (𝑟)𝑑𝑟1 𝑑𝑟2 ,

(5.24)

with implied summation over repeated 𝛽-indices. In this expression, 𝑔𝛽𝛼 (𝑚
⃗⃗ − 𝑟) is the
displacement of the substrate at a location 𝑚
⃗⃗ in the 𝛼-direction that results from a
concentrated unit force acting at a location 𝑟 in the 𝛽-direction. As such, there are nine
𝑔𝛽𝛼 (𝑚
⃗⃗ − 𝑟) , which are the components of Green’s tensor 𝐺(𝑚
⃗⃗ − 𝑟).
Since the substrate thickness is typically much greater than the maximum marker
displacements, the substrate underneath the cell can be treated as an elastic half-space. As
such, 𝑔𝛽𝛼 (𝑚
⃗⃗ − 𝑟) may be approximated by the Boussinesq equations for a semi-infinite
elastic medium24. The formulae for these quantities can be found in the study by Dembo
and Wang (1999), with a full derivation in Landau and Lifshitz (1986)24,275. The effects of
out-of-plane tractions on in-plane displacements are found to be negligible, so little is lost
⃗ (𝑟)
by tracking marker displacements only in the 𝑥𝑦-plane. Unfortunately, extracting 𝑇
from a map of the associated displacements is nonetheless an ill-posed inverse problem,
and small variations in the marker displacements due to noise may result in large changes
in the calculated traction forces per unit area. Several methods have been developed to
address this issue24,44–46,77.
TFM Software
TFM software was provided by Dr. Dembo24. The software package, 𝐿𝐼𝐵𝑇𝑅𝐶,
employs Bayesian statistics to find a map of the traction forces responsible for the observed
particle displacements. The details of its operation may be found in the LIBTRC manual276.
Briefly, the software first applies a mesh to an image of the cell under study. The forces
acting at the mesh nodes are then related to the bead displacements through
⃗ (𝑟𝑛 )𝑑𝐴𝑛
𝑑𝑘 = ∑ 𝐺(𝑚
⃗⃗⃗⃗⃗𝑘 𝑖 − 𝑟𝑛 ) 𝑇

(5.25)

𝑛

⃗ (𝑟𝑛 ) represents the force at the 𝑛𝑡ℎ mesh-node and 𝑑𝐴𝑛 is the area of the 𝑛𝑡ℎ
where 𝑇
segment. The tractions are found by maximizing the total Bayesian likelihood of the marker
displacements predicted by the solution. To function correctly, 𝐿𝐼𝐵𝑇𝑅𝐶 requires input of
a number of parameters, including the Young’s modulus and Poisson ratio of the substrate,
its thickness, and the distance of the bead layer from the top substrate surface. To verify
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that the software was set up correctly, several tests were successfully performed with the
examples provided with the program.

5.4 TIRF-compatible TFM substrates: Conceptual Design, Materials and Methods
Conceptual Design
The conceptual design of a TIRF-compatible TFM substrate for the study of forcegenerating mechanisms in efferocytosis is presented in Fig. 5.3. A TIRF-compatible
polymer is coated onto a glass coverslip. It is then functionalized with a monolayer of
covalently-attached fluorescent quantum dots and a monolayer of antibody fragments,
specific to the efferocytic or phagocytic receptor of interest. Such a design has a number
of advantages. If a cell is parachuted down onto this substrate, it can theoretically engage
the antibody fragments in a model of “frustrated engulfment”. The associated tractions can
be simultaneously captured through the motions of the quantum dots due to force-induced
substrate deformations. The monolayer coating of quantum dots eliminates the out-offocus fluorescence that would be detected if the markers were simply cast into the polymer
at a range of depths. Finally, visualizing the cell in TIRF can provide an opportunity for
easily tracking the diffusion of unengaged receptors, imaging actin close to the membrane,
and locally disrupting the cytoskeleton network by TIRF-activated photo-recruitable
protein regulators. The effect of TIRF-triggered cytoskeleton disruption on engulfment
forces can, in turn, be detected through the motions of the quantum dots.
Two lab groups have reported the successful production of functionalized, TIRFcompatible TFM substrates. In 2008, Iwadate and Yumura used silicone substrates to study
the migration of Dictyostelium cells with simultaneous TFM and TIRF64,65. Their substrates
had a relatively high refractive index of 1.40 and a Young’s modulus of 1.0 kPa. An
alternative method, with a different silicone, was described by Gutierrez et al. in 2011 66.
The material employed by Gutierrez and colleagues had a higher refractive index of 1.49
and was demonstrated to be TIRF-compatible. The Young’s modulus of the substrate was
measured for a range of crosslinker concentration. The higher refractive index of this
substrate, as well as of the available information about its Young’s modulus, made it a
better candidate for use in this project. The method of substrate preparation used initially
was therefore adapted from the method described by Gutierrez et al.66
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Figure 5.3. Design of a TIRF-compatible TFM substrate for the study of forces
and force-generating mechanisms in efferocytosis.
The substrate consists of a silicone gel coated onto a glass coverslip. The high
refractive index of the substrate allows for total internal reflection to occur between
the substrate and the cells, rather than between the coverslip and the substrate. The
substrate surface is coated with covalently-attached antibodies or other ligands
specific to the cell receptor of interest. Cells on the substrate are therefore engaged
by these ligands and initiate frustrated engulfment of the substrate surface. TIRF
microscopy allows for the visualization of cellular components directly in contact
with the substrate, as well as for the selective photo-activation of force-regulating
tools in a thin region of the cell near the cell-substrate boundary. The substrate
surface is also coated with a monolayer of covalently-linked, fluorescent quantum
dots. Their displacements can reflect substrate deformations in response to cellular
tractions.
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Materials and Methods
Coverslip Preparation: No. 1.5 round glass coverslips, 18 mm in diameter, were precleaned in the Western Nanofabrication Facility to eliminate potential organic impurities
and enhance smoothness. After a wash with double-distilled, deionized water (𝑑𝑑𝐻2 𝑂)
they were subjected to a 10 min oxygen plasma cleaning using the STS Reactive Ion Etch.
Clean coverslips were stored inside the Nanofabrication Laboratory in 6-well plates.
Silicone Materials: QGel920 silicone was purchased from Quantum Silicones. The gel is
prepared by mixing two components, QGel920A and QGel920B. QGel920A and
QGel920B were separately aliquoted into small 4 ml glass vials. To do so, the materials
were first warmed in a water bath to decrease their viscosity, improving the accuracy of
the dispensing. Disposable 1 ml plastic syringes were then used to add 1 ml of material per
vial, unless otherwise specified. When the gel was to be spin-coated in a solvent as
described below, 1 ml of toluene was added to each vial and left overnight to allow the
silicone and solvent to mix.
Spin-Coating and Curing: The spin-coating and curing procedures were performed at the
Fluidics and Sensors Laboratory (Western Nanofabrication Facility). Equal volumes of
QGel920A and QGel920B, with or without a toluene solvent, were mixed by adding the
contents of a vial with QGel920B to a vial with QGel920A with a disposable glass pipette.
If no solvent was used, the mixture was vortexed and subsequently degassed for 5 min
under vacuum. With a solvent, inverting the tube five times was found to be sufficient to
mix the two materials. A small volume of the mixture (9 drops with solvent, 4-5 drops
without) was then spin-coated onto a round glass coverslip. After a 12 s pre-spin at
250 rpm to evenly distribute the mixture, the spin-coating was performed at 3500 rpm for
30 s. The substrates were then placed on a flat glass plate and cured at 100 ℃ for a
minimum of 2 h in a vacuum oven.
ATPMS Treatment: To activate the otherwise inert silicone gel surface, primary amine
groups were added to the cured gels by treatment with 3-aminopropyltrimethoxysilane
(APTMS, Sigma-Aldrich), following the method of Gutierrez and colleagues66. As shown
in Fig. 5.4(a), APTMS is a silane coupling agent that reacts with the hydroxyl groups on
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Figure 5.4. Methods of substrate functionalization.

a) Substrate silanization with 3-aminopropyltrimethoxysilane (APTMS). Free
hydroxide groups on the cured substrate surface react with APTMS to yield a
covalently-attached monolayer of primary amine groups. The byproducts of this and
other reactions are not shown. b) Functionalization of substrate with 1-Ethyl-3-(3dimethylaminopropyl)carbodiimide hydrochloride (EDAC). EDAC reacts with
carboxylic acid groups on proteins, such as antibodies, and carboxylated quantum
dots to form unstable intermediates, which then react with amine groups on the
substrate surface. The quantum dots and antibodies are thus covalently attached to
the substrate by peptide bonds. c) Functionalization of substrate with sulfo-NHydroxysuccinimide(NHS)-biotin. Sulfo-NHS-biotin reacts with primary amines
on the substrate surface by means of the reactive sulfo-NHS group. As a result,
biotin molecules are covalently attached to the substrate via peptide bonds.
Streptavidin-conjugated quantum dots bind to biotin molecules on the substrate
surface due to the high affinity of biotin-streptavidin interactions. Anti-biotin
antibodies likewise recognize and bind to biotin.
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the substrate to form covalent Si-O-Si bonds, leaving primary amine groups exposed on
the substrate surface. APTMS treatment of the gels was attempted using both liquid-phase
and vapor deposition. Liquid-phase deposition was performed with 2% APTMS in
isopropanol and with a range of APTMS concentrations (2, 1, 0.04, 0.02, 0.008, 0.002
and 2 ∙ 10−6 %) in toluene. In each case, a 5 min treatment was followed by three 5 min
washes with 𝑑𝑑𝐻2 𝑂 and a final 10 min wash with 𝑑𝑑𝐻2 𝑂. The substrates were then airdried at 37 ℃ for 10 min. Vapor deposition was executed in a vacuum chamber. A 50 μL
aliquot of APTMS in a glass dish was placed at the bottom of the chamber. The substrates
were then added. The chamber was purged three times with 𝑁2 gas and evacuated. The
substrates were left to react with APTMS under conditions of reduced pressure for 24 h.
Substrate Functionalization with EDAC: APTMS-treated gels were functionalized with
fluorescent quantum dots and/or antibody molecules, as shown in Fig. 5.4(b). A 100 μg/ml
solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDAC, EDC
hydrochloride, Sigma-Aldrich) in 𝑑𝑑𝐻2 𝑂 was prepared immediately prior to
functionalization. To attach the fluorescent beads, carboxylated quantum dots (Qdot 655,
Life Technologies), with an excitation maximum at a wavelength of 405 nm and maximum
emission at 655 nm, were added to the EDAC solution at a dilution of 1: 10,000 and mixed
by vortexing. To test the attachment of antibody molecules, whole mouse antibodies of the
IgG type were added to the EDAC solution with and without the quantum dots, as specified
in each particular experiment. The concentration of IgG ranged from 0.02-1.00 mg/ml, as
indicated. In all cases, the EDAC solution was then promptly added to the substrates, which
were housed in the individual wells of a 6-well plate, until the substrates were completely
submerged. After a 10 min treatment at room temperature, the substrates were given three
5 min washes with 𝑑𝑑𝐻2 𝑂. In some cases a high-salt wash, using a 2 M NaCl solution,
was used instead. To visualize the presence of whole mouse IgG antibodies on substrates,
the substrates were labelled with a secondary donkey-anti-mouse 488 nm Fab antibody
(1: 1,000, Jackson ImmunoResearch) in phosphate-buffered saline (PBS) for 30 min,
followed by several quick washes with PBS. All substrates were kept in PBS prior to
imaging.
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Substrate Functionalization with Sulfo-NHS-Biotin: To test an alternative method of
substrate

functionalization,

APTMS-exposed

gels

were

treated

with

sulfo-N-

hydroxysuccinimide(NHS)-biotin (EZ-Link Sulfo-NHS-LC-Biotin, ThermoScientific). As
shown in Fig. 5.4(c), this reaction can functionalize the substrates with covalently-attached
biotin groups, which can subsequently be specifically-labeled by streptavidin-conjugated
quantum dots and anti-biotin antibodies. A fresh 10 mM solution of sulfo-NHS-biotin in
PBS was prepared. Excluding experiments where prior sonication of the biotin was
required, the solution was immediately added to the substrates, which were treated for
30 min. They were then washed three times with PBS. The gels were then labelled with a
streptavidin-conjugated Alexa-647 probe (1: 1,000, Life Technologies) in PBS for
15 min, followed by a triple wash with PBS. Alternatively, to test specificity of binding,
biotinylated substrates were labelled for 15 min with a donkey-anti-mouse 488 nm Fab
antibody (1: 1,000) in PBS, followed by a triple PBS wash. In all cases, functionalized
substrates were kept in PBS prior to imaging.
Substrate Functionalization with NHS-Alexa: To test the chemistry of the NHS-ester
reaction, APTMS-exposed gels were treated with a 0.5 mg/ml Alexa-NHS probe (Alexa
Fluor® 647 NHS Ester, Life Technologies) in PBS for 1 h. If indicated, the Alexa-NHS
solution was sonicated prior to its addition to the substrates. Following treatment, the
substrates were washed three times with PBS and stored in PBS prior to imaging.
Cell Line Culture and Methods: RAW264.7 macrophage cells were cultured in Dulbecco's
modified eagle's medium (DMEM) with 10% fetal bovine serum (FBS). Cultures were
split when they reached 80% confluency. For testing the capacity of substrates coated with
whole mouse IgG to induce frustrated phagocytosis, RAW cells were deposited on
antibody-free and antibody-coated (0.02, 0.1, and 0.5 mg/ml in an EDAC solution)
substrates. The cells were parachuted down onto the substrates using a pipette dropper and
imaged in a calcium-containing imaging buffer. The area of cellular spreading was
quantified using ImageJ software.
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5.5 TIRF-compatible TFM substrates: Results
Initial Substrate Preparation
Silicone substrates on round glass coverslips were initially prepared by mixing
equal volumes of QGel920A and QGel920B and spin-coating the mixture under solventfree conditions, followed by curing. Establishing a spin-coating protocol that produced
visually-uniform substrates proved difficult. Depositing the QGel920 mixture onto the
coverslip without prior de-gassing resulted in the formation of bubbles and associated
large-scale deformities in the spin-coated gels. This led to the conclusion that QGel920 had
to be degassed prior to placing it on the coverslip. A suitable volume of silicone per
coverslip and spin coating speed were next determined by making a series of substrates
and selecting the conditions that yielded the most uniform coating. All subsequent
substrates were manufactured by spin-coating at 3500 rpm for 30 s. The QGel920 mixture
was found to polymerize very quickly, with very noticeable changes in viscosity occurring
over times on the order of minutes. As a result, a new mixture had to be prepared for every
few substrates.
Substrate Silanization and EDAC-based Attachment of Quantum Dots
Once substrates free of large-scale non-uniformities were prepared, we sought to
test their compatibility with TIRF microscopy by attaching and imaging fluorescent
quantum dots on the substrate surface. To achieve this, the substrates were first silanized
with APTMS and then treated with carboxylated quantum dots in EDAC. As a
carbodiimide crosslinker, EDAC was expected to activate carboxyl groups of the quantum
dots, allowing them to spontaneously react with primary amines present on the silanized
gel surface. Gutierrez et al. reported the successful silanization of QGel920, although the
details of the APTMS treatment protocol were not provided66. We tested two silanization
methods. In a liquid-phase treatment, substrates were first treated with 2% APTMS in
isopropanol, which produced a cloudy solution that which eroded the gels. We next tried
treating the substrates with APTMS dissolved in toluene, over a range of APTMS
concentrations from 2% to 2 ∙ 10−6 %. This treatment was found to render the substrates
irreversibly opaque and also produced partial erosion at all tested APTMS concentrations.
In contrast, the appearance of substrates treated in toluene alone, with no APTMS, did not
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change significantly. The loss of transparency caused by liquid-phase silanization rendered
the gels unusable for any microscopy work. ATPMS treatment by vapor deposition,
however, did not visibly affect the appearance of the substrates. Vapor deposition was
therefore selected as the method used for APTMS silanization.
Once a silanization protocol was established, the TIRF-compatibility of the gels
was tested. A monolayer of fluorescent quantum dots was attached to the silanized
substrate surface using EDAC. The silicone gels were then imaged. Fig. 5.5(a-c) shows the
results. As seen in the differential interference contrast image shown in Fig. 5.5(a), the gel
surface was non-uniform at the 50 μm scale, with wave-like structures observed on the gel.
A successful TIRF-alignment was nonetheless achieved for the substrates and partial TIRF
was established. A TIRF image of the region shown in Fig. 5.5(a) is shown in Fig. 5.5(b).
The image shows the presence of fluorescent beads on the gel surface. The beads
preferentially deposit on the edges of the gel waves. In more uniform regions, such as the
one in Fig. 5. 5(c), the deposition of beads was more uniform. TIRF images of such regions
were found to display birefringence artifacts, such as those indicated by arrows in Fig.
5.5(c), suggesting that the gel material was optically anisotropic.
Improvement of the Spin-Coating Procedure
To help in the preparation of higher-quality substrates, the spin-coating procedure
was further improved by using a solvent. It was postulated that the rapid polymerization of
QGel920 was responsible for the presence of surface waves on the gel and the observed
optical anisotropy. To slow down the polymerization process, as well as to encourage more
efficient mixing of QGel920A and QGel920B, both components were individually diluted
with toluene prior to mixing. The solvent later evaporated from the silicone gel during the
spin-coating and curing procedures. After testing toluene concentrations of 33, 50, 66, and
80 %, a 1: 1 ratio of QGel to toluene was determined to achieve the best results. Substrates
prepared in this way were found to be largely free of surface waves and TIRF artifacts. As
shown in Fig. 5.5(d-e), the quantum dots were found to deposit more uniformly, albeit with
variations in density from substrate to substrate.
Measurements of Substrate Thickness
Once higher-quality substrates with a uniform distribution of quantum dots were

157

Figure 5.5. Presence of EDAC-attached fluorescent quantum dots on APTMStreated substrates visualized using TIRF microscopy, before and after
optimization of the spin-coating procedure.
a) Differential interference contrast microscopy image of a 180μm× 180μm region
of a substrate spin-coated onto a round glass coverslip without a solvent. This
substrate was salinized with APTMS by vapor deposition, followed by a treatment
with EDAC and carboxylated quantum dots. The waves present on the silicone gel
surface are characteristic of patterns observed on both treated and untreated
substrates spin-coated without a solvent. b) A fluorescent image corresponding to
the substrate region in (a), taken using TIRF microscopy with a penetration depth
of 90 nm. The bright wave regions correspond to greater concentrations of the
fluorescent quantum dots, showing their preferential deposition on uneven gel
edges. c) A representative 70 nm-TIRF image of fluorescent quantum dots showing
birefringence artifacts (arrows) observed with TIRF in substrates spin-coated under
solvent-free conditions. d) An artifact-free 70 nm-TIRF microscopy image of
quantum dots uniformly attached to the substrate surface. This image is
representative of 12 substrates, observed at 4 regions each, prepared by spin-coating
in a toluene solvent. e) A 70 nm-TIRF microscopy image of quantum dots,
uniformly deposited at a lower density on a substrate spin-coated in a toluene
solvent. This image, when compared to (d), shows the variations in quantum dot
density observed across substrates.
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successfully produced, measurements of substrate thickness were performed. To do so,
quantum dots were first covalently-attached to APTMS-silanized glass coverslips using
EDAC. QGel920 was then spin-coated onto these coverslips. A second layer of quantum
dots, likewise attached using EDAC, was then added on top of the gel post-silanization.
The substrates were then imaged, recording the 𝑧-position of each of the two layers of
quantum dots to determine the local gel thickness. Fig. 5.6 shows the quantum dots
attached to the coverslip below the gel (a) and to the gel surface (b) in the same field of
view. As seen in the images, although more quantum dots were deposited on the top surface
of the gel than on the glass surface, they nonetheless formed two distinguishable layers.
Ten different substrates, and a minimum of eight randomly-selected regions per substrate,
were used for the thickness measurements presented in Fig. 5.6(c). From these data, the
substrates were determined to have an average thickness of 9.91 ± 0.63 μm.
EDAC-based Attachment of Antibodies and Quantum Dots
After measuring substrate thickness, we sought to prepare substrates coated with
both fluorescent quantum dots and antibodies. In our planned experiments, antibodies
specific for CD93 or another efferocytic receptor of interest would be used. For preliminary
experiments, however, the better-characterized interaction between bound IgG antibodies
and phagocytic Fc receptors was used, since this interaction is known to be a potent inducer
of a well-established force-generation system11. Substrates successfully coated in IgG were
expected to trigger frustrated phagocytosis in RAW macrophage cells parachuted down
onto the substrate, making whole mouse IgG a suitable testing antibody for this system.
Gutierrez et al. reported using EDAC to functionalize Qgel920 substrates with fibronectin,
a glycoprotein of a high molecular weight66. EDAC was therefore tested for its capacity to
attach antibodies to the substrate surface.
Substrates were simultaneously treated with carboxylated quantum dots and whole
mouse IgG in EDAC, with a fixed concentration of quantum dots and different
concentrations of IgG. The concentrations of IgG tested were 0.02, 0.1, 0.5, and 1.0
mg/ml. A higher concentration of antibody was initially hypothesized to result in greater
coverage of the substrate. Imaging of several regions on each substrate showed that the
antibodies deposited irregularly, resulting in patterns containing regions of high density
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a)

b)
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Figure 5.6. Quantification of Substrate Thickness
a) Quantum dots attached to the glass coverslip surface and imaged using
epifluorescence microscopy. Glass coverslips were silanized with APTMS and
treated with carboxylated quantum dots in EDAC, and then spin-coated with
QGel920. After the gels were cured, the substrate was functionalized by silanization
and quantum dots were attached with EDAC. This image shows the bottom quantum
dot layer, below the gel. b) The top layer of quantum dots, on the upper surface of
the gel, for the same field of view as (a). c) A histogram of the substrate thickness,
measured for ten substrates and a minimum of eight randomly-selected regions per
substrate. The substrates were found to have a mean thickness of 9.91 ± 0.63 μm.
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IgG and low density patches, as shown in Fig. 5.7. Different regions on the same substrate
(fixed IgG concentration) displayed low-density IgG patches of different size. The
concentration of IgG had no effect on antibody deposition, with similar patterns of
deposition across all tested concentrations. The deposition of quantum dots, on the other
hand, remained fairly uniform. The experiment was repeated with substrates made and
treated on a different day, with similar results. The non-uniform deposition of IgG may
have been the result of preferential crosslinking of the antibodies to each other rather than
to the substrate surface. EDAC induces crosslinking between carboxylic acid groups and
primary amine groups, both of which are present in proteins. As such, the observed IgG
patterns could have arisen from EDAC-mediated cross-linking of antibodies, followed by
cross-linking of these aggregates to the substrate.
Despite the non-uniform distribution of antibodies, substrates coated with IgG and
quantum dots were nonetheless tested for their capacity to initiate frustrated phagocytosis
in RAW macrophage cells. RAW cells were parachuted down onto the substrates and
imaged using DIC microscopy. No significant difference in behavior was observed
between cells on antibody-coated substrates and on antibody-free substrates, as shown in
Fig. 5.8(a), nor did the cells display the rapid spreading behavior characteristic of frustrated
phagocytosis38. In all cases, the majority of the cells retained a classical, round shape,
indicative of no cellular spreading. Cells which did engage in spreading did so similarly on
both types of substrates and to a lesser extent than expected. Although cells which spread
on antibody-coated substrates appeared to have more filopodia for probing the
environment, no phagocytosis-associated rapid spreading was detected38. Fig. 5.8(b) shows
the area of cells on an antibody-coated and a control substrate. There was no significant
difference in the mean area occupied by cells on the two substrates. We therefore concluded
this method of substrate functionalization was incapable of inducing frustrated
phagocytosis.
Functionalization of Silanized Substrates with Sulfo-NHS-Biotin
As an alternative approach to substrate functionalization with quantum dots and
antibodies, as well as an independent means of assessing substrate activation with APTMS,
we tested the functionalization of APTMS-activated substrates with sulfo-NHS-biotin. The
sulfo-NHS chemical group reacts spontaneously with primary amines, without an
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Figure 5.7. Patterns of EDAC-attached whole mouse IgG and fluorescent
quantum dots on APTMS-treated substrates.
Silanized substrates were simultaneously treated with whole mouse IgG and
quantum dots in a solution of EDAC. The presence of antibodies on the substrate
surface was then detected using epifluorescence microscopy. Quantum dots were
imaged using TIRF with a 150 nm penetration depth. Images of three types of
coating patterns presented in this figure are representative of variations in antibody
coating observed from substrate to substrate and from region to region. These
patterns were found to be independent of whole mouse IgG concentration in EDAC.
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Figure 5.8. RAW macrophage cell behavior on whole mouse IgG coated
substrates.
a) RAW macrophage cells were parachuted down onto antibody-free and antibodycoated substrates and imaged using DIC microscopy. Two representative images are
given here for a control substrate and an antibody-treated (0.02 mg/ml in an EDAC
solution) substrate. b) Histograms of area occupied by cells on antibody-free and
antibody-coated substrates (𝑛 = 132). The area was measured using ImageJ. There
is no significant difference in the mean spreading area of cells between the
substrates.
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activation agent such as EDAC, so treating silanized substrates with sulfo-NHS-biotin was
expected to yield biotin molecules covalently attached to the substrate surface by peptide
bonds. Functionalization could then be completed by utilizing the strong affinity of the
protein streptavidin for the biotin molecules, thus enabling the attachment of streptavidinconjugated quantum dots to the silicone gels. Furthermore, the use of anti-biotin antibodies
could guarantee the binding of antibodies to the substrate surface in the correct orientation
for Fc receptor-mediated phagocytosis. To test this method, APTMS-silanized substrates
were treated with sulfo-NHS-biotin and then labelled with a streptavidin-conjugated
Alexa-647 fluorescent probe. Silanized substrates that had not been treated with sulfoNHS-biotin were likewise labelled with the probe, to test for non-specific binding of this
fluorophore to the gel surface. Biotinylated substrates were also exposed to an Alexa Fluor
488 conjugated Fab antibody fragment, to detect any non-specific binding of proteins to
the biotinylated surface.
The results of preliminary biotinylation experiments were inconclusive. As shown
in Fig. 5.9, the streptavidin-conjugated probe was detected on biotinylated surfaces. In
contrast, the probe was not observed on flat regions of un-biotinylated substrates, with only
limited binding to irregularities on the un-biotinylated gel surface. This indicates that
biotinylation was indeed taking place. The distribution of the biotin, however, appeared
non-uniform, and 488 nm antibody fragments were observed to bind non-specifically to
the biotinylated surface. The results were further complicated by great variations in the
observed substrate surface quality. While not all the examined regions of biotin-free
substrates were flat, the biotinylated substrates were comparatively less uniform than nonbiotinylated ones. All the examined regions of Alexa-647-labelled biotinylated gels were
highly irregular, with frequent crater-like deformities.
These results point to several issues which need to be addressed before this method
of substrate preparation can be pursued further. First, we sought to determine whether the
increased frequency of gel irregularities was a result of the chemistry of sulfo-NHSbiotinylation. Second, we wished to understand whether the non-uniform distribution of
biotin on the gels was the result of local irregularities in the gel surface. Finally, although
the substrates had not previously been reported to be adhesive, we wanted to assess the
inherent ability of the gels to bind molecules non-specifically, through electrostatic or non-
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Figure 5.9. Functionalization of silanized substrates with sulfo-NHS-biotin.

a) APTMS-silanized substrates were treated with sulfo-NHS-biotin and labelled
with a streptavidin-conjugated Alexa-647 probe. The deposition of biotin on the
substrate surface was then studied using epifluorescence microscopy. The
distribution of biotin on the gel, as reflected in the Alexa-647 signal, was determined
to be non-uniform, as shown in the representative image. The substrate surface
itself, imaged in DIC for the same field of view, was not conducive to good TIRF,
due to the presence of crater-like deformities. All imaged regions possessed similar
irregularities. b) APTMS-silanized substrates were treated with a streptavidinconjugated Alexa-647 probe in absence of prior biotinylation, to check for nonspecific binding. No probe was detected in flat regions of the gel, as shown in the
representative image. Not all the visualized substrate regions were flat, however,
though crater-like irregularities appeared less frequently than for biotinylated
substrates. c) APTMS-silanized substrates were treated with sulfo-NHS-biotin and
then incubated with a 488 nm antibody fragment, to test for non-specific binding of
proteins to the biotinylated gels. The quality of the observed substrate surface was
highly variable. Even in flat regions, however, non-specific binding of the 488 nm
antibody fragment was detected.
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polar interactions. Both the streptavidin-conjugated probe and the non-specific antibody
appeared to bind to biotinylated substrates. Since biotin molecules located too close
together are known to prevent the specific binding of streptavidin by steric hindrance, we
wanted to test the biotinylation chemistry without relying on a secondary label to visualize
the biotin molecules. To accomplish this, a fluorescent NHS-Alexa probe was used to test
the chemistry of the NHS-ester reaction.
Substrate Functionalization with NHS-Alexa-647
In prior experiments, the silanization of substrates with APTMS and their treatment
with quantum dots and EDAC yielded fairly uniform gels when the spin-coating was
performed in the presence of toluene. Substrate silanization was therefore unlikely to be
the cause of the substrate surface deformities observed on the biotinylated substrates. The
highly irregular nature of the functionalized substrates could, however, be caused by the
reaction of NHS-esters with primary amines. We therefore sought to test whether substrate
functionalization with NHS-Alexa-647 was related to the presence of substrate
irregularities, as well as to determine whether NHS-Alexa-647 could be covalently linked
to the gels in a uniform manner. Substrates were treated with NHS-Alexa-647, six with
and six without prior silanization. Unsilanized substrates were free from amine groups and
were thus not expected to react with NHS-Alexa-647. Examining unsilanized substrates
allowed us to evaluate whether incubating the gels with NHS-Alexa-647, in the absence
of an actual reaction, could result in the deformation of their surface. Six silanized
substrates treated with quantum dots and EDAC were also prepared, to confirm that the
presence of gel irregularities was not correlated with silanization itself.
All substrates were then imaged at a minimum of four regions per substrate and
each region was assigned a visual irregularity score of mild, moderate or severe.
Irregularity-free regions and regions with a predominantly flat surface were assigned a
score of “mild”. Completely unusable substrates, with gross irregularities spanning the
majority of the substrate surface, were assigned a score of “severe”. Ten out of twentyseven (37%) regions surveyed on the silanized, NHS-Alexa-647 treated gels were
moderately or severely irregular, compared to only four out of twenty five (16%) regions
on unsilanized, NHS-Alexa-647 treated gels. Five out of twenty seven (18.5%) regions on
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silanized substrates treated with EDAC and quantum dots were moderately to severely
irregular.
Gel regions with a more irregular surface, such as the one in Fig. 5.10(a), had a less
uniform deposition of NHS-Alexa-647, which appeared to preferentially react with the
edges of the deformities. As shown in Fig. 5.10(b), however, a flat surface did not
guarantee a uniform attachment of NHS-Alexa-647, which deposited in streaks or mosaiclike patterns, leaving patches of the surface uncoated. Substrates that were not pre-treated
with APTMS were free of NHS-Alexa-647 in all flat regions, with some non-specific
binding to surface irregularities in regions of lower quality. Both sulfo-NHS-biotin and
NHS-Alexa-647 are molecules with polar and non-polar regions, and could potentially
form micelles. We tested whether their non-uniform attachment to substrates could be
attributed to the formation of micelles by sonicating the sulfo-NHS-biotin and NHS-Alexa647 reagents prior to use, but this had no effect on the quality of the deposition.
Non-specific Binding of Quantum Dots to Substrate
To assess the inherent capacity of QGel920 substrates to non-specifically bind
molecules, they were treated with carboxylated quantum dots in EDAC, with or without
prior silanization with APTMS. Substrates with no chemical treatment at all were used a
negative control. Since unsilanized substrates have no primary amine groups, they could
not undergo EDAC-assisted covalent attachment of quantum dots during incubation with
the fluorophores. The presence of quantum dots on such substrates would instead indicate
non-specific binding due to electrostatic or non-polar interactions.
Fig. 5.11(a) shows the presence of quantum dots on both APTMS-treated and
APTMS-untreated gels, although the bead density appears higher in the first case. The
substrates were all imaged in at least four regions per substrate and the mean fluorescence
intensity (MFI), taken to be a measure of the amount of beads in the region, was measured.
Fig. 5.11(b) shows that the MFI of the APTMS-treated substrates is significantly higher
than that of the APTMS-untreated substrates. The APTMS-untreated substrates incubated
with quantum dots nonetheless have a greater MFI than the empty controls. Subjecting the
substrates to a high salt wash did not eliminate the non-specific binding of quantum dots,
suggesting that electrostatic attraction plays a limited role in this process.
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Figure 5.10. Functionalization of silanized substrates with NHS-Alexa.
APTMS-activated substrates were treated with NHS-Alexa, attaching the
fluorophore molecules to the substrate surface through peptide bonds. The
substrates were imaged using epifluorescence and DIC microscopy. a) The image
presented here is representative of the typical level of observed surface deformities,
with the associated nonuniform deposition of Alexa. b) A representative image
showing the nonuniform attachment of Alexa in a flat region of the substrate surface.
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Figure 5.11. Non-specific binding of carboxylated quantum dots to unsilanized
substrates.
a) Carboxylated quantum dots in an EDAC solution were incubated with six
APTMS-treated and six APTMS-untreated substrates. The substrates were then
imaged using epifluorescence, with four regions per substrate. A comparison of
silanized and unsilanized substrates shows that quantum dots are present on
unsilanized gels, but at a lower density that for silanized gels. b) Mean fluorescence
intensity (MFI), as a measure of the quantity of quantum dots on the substrate
surface, was determined using ImageJ (𝑛 = 24). Empty substrates, with no
chemical treatments, were used as a measure of background fluorescence. The MFI
of silanized substrates treated with quantum dots was significantly different from
the MFI of unsilanized substrates (Two-tailed T-Test, 𝑃 < 0.001). The MFI of
APTMS-free substrates incubated with quantum dots was also significantly
different from that of empty control substrates (Two-tailed T-Test, 𝑃 < 0.001).

173

a)

b)

174

5.6 TIRF-compatible TFM substrates: Discussion
Efficient clearance of cells undergoing programmed cell death by efferocytosis is
essential for maintaining homeostasis, regulating tissue inflammation and remodeling, and
resolving intracellular infections. The means by which apoptotic cells recruit efferocytic
cell types and are recognized by their membrane receptors have been studied extensively.
The subsequent internalization of apoptotic cells by efferocytes is, however, largely
uncharacterized and has been speculated to be governed by the same biophysical
mechanisms as phagocytic engulfment. In both processes, successful internalization is
mediated by cytoskeleton-driven forces applied to the target at the site of engulfment. The
complex relationship between cellular mechanisms of force generation and receptor
diffusion, however, remains poorly understood. In this study, we sought to manufacture
TIRF-compatible TFM substrates, functionalized for eventual use in simultaneously
investigating forces, force-generating mechanisms, and CD93 receptor diffusion in
frustrated efferocytosis.
Substrates suitable for use with TIRF microscopy were successfully manufactured
using QGel920, a silicone material with a high refractive index. The gels had a uniform,
reproducible thickness of approximately 10 μm. The initial method of functionalization
was adapted from the work of Gutierrez et al., who reported the use of QGel920 for making
TIRF-compatible TFM gels with covalently-linked quantum dots and fibronectin277. We
were unable to properly functionalize the substrates with covalently-attached quantum dots
and receptor antibodies using this method. An improved substrate silanization technique
was therefore first established. A uniformly-distributed monolayer of fluorescent quantum
dots was then successfully attached to the substrate surface. Attempts to functionalize the
surface with antibodies, however, were unsuccessful. Furthermore, the gel surface was
found to be very susceptible to the non-specific adsorption of quantum dots. We therefore
established that QGel920 substrates cannot be used for reliable traction force
measurements.
Oxidized silicone substrates can be functionalized with primary amino groups by
silane coupling agents, deposited in either the liquid or the vapor phase278. We tried using
both techniques to silanize QGel920 gels with APTMS, the chemical used by Gutierrez et
al. to treat the substrates66. As the silanization protocol employed by Gutierrez et al. was
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not described in their study, we attempted both liquid and vapor-phase deposition methods,
and were able to successfully silanize the substrates using chemical vapor deposition66. The
failure of the liquid-phase treatment to produce usable gels may be attributed to a number
of potential factors. The amount of 𝐻2 𝑂 present, silane concentration, temperature and
duration of treatment, choice of solvents, and substrate rinsing and drying conditions have
all been reported to influence the success of liquid-phase silanization278–281. The amount of
water in the reaction governs the rate of polymerization of aminosilanes at the surface and
in the solvent. Trace amounts of water are necessary, as without them the desired reaction
cannot take place281. Excess water, however, results in the formation of aminosilane
oligomers in the solvent and disorganized multilayers on the surface278. Keeping the
APTMS concentration low and performing the reaction at room temperature are two
measures believed to curb the aggregation of the agent in the solvent by preventing excess
collisions278,281. Rinsing the substrates with water following treatment has been found to
remove molecules hydrogen bonded to the surface278,280.
Toluene was chosen as the solvent in this study as it has been used successfully in
prior studies to dissolve aminosilanes279,280. Neither a high APTMS concentration nor a
high reaction temperature were used, and the substrates were adequately rinsed. The
protocol employed, however, did not remove excess water from the reaction, which should
ideally be performed under nitrogen gas. As such, the cloudy appearance of the substrates
following a liquid-phase treatment could be attributed to excess vertical polymerization,
wherein molecules in solution react with bound molecules on the substrate surface, and to
the deposition of pre-formed aminosilane oligomers and polymers on the gel278,280,281. An
improvement might therefore be achieved by working in a nitrogen atmosphere and
distilling the silane reagent prior to use. Even under optimal conditions, however, it has
been shown that liquid-phase treatment with APTMS can result in the formation of
multilayers, whose thickness is affected by humidity and reagent impurities278.
Chemical vapor deposition (CVD) is a superior method of silanization. Vaporphase treatments with APTMS have been reported to result in the formation of monolayers,
as opposed to the multilayers that arise from a liquid-phase approach278. CVD does not
require a solvent, involves no direct contact between the silane agent and the substrates
and, by virtue of the use of near-vacuum conditions, eliminates excess water from the
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reaction. As shown by Zhu et al., reagent impurities and humidity have less of an effect on
vapor-phase silanization, resulting in more reproducible substrates278. Pre-formed
oligomers and polymers in the aminosilane reagents have a negligible evaporation rate
when compared to single molecules of aminosilanes. Such aggregates are therefore
excluded from the reaction and prevented from depositing on the silicone surface.
Combined, these phenomena help to explain why the vapor-phase treatment of QGel920
substrates with APTMS was more successful than liquid-phase deposition. While not all
the aminosilanes covalently bind to the surface, post-CVD rinsing with water promotes the
formation of siloxane bonds and discourages hydrogen bonding278. Future treatments with
APTMS could therefore incorporate a rinsing and drying step for the CVD-processed gels.
Silanized QGel920 gels, rich in surface primary amino groups, were successfully
coated with a monolayer of covalently-attached quantum dots using a carbodiimide
crosslinking agent, EDAC. A significantly smaller number of beads was, however, found
to adhere non-specifically to the substrate surface and could not be disturbed under highsalt conditions. Despite identical treatment methods, the issue of non-specific adsorption
was not addressed by Gutierrez and colleagues in their study66. It is unlikely that this nonspecific binding of quantum dots poses a significant problem for TIRF measurements, since
it is not expected to alter the refractive index of the underlying silicone substrate. Such
non-specific adsorption is, however, very problematic for successful TFM, as changes in
marker position must reflect local substrate deformations for accurate traction force
microscopy. Since the adhesion strength of non-covalently bound beads is unknown, it is
difficult to predict their behavior in response to force-induced motion of the surface.
Specifically, the phagocytic forces exerted on the substrate by the cell may overcome these
non-specific interactions, thus separating the motion of non-covalently bound beads from
the underlying deformations of the substrate. The strength of these interactions could, in
principle, be assessed; for example, by using a microfluidic device. If the interactions of
the beads with the substrate are found to be sufficiently strong, changes in their positions
could be assumed to reflect real cellular tractions. Alternatively, the problem could be
overcome by casting the quantum dots directly into the gels, as was done in earlier TFM
protocols. Without a successful removal of the non-specifically bound beads from the
substrate surface, or a successful characterization of the strengths of their interactions,
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TFM measurements using these substrates cannot be deemed reliable.
Techniques for immobilization of antibodies on silanized or otherwise-prepared
substrates have been in development for over twenty years282. Antibodies have been bound
to substrates via non-specific adsorption, covalent cross-linking, immobilized antibodybinding proteins and avidin-biotin interactions282–284. For the immobilized antibodies to
retain their full functionality, they must be bound in the correct orientation, have an easilyaccessible antigen-binding site, and retain their conformational stability, with minimal
denaturing upon surface contact. While simple, the non-specific adsorption of antibodies
has been shown to result in protein denaturation and unstable binding with a random
orientation282,284.
Immobilization of antibodies using heterobifunctional crosslinking agents, such as
EDAC, yields a more stable coating. The most common method employs EDAC to activate
carboxyl groups on a prepared surface, turning them into unstable intermediates that react
with primary amino groups of antibodies. Amino groups, however, are present throughout
the antibody structure, so the orientation of amine-coupled antibodies remains random and
their active sites are frequently unavailable for molecular binding282. Glutaraldehyde(GA)assisted crosslinking, wherein GA first reacts with primary amines on silanized materials
and then with those of the proteins, likewise links proteins to the surface in a random
orientation285,286
An alternative crosslinking technique, which was attempted unsuccessfully in this
study, uses EDAC to activate the carboxyl groups of proteins, then binding them to primary
amino groups on a silanized surface283,287. This technique likewise suffers from the
immobilization of the antibodies in a random orientation. We did not observe successful
functionalization of silanized substrates with EDAC-activated antibodies, despite a prior
report describing the coating of QGel920 with EDAC-activated fibronectin66. The
antibodies were found to deposit nonuniformly and displayed insufficient functionality to
engage the cells in frustrated phagocytosis. The non-uniform deposition might be due to
the crosslinking of carboxyl groups on the antibodies to primary amines on other antibody
molecules and the formation of complexes, which could then covalently or non-specifically
adhere to the gel283. Crosslinked antibody oligomers could also help explain the inability
of the antibodies to engage the cells, since the active sites of antibodies in these oligomers
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could easily be obscured. It can be speculated that antibody-antibody crosslinking
dominates the reaction at the tested concentrations and might be alleviated at a greater
dilution, where the antibody molecules are be less likely to encounter each other. A 50𝑋
decrease in antibody concentration, however, resulted in no observable change in the
deposition patterns.
A number of studies have reported EDAC-induced immobilization of carboxyllinked antibodies on substrates287–289. In 2012, Vashist used EDAC (0.04 mg/ml) to
activate carboxyl groups of anti-human fetuin A antibodies (0.1 mg/ml), binding them to a
silanized silicone surface287. The antibodies were subsequently shown to be functional,
though their distribution on the substrates was not assessed. The same lab group later
employed this method to link anti-human lipocalin-2 antibodies to silanized microtiter
plates288. A 2012 study by Oliveros et al. also used EDAC to bind anti-myoglobin
antibodies to silanized silicon carbide substrates, stabilizing the reaction intermediates with
sulfo-NHS289. Oliveros and colleagues then used AFM to measure the surface uniformity.
Covalently-immobilized antibodies appeared to be distributed uniformly, while the
distribution of non-specifically adsorbed antibodies was more variable, with visible empty
gaps. This suggests that the non-uniform patterns of antibodies observed on our QGel920
substrates may be the result of their preferential non-specific adsorption to the gel, even in
the presence of EDAC.
Attempts to functionalize the substrate surface with sulfo-NHS-biotin yielded no
consistent results. Our preliminary tests suggest, however, that treatment of silanized gels
with reagents containing sulfo-NHS or NHS functional groups may lead to the
development of local deformities on the substrate surface. The reasons for this are unclear
and further tests would be required to confirm this effect. It is possible that something in
the QGel920 polymer, the exact composition of which is unknown, reacts with sulfo-NHS
and NHS esters, causing crater-like deformities to appear.
Several alternative means of immobilizing antibodies on the QGel920 surface could
be pursued in the future. Site-specific immobilization could be performed by attaching
antibodies to surface primary amino groups through oxidized oligosaccharide moieties on
the antibodies282. This method, however, also runs the risk of generating intermolecular
coupling between the antibodies themselves. A novel bifunctional linker for

179

immobilization of proteins, ProlinkerTM, has been developed from calixarene molecules by
Lee et al.290. ProlinkerTM can be chemically attached to primary-amine-containing surfaces
and has been shown by Soler et al. to bind antibodies in a proper orientation291. It would
be interesting to test ProlinkerTM on silanized QGel920 substrates.
In our preliminary experiments with QGel920, TIRF-compatible substrates of
uniform thickness were successfully produced, silanized and coated with covalentlyattached fluorescent quantum dots. Further troubleshooting of the functionalization
protocol is necessary to eliminate non-specific binding and immobilize functional antibody
molecules on the gel surface. Another silicone material, CY53-276, has been reported to
be TIRF-compatible by Iwadate and Yumura64. Although QGel920 was selected for this
study, experiments with CY53-276 substrates are currently underway in our group.
Activation of the CY53-276 substrates by chemical vapor deposition with a related silane
reagent, 3-aminopropyltriethoxysilane (APTES), has shown promise (Ryan Yip,
unpublished data). These substrates may prove to be more easily functionalized, using
related methods of treatment. Optimization of the preparation of TIRF-compatible TFM
substrates will, in turn, allow us to develop a technique for simultaneously characterizing
the forces, force-generating mechanisms and receptor diffusion in a model of frustrated
efferocytosis.
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Chapter 6
Conclusions
The biophysical mechanisms regulating efferocytic receptors, including the
diffusional control of these receptors, and the means by which such mechanisms modulate
the engulfment of apoptotic cells are poorly understood. In this work, we characterized the
diffusion of CD93, a putative efferocytic receptor. We also made progress towards the
development of a novel method for characterizing the forces involved in efferocytosis. The
long-term aim of this research is to elucidate the relationship between receptor diffusion,
the cytoskeleton, and force generation in efferocytic cells during apoptotic engulfment.
The motion of CD93 in resting cells was found to be complex and affected by
several biophysical factors. Seventy percent of endogenous CD93 molecules in human
monocytes were determined to be relatively stably (≥ 8 s) confined in membrane
compartments with a mean radius of 242 ± 7 nm. The average size and lifetimes of these
compartments were consistent with the actin corrals described in the picket-fence
membrane model3. Twenty six percent of the CD93 molecules underwent anomalous
diffusion unrestricted by such corrals, with a mean early-time diffusion coefficient of
0.07 ± 0.01 µm2/s, which was consistent with the coefficients observed for other immune
receptors55,58. From the shape of their extended MSD curves and ensemble van Hove
functions, both confined and free CD93 molecules were found to undergo anomalous
diffusion. All populations of CD93 displayed subdiffusive behavior, with motion that
became increasingly subdiffusive with decreasing corral size. These trends were observed
in both primary human monocytes and CHO cells expressing human CD93. Unlike
monocytes, however, CHO cells did not shed CD93 following treatment with a sheddinginducing agent, suggesting the absence of the metalloprotease responsible for the cleavage
of CD93 from CHO cells232,214.
Using the cage effect analysis to characterize the correlations between successive
motion steps, we demonstrated that confined CD93 molecules in both CHO and monocyte
cells were temporarily caged over time-scales shorter than that of their confinement by the
actin corrals203. This analysis indicated that there was no characteristic size for these
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“temporary” cages, but did demonstrate that CD93 molecules confined to smaller
membrane compartments to be trapped in stronger, longer-lasting cages. Unlike confined
CD93, freely diffusing CD93 molecules were found to experience very short-lived (≤ 0.5
s) caging, indication a potential distinct trapping mechanism. While the identity of these
short-lived cages is yet to be determined, it may be attributable to lipid rafts267. The cages
of confined CD93 molecules may likewise be the result of their interactions with lipid rafts
or may be formed by other membrane microstructures or co-confined molecules.
The diffusion of CD93 in CHO cells was found to exhibit several features of a
subdiffusive continuous time random walk, characterized by a series of temporary
immobilization events and a dependence on the total measurement time over which the
system was observed5,242. The confinement of CD93 in membrane compartments did not
influence the underlying CTRW behavior, as the motion of free and confined CD93
molecules was consistent with the predictions for unconfined and confined CTRWs
respectively. The immobilization events that give rise to the CTRW behavior may be the
result of interactions between CD93 molecules and one or more macromolecular
complexes, or with the cytoskeleton itself5,258,265. Future experiments on CD93 diffusion
will focus on identifying these interactions, as well as on evaluating the role that lipid rafts
and other membrane constituents may play in the caging of CD93.
The second objective of this research was to work towards the development of a
novel method for studying receptor diffusion and simultaneously quantifying the forces
generated in living efferocytic cells during engulfment. Our intended approach was to
create traction force microscopy (TFM) substrates compatible with total internal reflection
fluorescence (TIRF) microscopy and functionalized for use in frustrated efferocytosis.
Such substrates would enable the molecular tracking of CD93 and other receptors, while
allowing for the simultaneous study of the forces and force-generating mechanisms in
efferocytic cells.
We successfully manufactured TIRF-compatible TFM substrates with a uniform,
reproducible thickness of approximately 10 µm using QGel920, a silicone material with a
high refractive index. To activate the surface of the substrates for subsequent
functionalization, they were treated with a silane coupling agent using chemical vapor
deposition. The substrates were then successfully coated with a uniformly-distributed
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monolayer of quantum dots. Attempts to functionalize the substrate surface with antibodies
were, however, unsuccessful, even when a previously reported method was used66.
Furthermore, contrary to a prior report, we found the gel surface to be very susceptible to
the non-specific adsorption of quantum dots66. We concluded that QGel920 substrates were
unsuitable for reliable measurements of forces involved in efferocytosis.
Further work on the development of functionalized TIRF-compatible TFM
substrates may, in the future, lead to the development of a successful frustrated
efferocytosis system compatible with both diffusion and force measurements. To this end,
experiments with a different silicone substrate, CY53-276, are currently underway in our
group64. An improved knowledge of CD93 diffusion, together with the ability to assess
both the changes in its motion and the associated forces exerted by the efferocytes during
apoptotic cell engulfment, could help us understand the interplay between receptor
diffusion, the cytoskeleton, and force-generation in this process. A greater understanding
of the biophysical mechanisms underlying efferocytosis could, in turn, identify potential
therapeutic targets for the treatment of associated disease.
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